	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S18-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
S95-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S95-BMJ_2010_Apr_29_340_c1640	['maternal exposure and health of offspring\nthis report adds to other work SHOWING that maternal exposure to ambient ultraviolet radiation during Pregnancy MIGHT INFLUENCE subsequent health in the offspring.30313233in a new zealand Birth cohort, infants whose mothers were exposed to peak sunshine during the first Trimester were significantly heavier at Birth than infants whose mothers experienced trough levels of sunshine during the same trimester.30in the united kingdom, maternal ambient Ultraviolet B exposure in the third trimester HAS BEEN positively RELATED to bone Mineral density and content at age 9 in offspring.34there is now GROWING INTEREST in the ROLE of maternal Vitamin D deficiency in Pregnancy and the Development of Central Nervous System and Immune disorders, PARTICULARLY schizophrenia,33type 1 diabetes, and other disorders.35ALTHOUGH active Vitamin D3Concentrations in the mother increase substantially during Pregnancy, early fetal supplies are lower36and directly DEPENDENT on the mother.']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 538), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 639), ('SUPERFICIAL_RELATIONSHIP', 663), ('IMPORTANT_CONSIDERATION', 782), ('ANOMALY_CURIOUS_FINDING', 848), ('SUPERFICIAL_RELATIONSHIP', 991)]	10	[('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0009294', 'DNA mediated transformation', 313, 'trimester'), ('GO_0007567', 'parturition', 353, 'birth'), ('CHEBI_72754', 'bisphenol AF', 492, 'ultraviolet B'), ('CHEBI_46662', 'mineral', 574, 'mineral'), ('CHEBI_27300', 'vitamin D', 680, 'vitamin D'), ('GO_0007565', 'female pregnancy', 704, 'pregnancy'), ('GO_0008289', 'lipid binding', 722, 'development'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 737, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 737, 'central nervous system'), ('UBERON_0002405', 'immune system', 764, 'immune'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 866, 'vitamin D3concentrations'), ('GO_0007565', 'female pregnancy', 935, 'pregnancy')]
S99-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
S100-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S100-BMJ_2010_Apr_29_340_c1640	['the first trimester is also a sensitive period with regard to Prenatal Thymocyte differentiation, with Animal STUDIES SHOWING that chemicals such as Dioxin CAN alter this process, disrupt the development of central tolerance, and LEAD TO increased auto-reactive Peripheral T Cells.49FURTHERMORE, indirect EFFECTS of Vitamin D SHOULD BE CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 230), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('FUTURE_WORK', 326), ('FUTURE_WORK', 336)]	8	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CL_0000893', 'thymocyte', 71, 'thymocyte'), ('NCBITaxon_33208', 'Metazoa', 103, 'animal'), ('CHEBI_4553', 'dihydroanhydropodorhizol', 149, 'dioxin'), ('CL_0000111', 'peripheral neuron', 262, 'peripheral T cells'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin D')]
S101-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S101-BMJ_2010_Apr_29_340_c1640	['for example, Vitamin D can down-regulate Interleukin 6, an IMPORTANT mediator of the adverse EFFECT of maternal infection during Pregnancy on neural development in the fetus.505152\n\nPrenatal and Postnatal timing\nour results do not INDICATE that the POSSIBLE beneficial EFFECT of Ultraviolet radiation exposure is confined ONLY to the Prenatal period.']	[('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000008988', 'interleukin-1 family member 5', 41, 'interleukin 6'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'Prenatal'), ('GO_0007567', 'parturition', 195, 'postnatal'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 279, 'ultraviolet'), ('GO_0007565', 'female pregnancy', 334, 'prenatal')]
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
S153-PMC1281283	PMC1281283	10/2005	S153-PMC1281283	['HOWEVER, fish also contain Nutrients such as iron, Vitamin E, Selenium, and Long-Chain N-3 polyunsaturated Fatty Acids that MAY benefit Brain development (clarkson and strain 2003;national research council 2000;neuringer et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_33284', 'nutrient', 27, 'nutrients'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 62, 'selenium'), ('CHEBI_32805', 'cis-aconitic acid', 76, 'long-chain n-3'), ('CHEBI_35366', 'fatty acid', 107, 'fatty acids'), ('UBERON_0000955', 'brain', 136, 'brain')]
S0-PMC2396486	PMC2396486	6/2008	S0-PMC2396486	['Protein Expression in the Nucleus accumbens of Rats exposed to developmental Vitamin D deficiency\n\nabstract\n\nintroduction\ndevelopmental Vitamin D (Dvd) deficiency is a CANDIDATE risk factor for schizophrenia.']	[('INCOMPLETE_EVIDENCE', 168)]	1	[('GO_0045053', 'protein retention in Golgi apparatus', 0, 'Protein Expression'), ('GO_0005634', 'nucleus', 26, 'Nucleus'), ('NCBITaxon_10088', 'Mus <genus>', 47, 'Rats'), ('CHEBI_28384', 'vitamin K', 77, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 77, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 147, 'DVD')]
S10-PMC2396486	PMC2396486	6/2008	S10-PMC2396486	['conclusions\ndevelopmental Vitamin D deficiency was ASSOCIATED with subtle changes in protein Expression in the nucleus accumbens.']	[('SUPERFICIAL_RELATIONSHIP', 51)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0010467', 'gene expression', 93, 'expression')]
S11-PMC2396486	PMC2396486	6/2008	S11-PMC2396486	['disruptions in pathways RELATED to calcium-binding proteins and Mitochondrial function MAY underlie SOME of the behavioural features ASSOCIATED with Animal MODELS of developmental Vitamin D deficiency\n\nintroduction\nbased on CLUES from epidemiology, we have PROPOSED that low Prenatal Vitamin D MAY BE a risk factor for later development of schizophrenia[1].']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 294)]	8	[('GO_0005739', 'mitochondrion', 64, 'mitochondrial'), ('NCBITaxon_33208', 'Metazoa', 149, 'animal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
S97-PMC2396486	PMC2396486	6/2008	S97-PMC2396486	['discussion\ndevelopmental Vitamin D deficiency is ASSOCIATED with a subtle alteration in the Expression of protein INVOLVED in functions RELATED to calcium binding proteins, and Mitochondrial functioning.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0010467', 'gene expression', 92, 'expression'), ('GO_0005739', 'mitochondrion', 177, 'mitochondrial')]
S131-PMC2396486	PMC2396486	6/2008	S131-PMC2396486	['in conclusion, developmental Vitamin D deficiency is ASSOCIATED with subtle changes in a range of proteins in the nucleus accumbens.']	[('SUPERFICIAL_RELATIONSHIP', 53)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
S133-PMC2396486	PMC2396486	6/2008	S133-PMC2396486	['combined with OTHER experimental findings, THE CURRENT STUDY LENDS FURTHER CREDIBILITY to the NOTION that developmental Vitamin D deficiency IMPACTS adversely on normal Brain Development[30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007420', 'brain development', 169, 'brain development'), ('UBERON_0000955', 'brain', 169, 'brain')]
S13-PMC2405769	PMC2405769	5/2008	S13-PMC2405769	['background\nmultivitamin-Mineral supplementation is RECOMMENDED before and during Pregnancy to ensure adequate intake of several KEY Nutrients including Folate, iron, and more RECENTLY Vitamin D – all of which have IMPORTANCE among Pregnant women, women of Childbearing age, and during Fetal Development [1-6].']	[('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_46662', 'mineral', 24, 'mineral'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('CHEBI_33284', 'nutrient', 132, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 152, 'folate'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnant'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 256, 'childbearing'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 285, 'fetal development')]
S4-PMC2581757	PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]
S14-PMC2581757	PMC2581757	11/2008	S14-PMC2581757	['in preeclampsia, an inverse CORRELATION between Vitamin E levels and Lipid peroxidation HAS BEEN FOUND [10] SUGGESTING that Vitamin E content in Plasma MAY BE used as a prognostic MARKER of the LIKELY development of Preeclampsia [11].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 180), ('PROBABLE_UNDERSTANDING', 194)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin E'), ('CHEBI_18059', 'lipid', 69, 'lipid'), ('GO_0006266', 'DNA ligation', 69, 'lipid'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 145, 'plasma'), ('GO_0007128', 'meiotic prophase I', 216, 'preeclampsia')]
S18-PMC2581757	PMC2581757	11/2008	S18-PMC2581757	['the latter study does not SUPPORT the HYPOTHESIS of a causal RELATIONSHIP between decreased dietary Vitamin E consumption and Plasma levels and the development of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 100, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 126, 'plasma'), ('GO_0007128', 'meiotic prophase I', 163, 'preeclampsia')]
S195-PMC2581757	PMC2581757	11/2008	S195-PMC2581757	['we FOUND that the patients supplemented with Vitamin C 1000\xa0mg plus Vitamin E 400\xa0iu daily from the second Trimester of Pregnancy until Delivery showed improvements in certain biochemical indices during the Development Of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin E'), ('GO_0009294', 'DNA mediated transformation', 107, 'trimester'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('GO_0007567', 'parturition', 136, 'delivery'), ('GO_0070483', 'detection of hypoxia', 207, 'development of preeclampsia')]
S198-PMC2581757	PMC2581757	11/2008	S198-PMC2581757	['the activities of antioxidant enzymes were also INFLUENCED by the use of Vitamins C and E. the reduction of sod activity during the development of Preeclampsia was controlled as a CONSEQUENCE of Vitamin consumption: the decrease was FOUND TO BE 14% WHEREAS it was 23% in patients who had not used Vitamins C and E. the most prominent EFFECT of the use of these Vitamins was FOUND TO BE ASSOCIATED with the activity of Glutathione reductase.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('SUPERFICIAL_RELATIONSHIP', 334), ('ANOMALY_CURIOUS_FINDING', 374), ('SUPERFICIAL_RELATIONSHIP', 386)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamins C'), ('PR_000004900', 'complement C3', 82, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 88, 'E'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia'), ('CHEBI_33229', 'vitamin (role)', 195, 'vitamin'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('PR_000004900', 'complement C3', 306, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 312, 'E'), ('CHEBI_33277', 'gamma-tocotrienol', 361, 'vitamins'), ('CHEBI_16856', 'glutathione', 418, 'glutathione')]
S200-PMC2581757	PMC2581757	11/2008	S200-PMC2581757	['THUS, we conclude that use of Vitamins C and E DEFINITELY Controls certain IMPORTANT biochemical indices during the development of Preeclampsia, and that FURTHER STUDIES ARE NEEDED to DEVELOP STRATEGIES for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 47), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 154), ('FUTURE_WORK', 162), ('FUTURE_WORK', 184), ('FUTURE_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 211), ('IMPORTANT_CONSIDERATION', 255)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamins C'), ('PR_000004900', 'complement C3', 39, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('GO_0065007', 'biological regulation', 58, 'controls'), ('GO_0007128', 'meiotic prophase I', 131, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 225, 'preeclampsia')]
S21-PMC2582131	PMC2582131	11/2008	S21-PMC2582131	['data on the ROLE of Vitamin D in Glucose Homeostasis during Pregnancy and the development of Gestational Diabetes Mellitus (gdm) are SCANT and findings are INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_17234', 'glucose', 33, 'glucose'), ('GO_0042593', 'glucose homeostasis', 33, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0035193', 'larval central nervous system remodeling', 93, 'gestational diabetes mellitus')]
S8-PMC2685863	PMC2685863	5/2009	S8-PMC2685863	['the next step is determining HOW Vitamin D and Hla-Drb1*15 MIGHT INTERACT to Modulate the Autoimmune nature of ms. epidemiologic and Animal studies of ms POINT TO involvement of the Thymus Gland early in development.']	[('EXPLICIT_QUESTION', 29), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 47, 'HLA-DRB1'), ('GO_0065007', 'biological regulation', 77, 'modulate'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 133, 'animal'), ('UBERON_0002370', 'thymus', 182, 'thymus gland')]
S117-PMC2722583	PMC2722583	1/2009	S117-PMC2722583	['iron deficiency is an IMPORTANT RISK FACTOR for increased maternal mortality, low Birth weight and Preterm Delivery (brabin et al 2001) and the availability of calcium, Iodine, Folate and Vitamins A and D MAY Modulate fetal development (bartley et al 2005).']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('CHEBI_24859', 'iodine atom', 169, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 177, 'folate'), ('CHEBI_27300', 'vitamin D', 188, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('GO_0065007', 'biological regulation', 209, 'modulate')]
S11-PMC2841444	PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
S34-PMC2872349	PMC2872349	4/2010	S34-PMC2872349	['rickets has served as a longstanding example of an adverse Early Life environment, in the form of Vitamin D deficiency, disrupting the process of Bone Development and untreated CAN LEAD TO persistent changes in the child’s bone structure.']	[('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('UBERON_0001847', 'lobule of pinna', 59, 'early life'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0048539', 'bone marrow development', 146, 'bone development')]
S144-PMC2872349	PMC2872349	4/2010	S144-PMC2872349	['the maternal Vitamin D in osteoporosis study (mavidos) is a randomized controlled trial TO INVESTIGATE WHETHER supplementation of Vitamin D during Pregnancy serves to optimize offspring Skeletal Development, and commenced recruitment in 2008.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	2	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0001501', 'skeletal system development', 186, 'skeletal development'), ('UBERON_0004288', 'skeleton', 186, 'skeletal')]
S128-PMC2873552	PMC2873552	4/2010	S128-PMC2873552	"[""caption (table-wrap): table 2\n\nfunctions and diseases related to both ceu and yri Signaturesceuyri diabetes 1.70e-172.70e-20 Coronary Artery disease 3.78e-173.12e-13 Genetic disorder 1.09e-144.53e-14 Cardiovascular disease 1.34e-144.78e-11 non-Insulin-dependent diabetes mellitus 1.03e-128.66e-15 Endocrine System disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 Neurological disorder 2.49e-123.27e-12 crohn's disease 7.59e-127.25e-09 bipolar affective disease 3.50e-115.24e-09 Metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 Digestive System disorder 2.66e-091.31e-07 Skeletal and muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 Autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 shape change of Epithelial Cells 8.86e-07 alzheimer's disease 3.60e-062.27e-07 parkinson's disease 7.24e-065.29e-06 shape change of Dermal Cells 9.33e-06 Insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\n\nVitamin D HYPOTHESIS\nan INTERESTING HYPOTHESIS HAS BEEN PROPOSED by mcgrace [28] claiming that low Prenatal Vitamin D increases the risk of a wide range of diseases such as multiple sclerosis, diabetes, schizophrenia, Prostate cancer, Breast cancer and Colorectal cancer because of its versatile function in normal development.""]"	[('INCOMPLETE_EVIDENCE', 1099), ('ANOMALY_CURIOUS_FINDING', 1113), ('INCOMPLETE_EVIDENCE', 1125), ('INCOMPLETE_EVIDENCE', 1136), ('INCOMPLETE_EVIDENCE', 1145)]	5	[('GO_0036367', 'light adaption', 82, 'signaturesCEUYRI'), ('UBERON_0001621', 'coronary artery', 125, 'Coronary artery'), ('SO_0000704', 'gene', 166, 'Genetic'), ('UBERON_0004535', 'cardiovascular system', 200, 'Cardiovascular'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('UBERON_0000949', 'endocrine system', 297, 'Endocrine system'), ('UBERON_0001016', 'nervous system', 370, 'Neurological'), ('GO_0008152', 'metabolic process', 485, 'Metabolic'), ('UBERON_0004854', 'gastrointestinal system mesentery', 560, 'Digestive system'), ('UBERON_0004288', 'skeleton', 603, 'Skeletal'), ('UBERON_0005445', 'segment of pes', 697, 'Autoimmune'), ('CL_0000066', 'epithelial cell', 827, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 827, 'epithelial'), ('CL_0000346', 'hair follicle dermal papilla cell', 943, 'dermal cells'), ('PR_000045358', 'insulin family protein', 965, 'Insulin'), ('CHEBI_28384', 'vitamin K', 1089, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1188, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1197, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 1307, 'prostate'), ('UBERON_0000310', 'breast', 1324, 'breast'), ('UBERON_0012652', 'colorectum', 1342, 'colorectal')]
S131-PMC2873552	PMC2873552	4/2010	S131-PMC2873552	"[""second, in addition to mcgrace's list of diseases, Animal MODEL studies and epidemiological surveys have FURTHER LINKED Vitamin D insufficiency to Cardiovascular disease and Inflammatory Bowel disease [17,30,31], as well as abnormal Brain Development [31].""]"	[('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('NCBITaxon_33208', 'Metazoa', 51, 'animal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 147, 'cardiovascular'), ('UBERON_0001782', 'pigmented layer of retina', 174, 'inflammatory bowel'), ('GO_0007420', 'brain development', 233, 'brain development'), ('UBERON_0000955', 'brain', 233, 'brain')]
S137-PMC2873552	PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]
S0-PMC2889879	PMC2889879	5/2010	S0-PMC2889879	['dietary Intake of fish, Omega-3, Omega-6 polyunsaturated Fatty Acids and Vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population\n\nabstract\n\nbackground\nlow intake of fish, polyunsaturated Fatty Acids (pufa) and Vitamin D deficiency HAS BEEN SUGGESTED to play a ROLE in the development of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 287), ('SUPERFICIAL_RELATIONSHIP', 316)]	2	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_79370', 'ibho#10', 24, 'omega-3'), ('CHEBI_79370', 'ibho#10', 33, 'omega-6'), ('CHEBI_35366', 'fatty acid', 57, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 243, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D')]
S26-PMC2889879	PMC2889879	5/2010	S26-PMC2889879	['fatty fish is a rich dietary source of essential Fatty Acids and Vitamin D, both of which COULD BE IMPLICATED in the development of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_35366', 'fatty acid', 49, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
S136-PMC2889879	PMC2889879	5/2010	S136-PMC2889879	['Prenatal Vitamin D deficiency has been PROPOSED to be a risk factor for the development of schizophrenia [12].']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
S146-PMC2889879	PMC2889879	5/2010	S146-PMC2889879	['our results of the PROTECTIVE EFFECT of fatty fish COULD IN PART be due to the content of Vitamin D. WHILE the epidemiological EVIDENCE LINKING low Prenatal Vitamin D and schizophrenia REMAINS INCONCLUSIVE, Rodent MODELS have provided COMPELLING EVIDENCE about the ROLE of Vitamin D deficiency for Brain Development like larger lateral volumes [36], subtle Memory dysfunction and altered attention processing [37] which have IMPLICATIONS for neuropsychiatric disorders.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 235), ('SUPERFICIAL_RELATIONSHIP', 265), ('IMPORTANT_CONSIDERATION', 425)]	13	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'prenatal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 207, 'rodent'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('GO_0007420', 'brain development', 298, 'brain development'), ('UBERON_0000955', 'brain', 298, 'brain'), ('GO_0007613', 'memory', 357, 'memory')]
S138-PMC2963768	PMC2963768	10/2010	S138-PMC2963768	['beyond rickets, SPECULATION abounds regarding the POTENTIAL Extra-Skeletal CONSEQUENCES of suboptimal Vitamin D status during Foetal Development and infancy.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 50), ('PROBLEM_COMPLICATION', 75)]	3	[('UBERON_0005614', 'lens anterior epithelium', 60, 'extra'), ('UBERON_0004288', 'skeleton', 66, 'skeletal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0060324', 'face development', 126, 'foetal development')]
S103-PMC2996405	PMC2996405	11/2010	S103-PMC2996405	['an IMPORTANT factor HYPOTHESIZED to be both latitude DEPENDENT and Neural Development-RELATED is Vitamin D. we checked for an enrichment of lrgs in Vitamin D related (vdr) Genes by manually creating a list of 943 Genes that broadly comprised the most IMPORTANT processes in which it is INVOLVED, since a comprehensive list is not yet present in the literature (additional file4).']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 286)]	6	[('GO_0007399', 'nervous system development', 67, 'neural development'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 148, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 148, 'Vitamin'), ('SO_0000704', 'gene', 172, 'genes'), ('SO_0000704', 'gene', 213, 'genes')]
S147-PMC2996405	PMC2996405	11/2010	S147-PMC2996405	['searching for a mechanism that COULD CONNECT latitude and schizophrenia at a molecular level, we reasoned that a well-known phenomenon separately LINKED to both of them is Vitamin D. indeed, Vitamin D is ESSENTIAL for normal growth, calcium absorption and Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 146), ('IMPORTANT_CONSIDERATION', 204)]	4	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0001501', 'skeletal system development', 256, 'skeletal development'), ('UBERON_0004288', 'skeleton', 256, 'skeletal')]
S159-PMC2996405	PMC2996405	11/2010	S159-PMC2996405	['there is GROWING EVIDENCE that low Vitamin D levels adversely IMPACT on Brain Development [52].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain')]
S160-PMC2996405	PMC2996405	11/2010	S160-PMC2996405	['in Mice, it HAS BEEN SUGGESTED that changes in Brain Development induced by Prenatal Vitamin D deficiency LEAD TO specific functional alterations in hippocampal Synaptic plasticity [53].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('NCBITaxon_10088', 'Mus <genus>', 3, 'mice'), ('GO_0007420', 'brain development', 47, 'brain development'), ('UBERON_0000955', 'brain', 47, 'brain'), ('GO_0007565', 'female pregnancy', 76, 'prenatal'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0045202', 'synapse', 161, 'synaptic')]
S167-PMC2996405	PMC2996405	11/2010	S167-PMC2996405	['it is THEREFORE POSSIBLE that the same Genes COULD BE Regulated by Vitamin D levels also in Neurons during Brain Development that, in turn, HAVE BEEN ASSOCIATED to schizophrenia [47].']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 150)]	5	[('SO_0000704', 'gene', 39, 'genes'), ('GO_0065007', 'biological regulation', 54, 'regulated'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CL_0000540', 'neuron', 92, 'neurons'), ('GO_0007420', 'brain development', 107, 'brain development'), ('UBERON_0000955', 'brain', 107, 'brain')]
S212-PMC2996405	PMC2996405	11/2010	S212-PMC2996405	['as STATED, latitude acts directly OR indirectly, on a WIDE VARIETY of phenomena, THEREFORE it is expected that its EFFECTS are not limited just to Vitamin D and Neural Development.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007399', 'nervous system development', 161, 'neural development')]
S249-PMC2996405	PMC2996405	11/2010	S249-PMC2996405	['conclusions\nwe FOUND that frequencies of Genetic variants INVOLVED in Brain Development, schizophrenia and Vitamin D-RELATED processes significantly vary with latitude.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('SO_0000704', 'gene', 41, 'genetic'), ('GO_0007420', 'brain development', 70, 'brain development'), ('UBERON_0000955', 'brain', 70, 'brain'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
S235-PMC2999828	PMC2999828	3/2009	S235-PMC2999828	['numerous individual Nutrients consumed by the mother during Pregnancy HAVE BEEN SUGGESTED as being preventive for development of atopic diseases in the child; these include apples or fish,[80] Vitamin D,[107] Vitamin E,[108] and various Probiotics, the latter HAVING BEEN SHOWN to be effective in Mouse MODELS [109] and Human studies [110].']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 260), ('INCOMPLETE_EVIDENCE', 303)]	4	[('CHEBI_33284', 'nutrient', 20, 'nutrients'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin E'), ('CHEBI_26346', 'prostaglandins J', 237, 'probiotics'), ('NCBITaxon_10088', 'Mus <genus>', 297, 'mouse'), ('NCBITaxon_9606', 'Homo sapiens', 320, 'human')]
S149-PMC3004407	PMC3004407	12/2010	S149-PMC3004407	['infants who are Vitamin D deficient at Birth are at the highest RISK of impaired bone development [5] that APPEARS to persist in EVEN later childhood [37].']	[('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 129)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007567', 'parturition', 39, 'birth')]
S156-PMC3004407	PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
S30-PMC3034879	PMC3034879	12/2010	S30-PMC3034879	['the first was to follow WHETHER the Vitamin D-ASSOCIATED Skeletal EFFECTS observed at Birth persist during the first year of Life, and the second was TO EVALUATE the IMPACT of Postnatal Vitamin D status on bone growth and development in early infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004288', 'skeleton', 57, 'skeletal'), ('GO_0007567', 'parturition', 86, 'birth'), ('UBERON_0000104', 'life cycle', 125, 'life'), ('GO_0007567', 'parturition', 176, 'postnatal'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
S144-PMC3034879	PMC3034879	12/2010	S144-PMC3034879	['children in high Vitamin D group Learnt to walk with support later than children in low Vitamin D group, ALTHOUGH other developmental milestones were similar.']	[('ANOMALY_CURIOUS_FINDING', 105)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007612', 'learning', 33, 'learnt'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
S75-PMC3039633	PMC3039633	2/2011	S75-PMC3039633	['[30]302 children (australia)1,3(at 4 yrs)stanford-binet intelligence scale strengths and difficulties questionnaireiron vs. placebo20 weeks Gestation to Birth∅ 1,317/21\n1 = Cognitive Development\n2 = Motor Development\n3 = Behavioral Development\n4 = Visual Development\n5 = auditory development\n∅ = no effect of Nutrient(s) on development\n+ = positive EFFECT of Nutrient(s) on development\n- = negative EFFECT of Nutrient(s) on development\nmvm = multivitamin-Mineral\nHchp = high calorie, high protein\nlclp = low calorie, low protein\nmvm-a = multivitamin-Mineral without Vitamin a\nmvm+a = multivitamin-Mineral with Vitamin A\nld = lower dosage\ngiven the heterogeneity of methods and outcome measures in the studies reviewed, it was NOT FEASIBLE to compare effect sizes or to perform a meta-analysis.']	[('SUPERFICIAL_RELATIONSHIP', 349), ('SUPERFICIAL_RELATIONSHIP', 399), ('DIFFICULT_TASK', 726)]	3	[('GO_0007565', 'female pregnancy', 140, 'gestation'), ('GO_0007567', 'parturition', 153, 'birth'), ('GO_0007567', 'parturition', 158, '∅'), ('GO_0050787', 'detoxification of mercury ion', 173, 'cognitive development'), ('GO_0009653', 'anatomical structure morphogenesis', 199, 'motor development'), ('GO_0007420', 'brain development', 221, 'behavioral development'), ('GO_0007506', 'gonadal mesoderm development', 248, 'visual development'), ('CHEBI_33284', 'nutrient', 309, 'nutrient'), ('CHEBI_33284', 'nutrient', 359, 'nutrient'), ('CHEBI_33284', 'nutrient', 409, 'nutrient'), ('CHEBI_46662', 'mineral', 455, 'mineral'), ('CHEBI_17883', 'hydrogen chloride', 463, 'HCHP'), ('CHEBI_46662', 'mineral', 550, 'mineral'), ('CHEBI_33229', 'vitamin (role)', 566, 'vitamin'), ('CHEBI_46662', 'mineral', 597, 'mineral'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 618, 'A')]
S103-PMC3257641	PMC3257641	3/2010	S103-PMC3257641	['low maternal Vitamin D status MAY slow neonatal Cardiac Development [69] and alter Brain morphology [70,71], with changes in the latter persisting into Adulthood [72].']	[('INCOMPLETE_EVIDENCE', 30)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007507', 'heart development', 48, 'cardiac development'), ('UBERON_0000948', 'heart', 48, 'cardiac'), ('UBERON_0000955', 'brain', 83, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 152, 'adulthood')]
S105-PMC3257641	PMC3257641	3/2010	S105-PMC3257641	['Rats receiving very high-dose Vitamin D during Gestation and early development (CONSIDERABLY higher than would be administered to Humans) had adverse changes in elastin content and organization in the Aorta CONSISTENT with increased later risk of hypertension or aneurysm [73].']	[('ANOMALY_CURIOUS_FINDING', 80), ('INCOMPLETE_EVIDENCE', 207)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'gestation'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('UBERON_0000947', 'aorta', 201, 'aorta')]
S122-PMC3257641	PMC3257641	3/2010	S122-PMC3257641	['as Il-10 is IMPORTANT in the development of tolerance to exogenous Antigens and inhibition of Mast Cell Degranulation [57], these FINDINGS are CONSISTENT with the notion of low Vitamin D levels at Birth increasing the risk of an allergic propensity.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 143)]	3	[('PR_000001470', 'interleukin-28B', 3, 'IL-10'), ('CHEBI_59132', 'antigen', 67, 'antigens'), ('CL_0000097', 'mast cell', 94, 'mast cell'), ('GO_0030154', 'cell differentiation', 99, 'cell degranulation'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'birth')]
S152-PMC3257641	PMC3257641	3/2010	S152-PMC3257641	['the MERIT of achieving a relatively high Vitamin D status (>100 nmol/l) has NOT BEEN FULLY ESTABLISHED, particularly in RELATION to offspring Cardiovascular or atopic disease development.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 142, 'cardiovascular')]
S45-PMC3272870	PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
S14-PMC3276895	PMC3276895	11/2011	S14-PMC3276895	['[1]\nFolic Acid (Fa) is a Water-soluble Vitamin B which serves as a Cofactor in many enzymatic reactions RELATED to growth and development, Neuronal function, and Blood Cell production.']	[('SUPERFICIAL_RELATIONSHIP', 104)]	1	[('CHEBI_30751', 'formic acid', 4, 'Folic acid'), ('CHEBI_30751', 'formic acid', 16, 'FA'), ('CHEBI_15377', 'water', 25, 'water'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin B'), ('CHEBI_23357', 'cofactor', 67, 'cofactor'), ('CL_0000540', 'neuron', 139, 'neuronal'), ('CL_0000081', 'blood cell', 162, 'blood cell'), ('UBERON_0000178', 'blood', 162, 'blood')]
S9-PMC3277098	PMC3277098	12/2011	S9-PMC3277098	['aside from Skeletal health, Vitamin D HAS BEEN ASSOCIATED with various cancers and Autoimmune disorders [1] with EVIDENCE FOR a ROLE in development and maintenance of Lung structure and function [3,4,5].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('UBERON_0004288', 'skeleton', 11, 'skeletal'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 83, 'autoimmune'), ('UBERON_0002048', 'lung', 167, 'lung')]
S11-PMC3277098	PMC3277098	12/2011	S11-PMC3277098	['we AIM to review the CURRENT EVIDENCE on Vitamin D in RELATION to Immune mechanisms and FOCUS on the EFFECT of Pregnancy and Early Life exposure on Allergy Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002405', 'immune system', 66, 'immune'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('UBERON_0001847', 'lobule of pinna', 125, 'early life'), ('GO_0060021', 'roof of mouth development', 148, 'allergy development')]
S20-PMC3277098	PMC3277098	12/2011	S20-PMC3277098	['more RECENTLY variations in Vitamin D status and intake HAS BEEN IMPLICATED in Allergy Development and CONSIDERED AS one of a NUMBER OF EXPLANATIONS for epidemiological and immunological ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 103), ('PROBABLE_UNDERSTANDING', 114), ('INCOMPLETE_EVIDENCE', 126), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 187)]	9	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 79, 'allergy development')]
S35-PMC3277098	PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]
S113-PMC3277098	PMC3277098	12/2011	S113-PMC3277098	['WHILE Vitamin D MAY BE ASSOCIATED with the development of wheeze through OTHER mechanisms (seesection 4.3) these REPORTS of wheeze are NOT NECESSARILY RELATED to a true th2-dominant allergic response.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
S198-PMC3277098	PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
S201-PMC3277098	PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
S137-PMC3278486	PMC3278486	1/2012	S137-PMC3278486	"[""comparison with other studies\nour finding of no benefit, BUT a POSSIBLE adverse EFFECT from Folic Acid supplementation on cancer incidence is IN LINE WITH REPORTED results of studies on other Nutrient supplements, including Vitamin E, Β-Carotene (Vitamin-A precursor) or Selenium; all SHOWING no or an adverse EFFECT of supplementation in controlled clinical trials on cancer development.4243a RECENT meta-analysis of Folic Acid supplements by clarke and coworkers, in the ‘b-Vitamin treatment trialists' collaboration’3with individual patient data, FOUND no increased cancer risk in any subgroups.""]"	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 310), ('INCOMPLETE_EVIDENCE', 394), ('INCOMPLETE_EVIDENCE', 550)]	9	[('CHEBI_30751', 'formic acid', 92, 'folic acid'), ('CHEBI_33284', 'nutrient', 192, 'nutrient'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin E'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 235, 'β-carotene'), ('CHEBI_83326', 'tedizolid phosphate', 247, 'vitamin-A'), ('CHEBI_27568', 'selenium atom', 271, 'selenium'), ('CHEBI_30751', 'formic acid', 418, 'folic acid'), ('CHEBI_33229', 'vitamin (role)', 476, 'Vitamin')]
S19-PMC3296991	PMC3296991	2/2012	S19-PMC3296991	['DEMONSTRATED that maternal Vitamin D status CAN INFLUENCE Fetal Femoral Development as early as 19 weeks Gestation [15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007631', 'feeding behavior', 58, 'fetal'), ('GO_0009556', 'microsporogenesis', 64, 'femoral development'), ('UBERON_0000981', 'femur', 64, 'femoral'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
S21-PMC3296991	PMC3296991	2/2012	S21-PMC3296991	['HOWEVER, there are gaps in the understanding of WHETHER AND HOW Vitamin D INFLUENCES fetal Bone Development and WHETHER markers of bone turnover in Cord Blood PREDICT bone Mineral content.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('EXPLICIT_QUESTION', 48), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('EXPLICIT_QUESTION', 112), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0048539', 'bone marrow development', 91, 'bone development'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0000178', 'blood', 153, 'blood'), ('CHEBI_46662', 'mineral', 172, 'mineral')]
S102-PMC3296991	PMC3296991	2/2012	S102-PMC3296991	['because Vitamin D inadequacy during Gestation and its IMPACTS on offspring bone integrity are of PUBLIC HEALTH CONCERN, FURTHER STUDIES ARE WARRANTED to investigate the COMPLEX mechanisms LINKING in utero Vitamin D status to fetal Bone Development.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 120), ('FUTURE_WORK', 128), ('DIFFICULT_TASK', 169), ('SUPERFICIAL_RELATIONSHIP', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0048539', 'bone marrow development', 231, 'bone development')]
S43-PMC3309463	PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
S44-PMC3309463	PMC3309463	6/2011	S44-PMC3309463	['we SPECULATE that (a) developmental Vitamin D deficiency MAY underlie KEY features of the epidemiology of schizophrenia, (b) the Vitamin D deficiency during development decanalizes Brain Development and (c) schizophrenia is a behavioral phenotype ASSOCIATED with increased variance ASSOCIATED with this decanalization of Brain Development.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 247), ('SUPERFICIAL_RELATIONSHIP', 282)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007420', 'brain development', 181, 'brain development'), ('UBERON_0000955', 'brain', 181, 'brain'), ('GO_0007420', 'brain development', 321, 'brain development'), ('UBERON_0000955', 'brain', 321, 'brain')]
S45-PMC3309463	PMC3309463	6/2011	S45-PMC3309463	['we SPECULATE that Prenatal Vitamin D deficiency would be one of many DIFFERENT exposures that COULD decanalize Brain Development and lead TO an increased susceptibility to schizophrenia.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	4	[('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007420', 'brain development', 111, 'brain development'), ('UBERON_0000955', 'brain', 111, 'brain')]
S89-PMC3309463	PMC3309463	6/2011	S89-PMC3309463	['with respect to the epidemiology of schizophrenia, we OUTLINE HOW one CANDIDATE environmental RISK FACTOR, low Prenatal Vitamin D, CAN result in environmental editing of Brain Development.']	[('INCOMPLETE_EVIDENCE', 54), ('EXPLICIT_QUESTION', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 131)]	5	[('GO_0007565', 'female pregnancy', 111, 'prenatal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007420', 'brain development', 170, 'brain development'), ('UBERON_0000955', 'brain', 170, 'brain')]
S60-PMC3319623	PMC3319623	4/2012	S60-PMC3319623	['Animal MODELS of Gestational Vitamin D deficiency HIGHLIGHT the IMPORTANT ROLE of Vitamin D for correct Neurodevelopment[25].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 17, 'gestational'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007399', 'nervous system development', 104, 'neurodevelopment')]
S12-PMC3338544	PMC3338544	4/2012	S12-PMC3338544	['moreover, there is now CONVINCING EXPERIMENTAL EVIDENCE BASED ON a MODEL in sprague-dawley Rats that developmental Vitamin D (Dvd) deficiency is ASSOCIATED with a range of schizophrenia-related neurochemical, neuroanatomical, and behavioural phenotypes[4],[5].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 145)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rats'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD')]
S161-PMC3338544	PMC3338544	4/2012	S161-PMC3338544	['there are AS YET no epidemiological studies DEMONSTRATING a direct ASSOCIATION between autistic spectrum disorders and developmental Vitamin D levels, YET there are EFFECTS of season of Birth, latitude of Birth, and migrant status that MAY INDICATE a POSSIBLE ASSOCIATION (for review,[39]).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 67), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 251), ('SUPERFICIAL_RELATIONSHIP', 260)]	9	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth'), ('GO_0007567', 'parturition', 205, 'birth')]
S162-PMC3338544	PMC3338544	4/2012	S162-PMC3338544	['if FURTHER EVIDENCE CONTINUES to SUPPORT this ASSOCIATION, the Dvd-deficient Mouse MODEL MAY BE utilized to FURTHER EXAMINE the ROLE Vitamin D plays in Brain Development with RELEVANCE to autism.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 108), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 175)]	9	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 63, 'DVD'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007420', 'brain development', 152, 'brain development'), ('UBERON_0000955', 'brain', 152, 'brain')]
S170-PMC3338544	PMC3338544	4/2012	S170-PMC3338544	['such DIFFERENCES HIGHLIGHT the IMPORTANCE of species and strain selection in studies of altered Vitamin D Signalling and Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0048371', 'lateral mesodermal cell differentiation', 96, 'vitamin D signalling'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain')]
S15-PMC3347007	PMC3347007	4/2012	S15-PMC3347007	['in the unborn child, Vitamin D is IMPORTANT for fetal Bone Development through its ROLE in Regulating Calcium Homeostasis [6,7].']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0048539', 'bone marrow development', 54, 'bone development'), ('GO_0065007', 'biological regulation', 91, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 102, 'calcium homeostasis')]
S19-PMC3347007	PMC3347007	4/2012	S19-PMC3347007	['Animal studies SHOW a POSSIBLE ASSOCIATION between maternal Vitamin D status and Brain Development in pups, which COULD POSSIBLY play a ROLE in Cognitive and Neurological Development [4].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 136)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007420', 'brain development', 81, 'brain development'), ('UBERON_0000955', 'brain', 81, 'brain'), ('GO_0050890', 'cognition', 144, 'cognitive ...'), ('GO_0007399', 'nervous system development', 158, 'neurological development'), ('UBERON_0001016', 'nervous system', 158, 'neurological')]
S105-PMC3347028	PMC3347028	3/2012	S105-PMC3347028	['with rickets, Bone Formation and Development is SERIOUSLY altered with SEVERE Vitamin D ( i.e.']	[('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 71)]	2	[('GO_0048539', 'bone marrow development', 14, 'bone formation ... development'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S80-PMC3355895	PMC3355895	1/2011	S80-PMC3355895	['Calcium and Vitamin D, being key Nutrients in Bone Development, are prime CANDIDATES FOR INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 85)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33284', 'nutrient', 33, 'nutrients'), ('GO_0048539', 'bone marrow development', 46, 'bone development')]
S124-PMC3356951	PMC3356951	4/2012	S124-PMC3356951	"[""a cohort study based on the mini-finland health survey DEMONSTRATED that low Vitamin D levels MAY PREDICT the development of parkinson's disease.""]"	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
S142-PMC3356951	PMC3356951	4/2012	S142-PMC3356951	['age-related Macular Regeneration\nhigh Vitamin D Blood levels APPEAR TO BE ASSOCIATED with a decreased risk for the development of early age-related Macular degeneration (amd) among women younger than 75 years.']	[('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('UBERON_0000054', 'macula', 12, 'macular'), ('GO_0031099', 'regeneration', 20, 'regeneration'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0000054', 'macula', 148, 'macular')]
S269-PMC3385441	PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
S1-PMC3407995	PMC3407995	7/2012	S1-PMC3407995	['purpose: to highlight the POTENTIAL BENEFITS of maternal supplementation with Docosahexaenoic Acid (Dha) and other IMPORTANT complimentary Nutrients, including Vitamin D, Folic Acid and Iodine during Pregnancy and/or Breast feeding for Foetal and/or infant Brain Development and/or function.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 115)]	3	[('CHEBI_36003', 'decenoic acid', 78, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 100, 'DHA'), ('CHEBI_33284', 'nutrient', 139, 'nutrients'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_30751', 'formic acid', 171, 'folic acid'), ('CHEBI_24859', 'iodine atom', 186, 'iodine'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('UBERON_0000310', 'breast', 217, 'breast'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 236, 'foetal ...'), ('GO_0007420', 'brain development', 257, 'brain development'), ('UBERON_0000955', 'brain', 257, 'brain')]
S11-PMC3407995	PMC3407995	7/2012	S11-PMC3407995	['RECENT RESEARCH HAS SHOWN that maternal dietary deficiencies of Docosahexaenoic Acid (Dha), Vitamin D, Folic Acid and Iodine are ASSOCIATED with a variety of poor foetal and/or infant health outcomes MOSTLY IMPACTING Brain Development and/or function in infancy and OFTEN throughout Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 129), ('PROBABLE_UNDERSTANDING', 200), ('SUPERFICIAL_RELATIONSHIP', 207), ('PROBABLE_UNDERSTANDING', 266)]	6	[('CHEBI_36003', 'decenoic acid', 64, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 86, 'DHA'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_30751', 'formic acid', 103, 'folic acid'), ('CHEBI_24859', 'iodine atom', 118, 'iodine'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain'), ('UBERON_0000104', 'life cycle', 283, 'life')]
S13-PMC3407995	PMC3407995	7/2012	S13-PMC3407995	['a review of current literature was UNDERTAKEN to summarize the POTENTIAL benefits of maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine during Pregnancy and/or Breast feeding for Foetal and/or infant Brain Development and/or function.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_17874', 'dihydrozeatin', 115, 'DHA'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_30751', 'formic acid', 131, 'folic acid'), ('CHEBI_24859', 'iodine atom', 146, 'iodine'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('UBERON_0000310', 'breast', 177, 'breast'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 196, 'foetal ...'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain')]
S18-PMC3407995	PMC3407995	7/2012	S18-PMC3407995	['data was reviewed and summarized to discuss the RELEVANCE of dietary Dha, Vitamin D, Folic Acid and Iodine to Foetal and infant Brain Development and function, to PRESENT EVIDENCE DEMONSTRATING dietary deficiency of these Nutrients in many populations, to highlight the POTENTIAL benefits of maternal supplementation during Pregnancy and/or Lactation on foetal and/or infant outcomes and to include SAFE Intake RECOMMENDATIONS.']	[('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 399), ('FUTURE_WORK', 411)]	6	[('CHEBI_17874', 'dihydrozeatin', 69, 'DHA'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30751', 'formic acid', 85, 'folic acid'), ('CHEBI_24859', 'iodine atom', 100, 'iodine'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 110, 'foetal ...'), ('GO_0007420', 'brain development', 128, 'brain development'), ('UBERON_0000955', 'brain', 128, 'brain'), ('CHEBI_33284', 'nutrient', 222, 'nutrients'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('GO_0007595', 'lactation', 341, 'lactation'), ('GO_0007631', 'feeding behavior', 404, 'intake')]
S98-PMC3407995	PMC3407995	7/2012	S98-PMC3407995	['promote normal Brain Development—PRELIMINARY RESEARCH SUGGESTS that Gestational Vitamin D insufficiency HAS BEEN LINKED to altered Brain Development and Adult mental health [49], in particular schizophrenia [54].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('GO_0007420', 'brain development', 15, 'brain development'), ('UBERON_0000955', 'brain', 15, 'brain'), ('GO_0007565', 'female pregnancy', 68, 'gestational'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007420', 'brain development', 131, 'brain development'), ('UBERON_0000955', 'brain', 131, 'brain'), ('UBERON_0007023', 'adult organism', 153, 'adult')]
S99-PMC3407995	PMC3407995	7/2012	S99-PMC3407995	['there is also evidence from observational studies SUGGESTING that adequate Vitamin D during early Life MAY PREVENT development of Immunological Diseases in the offspring later in Life such as type 1 diabetes [55], allergic diseases [53] and Lower Respiratory Tract infections, wheezing and asthma [56].']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life'), ('GO_0007567', 'parturition', 130, 'immunological diseases'), ('UBERON_0003222', 'flexor digitorum superficialis', 130, 'immunological'), ('UBERON_0000104', 'life cycle', 179, 'life'), ('UBERON_0004905', 'articulation', 241, 'lower respiratory tract')]
S258-PMC3407995	PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]
S263-PMC3407995	PMC3407995	7/2012	S263-PMC3407995	['evidence from RECENT STUDIES SUGGESTS an early Prenatal INFLUENCE of maternal Vitamin D status on foetal Skeletal Development, with lasting Postnatal EFFECTS [141].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0001501', 'skeletal system development', 105, 'skeletal development'), ('UBERON_0004288', 'skeleton', 105, 'skeletal'), ('GO_0007567', 'parturition', 140, 'postnatal')]
S293-PMC3407995	PMC3407995	7/2012	S293-PMC3407995	['THERE IS EVIDENCE that Vitamin D during Pregnancy is INVOLVED in foetal Brain Development and that maternal Vitamin D deficiency during Pregnancy CAN alter the structure and function of the Brain resulting in Life long behavioural changes in the offspring [146,147,148].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 146)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('UBERON_0000955', 'brain', 190, 'brain'), ('UBERON_0000104', 'life cycle', 209, 'life')]
S480-PMC3407995	PMC3407995	7/2012	S480-PMC3407995	['HOWEVER, common dietary DEFICIENCIES within many populations of particular Nutrients including dha, Vitamin D, Folic Acid, and Iodine, that all play CRITICAL ROLES at various developmental stages, HAVE BEEN SHOWN to CONTRIBUTE to functional abnormalities, many of which have lasting EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24), ('IMPORTANT_CONSIDERATION', 149), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 283)]	7	[('CHEBI_33284', 'nutrient', 75, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30751', 'formic acid', 111, 'folic acid'), ('CHEBI_24859', 'iodine atom', 127, 'iodine')]
S486-PMC3407995	PMC3407995	7/2012	S486-PMC3407995	['epidemiological studies have LINKED low maternal Vitamin D status to SEVERE Preeclampsia resulting in Miscarriage, risk of low Birth weight and small-for-Gestational age infants, neonatal hypocalcaemia with seizures and POSSIBLE INVOLVEMENT in the development of schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 229)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 102, 'miscarriage'), ('GO_0007567', 'parturition', 127, 'birth'), ('GO_0007565', 'female pregnancy', 154, 'gestational')]
S492-PMC3407995	PMC3407995	7/2012	S492-PMC3407995	['maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine within RECOMMENDED SAFE intake quantities in a large segment of the population that is currently DEFICIENT in these Nutrients, COULD significantly prevent many Brain and Central Nervous System malfunctions and EVEN enhance Brain Development and function in future generations.']	[('FUTURE_WORK', 75), ('IMPORTANT_CONSIDERATION', 87), ('IMPORTANT_CONSIDERATION', 165), ('INCOMPLETE_EVIDENCE', 195), ('ANOMALY_CURIOUS_FINDING', 278)]	5	[('CHEBI_17874', 'dihydrozeatin', 30, 'DHA'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_30751', 'formic acid', 46, 'folic acid'), ('CHEBI_24859', 'iodine atom', 61, 'iodine'), ('CHEBI_33284', 'nutrient', 184, 'nutrients'), ('UBERON_0000955', 'brain', 228, 'brain'), ('UBERON_0001017', 'central nervous system', 238, 'central nervous system'), ('GO_0007420', 'brain development', 291, 'brain development'), ('UBERON_0000955', 'brain', 291, 'brain')]
S13-PMC3411795	PMC3411795	8/2012	S13-PMC3411795	['in particular those Animal MODELS that HAVE BEEN developed specifically to address KNOWN epidemiological risk factors for schizophrenia, such as Prenatal Vitamin D deficiency or Prenatal infection, reveal very early changes in Da Development[9],[10],[11],[12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 83)]	4	[('NCBITaxon_33208', 'Metazoa', 20, 'animal'), ('GO_0007565', 'female pregnancy', 145, 'prenatal'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'prenatal'), ('GO_0060539', 'diaphragm development', 227, 'DA development')]
S66-PMC3417531	PMC3417531	7/2012	S66-PMC3417531	"[""(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?""]"	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
S16-PMC3424155	PMC3424155	8/2012	S16-PMC3424155	['HOWEVER, NEW EVIDENCE SUGGESTS that Vitamin D COULD BE VITAL to normal fetal Development and that Vitamin D restriction in this period MAY AFFECT chronic disease susceptibility post-Natal Life[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 139)]	7	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'natal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
S22-PMC3424155	PMC3424155	8/2012	S22-PMC3424155	['therefore, the adverse EFFECTS of Vitamin D restriction during Kidney Development NEED FURTHER exploration.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0001822', 'kidney development', 63, 'kidney development'), ('UBERON_0002113', 'kidney', 63, 'kidney')]
S23-PMC3424155	PMC3424155	8/2012	S23-PMC3424155	['THIS STUDY investigates the EFFECTS of maternal Vitamin D deficiency on Glomerular Development in early Postnatal Life and its EFFECTS on Renal structure at maturity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0032835', 'glomerulus development', 72, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 72, 'glomerular'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('UBERON_0000104', 'life cycle', 114, 'life'), ('UBERON_0002113', 'kidney', 138, 'renal')]
S164-PMC3424155	PMC3424155	8/2012	S164-PMC3424155	['discussion\nmicronutrient deficiency during development, such as maternal Vitamin D deficiency, is a subject of increasing IMPORTANCE BECAUSE of the nutritional deficiencies caused by excessive consumption of junk Food during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 133)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_33290', 'food', 213, 'food'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy')]
S167-PMC3424155	PMC3424155	8/2012	S167-PMC3424155	['in the PRESENT STUDY, maternal Vitamin D deficiency in Mice LED TO significant changes in Kidney Development in the offspring, such as retardation of Glomerular Maturation and an increase in the number of Glomeruli.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'mice'), ('GO_0001822', 'kidney development', 90, 'kidney development'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 150, 'glomerular'), ('GO_0007618', 'mating', 161, 'maturation'), ('UBERON_0000074', 'renal glomerulus', 205, 'glomeruli')]
S179-PMC3424155	PMC3424155	8/2012	S179-PMC3424155	['in Rats, it has been OBSERVED that maternal Vitamin D deficiency LEADS to a significant increase in the number of Glomeruli, which is a UNIQUE and IMPORTANT EFFECT of Vitamin D restriction during fetal development[13].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 65), ('ANOMALY_CURIOUS_FINDING', 136), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 114, 'glomeruli'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
S208-PMC3424155	PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
S210-PMC3424155	PMC3424155	8/2012	S210-PMC3424155	['furthermore, the literature SHOWS SOME RELATIONSHIP between Vitamin D deficiency and Adipose Tissue Development, and OTHER STUDIES SHOULD evaluate such EFFECTS, and the transgenerational EFFECTS.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 39), ('FUTURE_WORK', 117), ('FUTURE_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 187)]	7	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 85, 'adipose tissue development'), ('UBERON_0001013', 'adipose tissue', 85, 'adipose tissue')]
S21-PMC3427192	PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
S22-PMC3437304	PMC3437304	8/2012	S22-PMC3437304	['Prenatal exposure to Pets, Vitamin D supplement, or antioxidants such as mediterranean diet is shown to be PROTECTIVE from the development of asthma.']	[('SUPERFICIAL_RELATIONSHIP', 107)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('NCBITaxon_10088', 'Mus <genus>', 21, 'pets'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
S10-PMC3458940	PMC3458940	9/2012	S10-PMC3458940	['such a catalogue will guide FURTHER STUDIES on molecular mediators of endogenous tra/rars during Kidney Development and in RELATION to Renal defects ASSOCIATED with Vitamin A deficiency.']	[('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('GO_0001822', 'kidney development', 97, 'kidney development'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002113', 'kidney', 135, 'renal'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin A')]
S20-PMC3458940	PMC3458940	9/2012	S20-PMC3458940	['EVEN mild Gestational Vitamin A deficiency LEADS to a deficit in Nephron number, which MAY predispose the Kidney to abnormal development or function when ASSOCIATED with other morbidities[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001285', 'nephron', 65, 'nephron'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
S40-PMC3465343	PMC3465343	10/2012	S40-PMC3465343	['ra is a derivative of Vitamin A and is REQUIRED for synchronous left-right Development Of Somites, either maternal vad during Pregnancy or an Embryonic defect in Metabolism from Vitamin A to ra MIGHT be ASSOCIATED with increased risk of Human vertebral defects.']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 194), ('SUPERFICIAL_RELATIONSHIP', 203)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0042461', 'photoreceptor cell development', 75, 'development of somites'), ('UBERON_0002329', 'somite', 90, 'somites'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0000922', 'embryo', 142, 'embryonic'), ('GO_0008152', 'metabolic process', 162, 'metabolism'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'human')]
S67-PMC3465343	PMC3465343	10/2012	S67-PMC3465343	['vad induced Skeletal abnormalities in neonatal Rats\nbecause Vitamin A is REQUIRED for Skeletal Development during Embryo Development, we also exmined the OTHER Skeletal System of neonatal Rats by the same anteroposterior radiography.']	[('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	2	[('UBERON_0004288', 'skeleton', 12, 'skeletal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rats'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0001501', 'skeletal system development', 86, 'skeletal development'), ('UBERON_0004288', 'skeleton', 86, 'skeletal'), ('GO_0009790', 'embryo development', 114, 'embryo development'), ('UBERON_0000922', 'embryo', 114, 'embryo'), ('UBERON_0001434', 'skeletal system', 160, 'skeletal system'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 188, 'rats')]
S126-PMC3465343	PMC3465343	10/2012	S126-PMC3465343	['the phenomenon that Gestational Vitamin A deficiency disrupts Embryonic Development HAS BEEN KNOWN for over 80 years.']	[('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 93)]	2	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin A'), ('GO_0009790', 'embryo development', 62, 'embryonic development'), ('UBERON_0000922', 'embryo', 62, 'embryonic')]
S154-PMC3465343	PMC3465343	10/2012	S154-PMC3465343	['ra is the active form of Vitamin A and plays a CRUCIAL ROLE in stimulating Nuclear receptor signaling during development.']	[('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0005634', 'nucleus', 75, 'nuclear')]
S15-PMC3470091	PMC3470091	9/2012	S15-PMC3470091	['these changes occur ACCORDING TO the needs for the mineralization of the fetus Bones as well as adequate secretion of Vitamin D in mother’s Milk.1\nDUE TO rapid fetal development, PARTICULARLY bone Calcification at the terminal stages of Pregnancy, there is a POSSIBILITY of Vitamin D deficiency to occur in mothers.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('PROBABLE_UNDERSTANDING', 147), ('IMPORTANT_CONSIDERATION', 179), ('INCOMPLETE_EVIDENCE', 259)]	4	[('UBERON_0001474', 'bone element', 79, 'bones'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001913', 'milk', 140, 'milk'), ('GO_0051301', 'cell division', 197, 'calcification'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
S18-PMC3471827	PMC3471827	10/2012	S18-PMC3471827	['after DEMONSTRATING the Embryonic requirement for Vitamin E we next queried HOW Α-Tocopherol is transferred into the Embryo during development.']	[('INCOMPLETE_EVIDENCE', 6), ('EXPLICIT_QUESTION', 76)]	2	[('UBERON_0000922', 'embryo', 24, 'embryonic'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin E'), ('CHEBI_27725', 'butin', 80, 'α-tocopherol'), ('UBERON_0000922', 'embryo', 117, 'embryo')]
S105-PMC3471827	PMC3471827	10/2012	S105-PMC3471827	['the phenotype, especially impaired Brain Formation in ttp knockdown Zebrafish Embryos RAISES the INTRIGUING POSSIBILITY that low Vitamin E status has adverse events in early Central Nervous System development in other Animals, including Humans.']	[('EXPLICIT_QUESTION', 86), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 108)]	3	[('GO_0001503', 'ossification', 35, 'brain formation'), ('UBERON_0000955', 'brain', 35, 'brain'), ('NCBITaxon_7955', 'Danio rerio', 68, 'zebrafish'), ('UBERON_0000922', 'embryo', 78, 'embryos'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 174, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 174, 'central nervous system'), ('NCBITaxon_33208', 'Metazoa', 218, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'humans')]
S116-PMC3471827	PMC3471827	10/2012	S116-PMC3471827	['the Mammalian maternal Vitamin E REQUIREMENTS occur prior to the developmental stage in which ttp is REQUIRED in the Zebrafish, creating a BARRIER to the study of ttp in Placental MODELS.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 101), ('DIFFICULT_TASK', 139), ('INCOMPLETE_EVIDENCE', 180)]	4	[('NCBITaxon_40674', 'Mammalia', 4, 'mammalian'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 117, 'zebrafish'), ('UBERON_0001987', 'placenta', 170, 'placental')]
S129-PMC3471827	PMC3471827	10/2012	S129-PMC3471827	['we PREVIOUSLY DEMONSTRATED the REQUIREMENT of Vitamin E during Zebrafish development using diet-induced Vitamin E deficient Embryos[7].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 63, 'zebrafish'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('UBERON_0000922', 'embryo', 124, 'embryos')]
S12-PMC3472720	PMC3472720	8/2012	S12-PMC3472720	['IN ORDER TO TEST the HYPOTHESIS that low Vitamin D status during Gestation is a RISK FACTOR for ms, we explored a well-DESCRIBED developmental Vitamin D (dvd) deficiency Rodent MODEL, [11,12].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 177)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestation'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 170, 'rodent')]
S13-PMC3472720	PMC3472720	8/2012	S13-PMC3472720	['in this MODEL, the Vitamin D deficiency experienced by the offspring is restored by the 1st week of Life, therefore the MODEL is not associated with any abnormal Bone Development and calcium and pth levels in the Adult offspring are normal [13].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('GO_0048539', 'bone marrow development', 162, 'bone development'), ('UBERON_0007023', 'adult organism', 213, 'adult')]
S31-PMC3472720	PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
S108-PMC3476426	PMC3476426	8/2012	S108-PMC3476426	['maternal Vitamin D deficiency MAY BE a risk factor for autism, POSSIBLY by AFFECTING fetal Brain Development as well as by AFFECTING maternal Immune System status during Pregnancy [37,38].']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 123)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007420', 'brain development', 91, 'brain development'), ('UBERON_0000955', 'brain', 91, 'brain'), ('UBERON_0002405', 'immune system', 142, 'immune system'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
S5-PMC3488410	PMC3488410	10/2012	S5-PMC3488410	['we will specifically discuss the Vitamin D deficiency MODEL, the poly i:c MODEL, the Ketamine MODEL, and the Postnatal Ventral Hippocampal lesion MODEL, all of which REFLECT core Neurodevelopmental ISSUES UNDERLYING schizophrenia onset.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 166), ('IMPORTANT_CONSIDERATION', 198), ('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_6121', 'ketamine', 85, 'ketamine'), ('GO_0007567', 'parturition', 109, 'postnatal'), ('UBERON_0000218', 'vertebral arch of axis', 119, 'ventral hippocampal'), ('GO_0007399', 'nervous system development', 179, 'neurodevelopmental')]
S113-PMC3488410	PMC3488410	10/2012	S113-PMC3488410	['the Vitamin D deficiency MODEL APPEARS TO BE useful to study the IMPACT of Brain disturbances during Embryonic/fetal Development [127,128].']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000955', 'brain', 75, 'brain'), ('GO_0009790', 'embryo development', 101, 'embryonic ... development'), ('UBERON_0000922', 'embryo', 101, 'embryonic')]
S114-PMC3488410	PMC3488410	10/2012	S114-PMC3488410	['INTERESTINGLY, SOME of the Vitamin D deficiency EFFECTS COULD BE RELATED to later Gestational periods THUS POSSIBLY expanding the HAZARDOUS time window for the neurobiological development of schizophrenia [129].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 107), ('IMPORTANT_CONSIDERATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'gestational')]
S223-PMC3501517	PMC3501517	11/2012	S223-PMC3501517	['the DIFFERENCES that the OTHER group saw MAY BE more the result of maternal and early Gestational Vitamin D deficiency and its EFFECTS on Fetal Lung Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007631', 'feeding behavior', 138, 'fetal'), ('GO_0030324', 'lung development', 144, 'lung development'), ('UBERON_0002048', 'lung', 144, 'lung')]
S224-PMC3501517	PMC3501517	11/2012	S224-PMC3501517	['this is SUPPORTED by Human data SUGGESTING that maternal Vitamin D MAY AFFECT fetal Lung Development[28].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('NCBITaxon_9606', 'Homo sapiens', 21, 'human'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0030324', 'lung development', 84, 'lung development'), ('UBERON_0002048', 'lung', 84, 'lung')]
S22-PMC3509518	PMC3509518	11/2012	S22-PMC3509518	['a LIMITED NUMBER OF Birth cohort STUDIES have SUGGESTED beneficial ASSOCIATIONS between higher maternal intakes of Antioxidants such as Vitamin E [9,10,11] and zinc [9] and the development of early childhood wheeze, and asthma [12].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('GO_0007567', 'parturition', 20, 'birth'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 115, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
S105-PMC3509518	PMC3509518	11/2012	S105-PMC3509518	['furthermore, maternal dietary Vitamin C intake in Pregnancy APPEARED PROTECTIVE against Development Of Wheeze in the first year of Life.']	[('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0060041', 'retina development in camera-type eye', 88, 'development of wheeze'), ('UBERON_0000104', 'life cycle', 131, 'life')]
S1-PMC3515553	PMC3515553	12/2012	S1-PMC3515553	['Brain Development occurs primarily in utero and early infancy, BUT the ROLE of maternal Vitamin B-12 status during Pregnancy on offspring Cognitive function is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 63), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 160)]	3	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0050890', 'cognition', 138, 'cognitive')]
S15-PMC3515553	PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
S143-PMC3515553	PMC3515553	12/2012	S143-PMC3515553	['PREVIOUS STUDIES of the EFFECT of Plasma Vitamin B-12 on Neurological Development in children SUGGEST that cobalamin deficiency has an adverse EFFECT on children’s Cognitive ability and motor skills.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('UBERON_0001969', 'blood plasma', 34, 'plasma'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 41, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 51, '12'), ('GO_0007399', 'nervous system development', 57, 'neurological development'), ('UBERON_0001016', 'nervous system', 57, 'neurological'), ('GO_0050890', 'cognition', 164, 'cognitive')]
S155-PMC3515553	PMC3515553	12/2012	S155-PMC3515553	['in mexico, a study that assessed maternal diet during the first Trimester of Pregnancy and offspring Neurodevelopment REPORTED a decrease in Cognition test scores among children of mothers with a deficient intake of Vitamin B-12 (<2 µg/day)[7].']	[('INCOMPLETE_EVIDENCE', 118)]	1	[('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 101, 'neurodevelopment'), ('GO_0050890', 'cognition', 141, 'cognition'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 216, 'vitamin B-12')]
S12-PMC3552819	PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
S261-PMC3586494	PMC3586494	2/2013	S261-PMC3586494	['as discussed in the section on epigenetics, experimental studies on the IMPACT of methyl-supplemented diets containing added Folate and Vitamin B-12 REVEALED the POTENTIAL ROLE of these Micronutrients in inducing major changes in offspring phenotype, including the ability to IMPACT the development of chronic diseases.']	[('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 276)]	5	[('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 136, 'vitamin B-12'), ('CHEBI_33839', 'macromolecule', 186, 'micronutrients')]
S198-PMC3599191	PMC3599191	1/2013	S198-PMC3599191	['furthermore, levels of maternal Vitamin E AFFECT the development of fetal biometrics (Crown-Rump length, Femur length and biparietal diameter) and Lung Development: for every millimeter of increase in fetus length, there is an increase of up to 5 ml of fev1and 6 ml of fvc [107].']	[('SUPERFICIAL_RELATIONSHIP', 42)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin E'), ('UBERON_0002283', 'nail matrix', 86, 'crown-rump'), ('UBERON_0000981', 'femur', 105, 'femur'), ('GO_0030324', 'lung development', 147, 'lung development'), ('UBERON_0002048', 'lung', 147, 'lung')]
S0-PMC3651971	PMC3651971	5/2013	S0-PMC3651971	['cognitive and motor skills in school-aged children following maternal Vitamin A supplementation during Pregnancy in rural nepal: a follow-up of a placebo-controlled, randomised cohort\n\nabstract\n\nobjective\nTO DETERMINE the EFFECTS of maternal Vitamin A supplementation from Preconception through Postpartum on Cognitive and Motor Development of children at 10–13\u2005years of age in rural nepal.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('SUPERFICIAL_RELATIONSHIP', 222)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin A'), ('GO_0007565', 'female pregnancy', 273, 'preconception'), ('GO_0007565', 'female pregnancy', 295, 'postpartum'), ('GO_0050890', 'cognition', 309, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 323, 'motor development')]
S19-PMC3651971	PMC3651971	5/2013	S19-PMC3651971	['this research SUGGESTS that Central Nervous System Development MAY BE PROTECTED in Vitamin A deficiency, POSSIBLY BECAUSE Vitamin A is preferentially allocated to the developing fetus.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 105), ('PROBABLE_UNDERSTANDING', 114)]	5	[('GO_0003204', 'cardiac skeleton development', 28, 'central nervous system development'), ('UBERON_0001017', 'central nervous system', 28, 'central nervous system'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
S24-PMC3651971	PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
S25-PMC3651971	PMC3651971	5/2013	S25-PMC3651971	['there are SUGGESTIONS from SPARSE Human data that fetal Vitamin A deficiency MAY adversely AFFECT childhood development.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 91)]	4	[('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin A')]
S26-PMC3651971	PMC3651971	5/2013	S26-PMC3651971	['in a study of healthy chinese mothers and newborns, a positive RELATIONSHIP was OBSERVED between Cord Blood Retinol level and motor skill achievements by age 2.17in indonesia, newborn Vitamin A supplementation resulted in modest improvement in Motor Development scores after 3\u2005years,18while Vitamin A supplementation to hiv-positive tanzanian women exerted no detectable changes in infant Psychomotor Development.19there REMAINS, HOWEVER, a NEED FOR ADDITIONAL causal data on early Life Vitamin A exposure and Neurocognitive and motor function.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 421), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 430), ('FUTURE_WORK', 441)]	5	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 244, 'motor development'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin A'), ('GO_0030324', 'lung development', 389, 'psychomotor development'), ('UBERON_0000104', 'life cycle', 482, 'life'), ('CHEBI_27300', 'vitamin D', 487, 'vitamin A'), ('GO_0050905', 'neuromuscular process', 510, 'neurocognitive')]
S140-PMC3651971	PMC3651971	5/2013	S140-PMC3651971	['the HYPOTHESISED EFFECT of Gestational Vitamin A supplementation on Cognition and Motor Development is BASED ON sound THEORY.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 103), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 118)]	5	[('GO_0007565', 'female pregnancy', 27, 'gestational'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('GO_0050890', 'cognition', 68, 'cognition'), ('GO_0009653', 'anatomical structure morphogenesis', 82, 'motor development')]
S142-PMC3651971	PMC3651971	5/2013	S142-PMC3651971	['the Human studies that have SUGGESTED a ROLE for Vitamin A in Cognitive and Motor Development are LIMITED to much younger children.1718another POSSIBLE EXPLANATION for our results is that differences between groups were attenuated by routine supplementation from the national Vitamin A programme started in 1995.30given the wide cis for experimental measures of Cognitive and motor development, and the POTENTIAL for Brain plasticity, the supplementation programme MIGHT have attenuated a treatment EFFECT, allowing placebo group children to regain the nutritional losses of their early Life.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 152), ('INCOMPLETE_EVIDENCE', 403), ('INCOMPLETE_EVIDENCE', 465), ('SUPERFICIAL_RELATIONSHIP', 499)]	8	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('GO_0050890', 'cognition', 62, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 76, 'motor development'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A'), ('GO_0050890', 'cognition', 362, 'cognitive'), ('UBERON_0000955', 'brain', 417, 'brain'), ('UBERON_0000104', 'life cycle', 587, 'life')]
S143-PMC3651971	PMC3651971	5/2013	S143-PMC3651971	['there are also a host of OTHER nutritional INFLUENCES on Cognitive Development, SOME of which MIGHT obscure the RELATIONSHIP between early Vitamin A deficiency and developmental outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('GO_0050787', 'detoxification of mercury ion', 57, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A')]
S161-PMC3651971	PMC3651971	5/2013	S161-PMC3651971	['in conclusion, in this Vitamin A deficient setting, where maternal Vitamin A supplementation reduced maternal night blindness and mortality, no long-term EFFECTS have BEEN observed on the Cognitive and motor skill development of Prepubescent offspring.']	[('SUPERFICIAL_RELATIONSHIP', 154), ('ANOMALY_CURIOUS_FINDING', 167)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('GO_0050890', 'cognition', 188, 'cognitive ...'), ('GO_0048633', 'positive regulation of skeletal muscle tissue growth', 229, 'prepubescent')]
S106-PMC3659910	PMC3659910	1/2013	S106-PMC3659910	['induction of the 1α-hydroxylase in early Gestation MIGHT provide a mechanism by which environmental or dietary Vitamin D CAN INFLUENCE fetal-Placental Development.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0001890', 'placenta development', 141, 'placental development'), ('UBERON_0001987', 'placenta', 141, 'placental')]
S126-PMC3659910	PMC3659910	1/2013	S126-PMC3659910	['Animal MODELS of Vitamin D deficiency HAVE SHOWN just how IMPORTANT adequate nutritional intakes of Vitamin D are to Skeletal, Cardiovascular, and Neurologic Development in experimental Animals.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 58)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0001501', 'skeletal system development', 117, 'skeletal ...'), ('UBERON_0001442', 'skeleton of manus', 117, 'skeletal ...'), ('GO_0002026', 'regulation of the force of heart contraction', 127, 'cardiovascular ...'), ('UBERON_0004535', 'cardiovascular system', 127, 'cardiovascular'), ('GO_0007399', 'nervous system development', 147, 'neurologic development'), ('UBERON_0001016', 'nervous system', 147, 'neurologic'), ('NCBITaxon_33208', 'Metazoa', 186, 'animals')]
S128-PMC3659910	PMC3659910	1/2013	S128-PMC3659910	['a RECENT STUDY provides EVIDENCE with reference to the CONSEQUENCES of Vitamin D deficiency on the Neurodevelopment Of the Fetus during Pregnancy in a Rat MODEL.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0001503', 'ossification', 99, 'neurodevelopment of ... fetus'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 151, 'rat')]
S145-PMC3659910	PMC3659910	1/2013	S145-PMC3659910	['[35] maternal Vitamin D deficiency also has been ASSOCIATED with craniotabes,[35] a softening of Skull Bones that is one of the earliest signs of vitamin d deficiency, in a case study with neonatal seizures of a hypocalcemic infant and with impaired Skeletal Development in utero.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0003215', 'alveolus', 97, 'skull bones'), ('GO_0001501', 'skeletal system development', 250, 'skeletal development'), ('UBERON_0004288', 'skeleton', 250, 'skeletal')]
S146-PMC3659910	PMC3659910	1/2013	S146-PMC3659910	['[34] INTERESTINGLY, Vitamin D deficiency during Pregnancy is also ASSOCIATED with RISKS of health PROBLEMS later in childhood, including improper Bone Development at 9 yrs of age, asthma,[36] Dental Cavities, schizophrenia, and type i diabetes.']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0048539', 'bone marrow development', 146, 'bone development'), ('UBERON_0001076', 'neural spine', 192, 'dental cavities')]
S194-PMC3659910	PMC3659910	1/2013	S194-PMC3659910	"['FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting"" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.']"	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]
S0-PMC3672018	PMC3672018	5/2013	S0-PMC3672018	['the INFLUENCE of early exposure to Vitamin D for development of Diseases later in Life\n\nabstract\n\nbackground\nVitamin D deficiency is common among otherwise healthy Pregnant women and MAY have CONSEQUENCES for them as well as the early Development and long-term health Of their Children.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 183), ('IMPORTANT_CONSIDERATION', 192)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007586', 'digestion', 64, 'diseases'), ('UBERON_0000104', 'life cycle', 82, 'life'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0001709', 'cell fate determination', 235, 'development ... - ... of ... children')]
S2-PMC3672018	PMC3672018	5/2013	S2-PMC3672018	['the PRESENT STUDY includes an in-depth examination of the INFLUENCE of exposure to Vitamin D early in Life for development of fractures of the Wrist, Arm and Clavicle; obesity, and type 1 diabetes (t1d) during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life'), ('UBERON_0004452', 'carpal region', 143, 'wrist'), ('UBERON_0001460', 'arm', 150, 'arm'), ('UBERON_0001105', 'clavicle bone', 158, 'clavicle'), ('UBERON_0000113', 'post-juvenile adult stage', 221, 'adulthood')]
S34-PMC3672018	PMC3672018	5/2013	S34-PMC3672018	['adverse health EFFECTS of low Vitamin D MAY THEREFORE be MOST evident in Organs or Tissues whose development occurs in these trimesters, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 57)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000062', 'organ', 73, 'organs'), ('UBERON_0000479', 'tissue', 83, 'tissues')]
S50-PMC3672018	PMC3672018	5/2013	S50-PMC3672018	['this allows for the examination of the EFFECTS of exposure to additional Vitamin D via fortified Foods during fetal Life in RELATION to later development of particular diseases.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_33290', 'food', 97, 'foods'), ('UBERON_0000104', 'life cycle', 116, 'life')]
S51-PMC3672018	PMC3672018	5/2013	S51-PMC3672018	['initially the PRESENT STUDY will include an in-depth examination of the INFLUENCE of exposure to Vitamin D during Pregnancy for development of fractures of the Wrist, forearm, upper Arm and Shoulder, as well as fractures of Ankle; development of obesity; and development of t1d during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('UBERON_0004452', 'carpal region', 160, 'wrist'), ('UBERON_0001460', 'arm', 182, 'arm'), ('UBERON_0001467', 'shoulder', 190, 'shoulder'), ('UBERON_0004454', 'tarsal region', 224, 'ankle'), ('UBERON_0000113', 'post-juvenile adult stage', 296, 'adulthood')]
S52-PMC3672018	PMC3672018	5/2013	S52-PMC3672018	['furthermore, the large number of subjects that will be followed will ensure that the EFFECTS of Vitamin D exposure in RELATION to the timing of the seasons of Gestational development also can be examined.']	[('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 118)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'gestational')]
S54-PMC3672018	PMC3672018	5/2013	S54-PMC3672018	['the main HYPOTHESIS is that low levels of Vitamin D during CRITICAL phases of development have adverse EFFECTS on the long term risk of developing the above mentioned disease outcomes, and that exposure to extra Vitamin D from Food fortification has beneficial EFFECTS PREVENTING the mentioned diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 269)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'food')]
S56-PMC3672018	PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
S58-PMC3672018	PMC3672018	5/2013	S58-PMC3672018	['the figure provides examples of designs for examining the EFFECTS of Vitamin D fortification on Development Of Diseases for a follow-up period of up to 50ὕyears.']	[('SUPERFICIAL_RELATIONSHIP', 58)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 96, 'development of diseases')]
S65-PMC3672018	PMC3672018	5/2013	S65-PMC3672018	['databases\nin a first effort, we will EXAMINE INFLUENCE of additional early exposure to Vitamin D on subsequent development of fractures, obesity, and t1d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
S82-PMC3672018	PMC3672018	5/2013	S82-PMC3672018	['in the FUTURE, a third phase will be PLANNED and will examine ASSOCIATION between additional exposure to Vitamin D in fetal Life and later development of other Immunological disorders, including severe asthma, crohn’s disease, Inflammatory Bowel diseases, and juvenile idiopathic arthritis.']	[('FUTURE_WORK', 7), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life'), ('UBERON_0003222', 'flexor digitorum superficialis', 160, 'immunological'), ('UBERON_0001782', 'pigmented layer of retina', 227, 'inflammatory bowel')]
S94-PMC3672018	PMC3672018	5/2013	S94-PMC3672018	['the HYPOTHESIS is that Individuals Born 1–2\u2009years after commencement of mandatory fortification (1961) and thus exposed to extra Vitamin D during Fetal Development and for the next 24–25\u2009years until 1985 (where fortification was ended), ALTHOUGH unexposed thereafter, will have a lower lifetime risk of developing the aforementioned disease entities COMPARED TO Individuals Born 1\u2009–2\u2009years before fortification.']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 237), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 350)]	3	[('NCBITaxon_1', 'root', 23, 'individuals'), ('GO_0007567', 'parturition', 35, 'born'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 146, 'fetal development'), ('NCBITaxon_1', 'root', 362, 'individuals'), ('GO_0007567', 'parturition', 374, 'born')]
S96-PMC3672018	PMC3672018	5/2013	S96-PMC3672018	['LIKEWISE, Individuals Born 1–2\u2009years after mandatory fortification terminated in 1985, and who were unexposed to Vitamin D both during Fetal Development and subsequently, will have a higher risk of later developing the diseases COMPARED TO those exposed during fetal Life.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	2	[('NCBITaxon_1', 'root', 10, 'individuals'), ('GO_0007567', 'parturition', 22, 'born'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 135, 'fetal development'), ('UBERON_0000104', 'life cycle', 267, 'life')]
S97-PMC3672018	PMC3672018	5/2013	S97-PMC3672018	['similar comparisons of disease development can be made in RELATION to higher exposure to Vitamin D from 1972–1976, when fortified low fat Milk was permitted.']	[('SUPERFICIAL_RELATIONSHIP', 58)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001913', 'milk', 138, 'milk')]
S139-PMC3672018	PMC3672018	5/2013	S139-PMC3672018	['discussion\n\nstrengths and limitations\nthe study takes advantage of a Vitamin D fortification policy implemented in denmark almost fifty years ago, and nests this “societal experiment” in a setting where the EFFECT of conditions from Conception (and before) for development of certain Diseases can be followed among Individuals from Birth through Adulthood.']	[('SUPERFICIAL_RELATIONSHIP', 207)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007620', 'copulation', 233, 'conception'), ('GO_0007586', 'digestion', 284, 'diseases'), ('NCBITaxon_1', 'root', 315, 'individuals'), ('GO_0007567', 'parturition', 332, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 346, 'adulthood')]
S142-PMC3672018	PMC3672018	5/2013	S142-PMC3672018	['the comprehensive linkage of different datasets makes it possible to study the mediation, CONFOUNDING or modification of EFFECTS of Vitamin D for selected conditions through the development of sophisticated models in which Individuals can be followed for periods of up to 50\u2009years.']	[('PROBLEM_COMPLICATION', 90), ('SUPERFICIAL_RELATIONSHIP', 121)]	2	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('NCBITaxon_1', 'root', 223, 'individuals')]
S143-PMC3672018	PMC3672018	5/2013	S143-PMC3672018	['moreover, the large number of subjects that will be followed ensures that the EFFECTS of Vitamin D exposure in RELATION to the timing of the seasons and Gestational Development can also be examined.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007536', 'activation of recombination (HML)', 153, 'gestational development')]
S175-PMC3672018	PMC3672018	5/2013	S175-PMC3672018	['Growth and Pubertal Development, POSSIBILITY RELATED to Vitamin D exposures in early Life, PERHAPS EVEN before Conception, in addition to the outcomes studied.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 91), ('ANOMALY_CURIOUS_FINDING', 99)]	4	[('GO_0040007', 'growth', 0, 'growth ...'), ('GO_0060021', 'roof of mouth development', 11, 'pubertal development'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000104', 'life cycle', 85, 'life'), ('GO_0007620', 'copulation', 111, 'conception')]
S178-PMC3672018	PMC3672018	5/2013	S178-PMC3672018	['it THUS allows examination of the EFFECTS of low Vitamin D during fetal Life in RELATION to later development of particular diseases.']	[('PROBABLE_UNDERSTANDING', 3), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life')]
S137-PMC3685533	PMC3685533	6/2013	S137-PMC3685533	['identifying Vitamin D deficiency at Birth is ESSENTIAL for the development of public policy for PREVENTION and supplementation.']	[('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007567', 'parturition', 36, 'birth')]
S19-PMC3691177	PMC3691177	6/2013	S19-PMC3691177	['the active Metabolite of Vitamin D, 1,25-Dihydroxyvitamin D, HAS BEEN SHOWN in Animal and in vitro MODELS to have potent Immune EFFECTS[12]and a ROLE in early Lung Development[13].']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_39382', 'flufenoxuron', 11, 'metabolite'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 36, '1,25-dihydroxyvitamin D'), ('NCBITaxon_33208', 'Metazoa', 79, 'animal'), ('UBERON_0002405', 'immune system', 121, 'immune'), ('GO_0030324', 'lung development', 159, 'lung development'), ('UBERON_0002048', 'lung', 159, 'lung')]
S117-PMC3691177	PMC3691177	6/2013	S117-PMC3691177	['the 95% confidence interval for our primary outcome measure was 0.49 to 1.50, so we are UNABLE TO confidently exclude EFFECTS of Prenatal vitamin D supplementation on RISK of wheezing, or on the development of atopy especially in mothers treated with daily Vitamin D. third, we DID NOT assess Vitamin D receptor polymorphisms or OTHER POTENTIALLY IMPORTANT genotypic variations.']	[('DIFFICULT_TASK', 88), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 278), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 347)]	7	[('GO_0007565', 'female pregnancy', 129, 'prenatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 146, 'D'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
S19-PMC3695234	PMC3695234	7/2013	S19-PMC3695234	['there has also been increasing AWARENESS of the IMPORTANCE of one POTENTIAL FACTOR-Vitamin D-in the development and progress of atopic Diseases.']	[('IMPORTANT_CONSIDERATION', 31), ('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007586', 'digestion', 135, 'diseases')]
S60-PMC3695234	PMC3695234	7/2013	S60-PMC3695234	['supplementation with oral Vitamin D in 14 atopic subjects with moderate-to-severe atopic dermatitis for 21 days resulted in a significant increase in Cathelicidin Expression in ad-lesional skin.11ANOTHER pilot STUDY of winter-time onset or exacerbation of ad also SHOWED a favorable IMPACT of Vitamin D supplementation.12HOWEVER, there are CONFLICTING data surrounding the EFFECT of Vitamin D on the development of allergic Skin disease.']	[('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 283), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 319), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 373)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 150, 'cathelicidin'), ('GO_0010467', 'gene expression', 163, 'expression'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 424, 'skin')]
S25-PMC3702245	PMC3702245	6/2013	S25-PMC3702245	['there is CONTROVERSY concerning the EFFECT of maternal Vitamin D deficiency on Skeletal Development Of the Fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0000901', 'translation repressor activity, non-nucleic acid binding', 79, 'skeletal development of ... fetus'), ('UBERON_0004288', 'skeleton', 79, 'skeletal')]
S26-PMC3702245	PMC3702245	6/2013	S26-PMC3702245	['from Animal studies and SOME Human data, it is SUGGESTED that mineralization of the Fetal Skeleton is independent of Vitamin D and, THEREFORE, maternal Vitamin D deficiency has little EFFECT on fetal Skeletal Development.59IN CONTRAST, SOME recent OBSERVATIONAL STUDIES SUGGEST that Vitamin D nutrition during Pregnancy MAY AFFECT fetal Bone Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 324)]	10	[('NCBITaxon_33208', 'Metazoa', 5, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 29, 'human'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0004288', 'skeleton', 90, 'skeleton'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0001501', 'skeletal system development', 200, 'skeletal development'), ('UBERON_0004288', 'skeleton', 200, 'skeletal'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0048539', 'bone marrow development', 337, 'bone development')]
S30-PMC3702245	PMC3702245	6/2013	S30-PMC3702245	['maternal 25(Oh)D concentrations during Pregnancy was SHOWN in ONE uk STUDY48TO AFFECT childhood bone mass at nine years of age, but this WAS NOT confirmed in a larger more RECENT STUDY from the uk.61in populations where Vitamin D deficiency is very SEVERE, maternal Vitamin D deficiency during Pregnancy HAS BEEN ASSOCIATED with neonatal craniotabes62and congenital rickets.63–65taken TOGETHER, the results from OBSERVATIONAL studies SUGGEST a POSSIBLE EFFECT of low maternal 25(Oh)D during Pregnancy on Fetal Bone Development, BUT the ASSOCIATION with lower childhood bone mass is UNPROVEN.']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 172), ('IMPORTANT_CONSIDERATION', 249), ('INCOMPLETE_EVIDENCE', 304), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 385), ('INCOMPLETE_EVIDENCE', 412), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 444), ('SUPERFICIAL_RELATIONSHIP', 453), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 528), ('ANOMALY_CURIOUS_FINDING', 528), ('SUPERFICIAL_RELATIONSHIP', 536), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582)]	19	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 9, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 476, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 479, 'OH ... D'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('GO_0007631', 'feeding behavior', 504, 'fetal'), ('GO_0048539', 'bone marrow development', 510, 'bone development')]
S31-PMC3702245	PMC3702245	6/2013	S31-PMC3702245	['RANDOMIZED controlled TRIALS with large sample sizes ARE NEEDED to assess the EFFECT of maternal Vitamin D supplementation on fetal Bone Development.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0048539', 'bone marrow development', 132, 'bone development')]
S40-PMC3702245	PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]
S57-PMC3702245	PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
S30-PMC3705146	PMC3705146	5/2013	S30-PMC3705146	['mcgrath and welham (1999) have PROPOSED that Vitamin D availability MAY Modulate the eventual development of schizophrenia, and kinney et al.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 68)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0065007', 'biological regulation', 72, 'modulate')]
S208-PMC3705146	PMC3705146	5/2013	S208-PMC3705146	['with respect to the POSSIBLE ROLE of sunlight intensity in behavioral phenotypes, it HAS BEEN PROPOSED that cutaneous Vitamin D generation MAY BE INVOLVED in Gestational EFFECTS that Modulate the eventual development of schizophrenia (mcgrath and welham,1999).']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'gestational'), ('GO_0065007', 'biological regulation', 183, 'modulate')]
S224-PMC3705146	PMC3705146	5/2013	S224-PMC3705146	['an INTERACTION between Vitamin D and the melanotropin system during development HAS BEEN DEMONSTRATED by eyles et al.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 80)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
S0-PMC3713405	PMC3713405	7/2013	S0-PMC3713405	['altered Dopamine ontogeny in the developmentally Vitamin D deficient Rat and its relevance to schizophrenia\n\nabstract\nschizophrenia is a heterogeneous group of disorders with UNKNOWN etiology.']	[('FULL_UNKNOWN', 175)]	1	[('CHEBI_18243', 'dopamine', 8, 'dopamine'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 69, 'rat')]
S4-PMC3713405	PMC3713405	7/2013	S4-PMC3713405	['to address this we created an Animal MODEL of one such RISK FACTOR, developmental Vitamin D (Dvd) deficiency.']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('NCBITaxon_33208', 'Metazoa', 30, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 93, 'DVD')]
S29-PMC3713405	PMC3713405	7/2013	S29-PMC3713405	['EVIDENCE CONTINUES to mount from both epidemiological and pre-clinical studies to INDICATE that developmental Vitamin D (Dvd) deficiency MAY BE also an IMPORTANT developmental RISK factor for schizophrenia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 137), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 121, 'DVD')]
S40-PMC3713405	PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
S50-PMC3713405	PMC3713405	7/2013	S50-PMC3713405	['taken TOGETHER, these data SUPPORT the HYPOTHESIS that an absence of Vitamin D during development MAY lead to an INCREASED RISK of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S51-PMC3713405	PMC3713405	7/2013	S51-PMC3713405	['to establish the biological PLAUSIBILITY of WHETHER Dvd deficiency COULD BE RELATED to schizophrenia, our group ESTABLISHED a Dvd-deficient Rat MODEL which HAS SHOWN that low Prenatal Vitamin D adversely AFFECTS Brain Development and Adult behavior, ESPECIALLY da development and da-RELATED behaviors.']	[('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 204), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 283)]	10	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 52, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rat'), ('GO_0007565', 'female pregnancy', 175, 'prenatal'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007420', 'brain development', 212, 'brain development'), ('UBERON_0000955', 'brain', 212, 'brain'), ('UBERON_0007023', 'adult organism', 234, 'adult')]
S85-PMC3713405	PMC3713405	7/2013	S85-PMC3713405	['gross brain anatomy, mitosis and apoptosis\nthe initial absence of Vitamin D also AFFECTS OTHER, more general, aspects of Brain Development that do not directly RELATE to Da Neurons.']	[('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain'), ('CL_0000589', 'cochlear inner hair cell', 170, 'DA neurons')]
S133-PMC3713405	PMC3713405	7/2013	S133-PMC3713405	['the mechanism for HOW the developmental absence of Vitamin D MAY INFLUENCE Da Signaling in the Adult REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 18), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 101)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0038162', 'erythropoietin-mediated signaling pathway', 75, 'DA signaling'), ('UBERON_0007023', 'adult organism', 95, 'adult')]
S144-PMC3713405	PMC3713405	7/2013	S144-PMC3713405	['dvd-deficient e12 Embryos show decreased Gene Expression of nurr1, P57Kip2 and th (cui et al., 2010) SUGGESTING altered Vitamin D Signaling AFFECTS early Monoamine Cell Development, PERHAPS EVEN prior to e12.']	[('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 190)]	4	[('UBERON_0000922', 'embryo', 18, 'embryos'), ('GO_0010467', 'gene expression', 41, 'gene expression'), ('SO_0000704', 'gene', 41, 'gene'), ('PR_000004267', 'AT-rich interactive domain-containing protein 4A', 67, 'p57Kip2'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0043931', 'ossification involved in bone maturation', 120, 'vitamin D signaling'), ('CHEBI_17134', 'octopamine', 154, 'monoamine'), ('GO_0048468', 'cell development', 164, 'cell development')]
S150-PMC3713405	PMC3713405	7/2013	S150-PMC3713405	['CONSISTENT with the PREMISE that Vitamin D plays a ROLE in Dopaminergic Cell Development, Vdr Expression in the differentiating Field Of the Midbrain and Basal Ganglia can be observed by e15 (veenstra et al., 1998).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_18243', 'dopamine', 59, 'dopaminergic'), ('CL_0000700', 'dopaminergic neuron', 59, 'dopaminergic cell'), ('GO_0048569', 'post-embryonic animal organ development', 59, 'dopaminergic cell development'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 90, 'VDR'), ('GO_0010467', 'gene expression', 94, 'expression'), ('UBERON_0002615', 'ventral tegmental decussation', 128, 'field of ... midbrain'), ('UBERON_0002420', 'basal ganglion', 154, 'basal ganglia')]
S69-PMC3717170	PMC3717170	5/2013	S69-PMC3717170	"[""in addition, FEW randomized controlled trials HAVE BEEN conducted in Pregnant women to determine optimal Vitamin D status.13–15\ncarol l. wagner (medical university of south carolina) DISCUSSED two RECENT STUDIES performed by her group in collaboration with bruce hollis's group—the national institute of child health and Human development (nichd) Vitamin D Pregnancy trial12and the thrasher research fund Vitamin D community-based supplementation trial16—that INDICATE that 400 iu Vitamin D, the amount found in MOST Prenatal Vitamins, is INADEQUATE and that 4000 iu/day is NECESSARY to optimize 1,25(Oh)2D3Production, achieved when total circulating 25(Oh)d3is at least 40 ng/ml (fig.""]"	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 460), ('PROBABLE_UNDERSTANDING', 512), ('IMPORTANT_CONSIDERATION', 539), ('PROBLEM_COMPLICATION', 539), ('IMPORTANT_CONSIDERATION', 574)]	9	[('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 321, 'Human'), ('CHEBI_28384', 'vitamin K', 347, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 405, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 405, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 481, 'vitamin D'), ('GO_0007565', 'female pregnancy', 517, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 526, 'vitamins'), ('CHEBI_37983', 'sulfur-35 atom', 596, '1'), ('CHEBI_74151', 'S-palmitoyl-L-cysteine residue', 597, ',25(OH)2D3production'), ('PR_000029121', 'leucine-rich repeat and guanylate kinase domain-containing protein', 604, '2D3production'), ('CHEBI_33310', 'neon atom', 653, '(OH)')]
S139-PMC3717170	PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
S23-PMC3728489	PMC3728489	7/2013	S23-PMC3728489	['we will highlight examples of three Micronutrients—Folate, Iodine, and Vitamin D—and discuss their PROVEN and POTENTIAL preventive EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 131)]	3	[('CHEBI_33839', 'macromolecule', 36, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 51, 'folate'), ('CHEBI_24859', 'iodine atom', 59, 'iodine'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007399', 'nervous system development', 142, 'neurodevelopmental')]
S169-PMC3728489	PMC3728489	7/2013	S169-PMC3728489	['it HAS also BEEN SUGGESTED that maternal Intake of Vitamin E and polyunsaturated Fatty Acids during Pregnancy MAY INFLUENCE Development Of the Immune System and be IMPLICATED in childhood asthma and allergy.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 164)]	5	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_35366', 'fatty acid', 81, 'fatty acids'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0002020', 'protease binding', 124, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
S282-PMC3728489	PMC3728489	7/2013	S282-PMC3728489	['for illustration, we have selected three Micronutrients—Folate, Iodine, and Vitamin D—and discuss their PROVEN and POTENTIAL PREVENTIVE EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_33839', 'macromolecule', 41, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 56, 'folate'), ('CHEBI_24859', 'iodine atom', 64, 'iodine'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007399', 'nervous system development', 147, 'neurodevelopmental')]
S311-PMC3728489	PMC3728489	7/2013	S311-PMC3728489	['Vitamin D\nwe have DESCRIBED earlier HOW Vitamin D is PIVOTAL in early Immune Development and it is also known to be CRUCIAL for early Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 18), ('EXPLICIT_QUESTION', 36), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001822', 'kidney development', 70, 'immune development'), ('UBERON_0002405', 'immune system', 70, 'immune'), ('GO_0001501', 'skeletal system development', 134, 'skeletal development'), ('UBERON_0004288', 'skeleton', 134, 'skeletal')]
S312-PMC3728489	PMC3728489	7/2013	S312-PMC3728489	['it HAS BEEN PROPOSED, THOUGH NOT PROVEN, that low levels of Vitamin D during Pregnancy and infancy COULD increase the RISK of Neurodevelopmental disorders, and that supplementation COULD play a ROLE in prevention.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 126, 'neurodevelopmental')]
S319-PMC3728489	PMC3728489	7/2013	S319-PMC3728489	['fish oil (that commonly contains Vitamin D) and OTHER omega 3 Fatty Acid supplements taken in infancy HAVE BEEN ASSOCIATED with improved Cognitive development, THOUGH this evidence is also far from definitive (auestad et al.,2003; karr et al.,2011; meldrum et al.,2012; luchtman and song,2013).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acid'), ('GO_0050890', 'cognition', 137, 'cognitive')]
S340-PMC3728489	PMC3728489	7/2013	S340-PMC3728489	['they also HAVE BEEN ASSOCIATED with increased offspring risk for Respiratory infections (Vitamin D), Intestinal inflammation and diarrhea (Folate and Vitamin A), allergy and asthma (Vitamin E and Folate) and Neurodevelopmental disorders (Folate).']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0001004', 'respiratory system', 65, 'respiratory'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000160', 'intestine', 101, 'intestinal'), ('CHEBI_30863', '5-azaorotic acid', 139, 'folate'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 196, 'folate'), ('GO_0007399', 'nervous system development', 208, 'neurodevelopmental'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]
S348-PMC3728489	PMC3728489	7/2013	S348-PMC3728489	['we REPORTED three examples of Micronutrients—Folate, Iodine, and Vitamin D—and discussed their PROVEN and POTENTIAL preventive EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_33839', 'macromolecule', 30, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 45, 'folate'), ('CHEBI_24859', 'iodine atom', 53, 'iodine'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007399', 'nervous system development', 138, 'neurodevelopmental')]
S43-PMC3734354	PMC3734354	7/2013	S43-PMC3734354	['WHILE many Nutrients have a ROLE to play in Brain Development, certain ones SEEM TO BE of particular IMPORTANCE during fetal and neonatal life: protein, iron, zinc, Selenium, Iodine, Folate, Vitamin A, Choline, and Long-Chain polyunsaturated Fatty Acids (lcpufas) (georgieff,2007).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 76), ('IMPORTANT_CONSIDERATION', 101)]	4	[('CHEBI_33284', 'nutrient', 11, 'nutrients'), ('GO_0007420', 'brain development', 44, 'brain development'), ('UBERON_0000955', 'brain', 44, 'brain'), ('CHEBI_27568', 'selenium atom', 165, 'selenium'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_15354', 'choline', 202, 'choline'), ('CHEBI_28911', 'cob(III)alamin', 215, 'long-chain'), ('CHEBI_35366', 'fatty acid', 242, 'fatty acids')]
S20-PMC3739737	PMC3739737	8/2013	S20-PMC3739737	['WHILE there is now a considerable body of research examining the IMPACT of developmental Vitamin D (dvd) deficiency on Brain outcomes, there is relatively LITTLE KNOWN about the IMPACT of Adult Vitamin D (avd) deficiency on Rodent behaviour.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 155), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 224, 'rodent')]
S120-PMC3739737	PMC3739737	8/2013	S120-PMC3739737	['IN CONTRAST TO behavioural features IDENTIFIED in Rats exposed to developmental Vitamin D deficiency, avd deficiency was not associated with altered responses to Mk-801[13]or Amphetamine[14].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 50, 'rats'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('PR_000000124', 'ribosomal protein S6 kinase beta-2', 162, 'MK-801'), ('CHEBI_2687', 'amsacrine', 175, 'amphetamine')]
S39-PMC3760821	PMC3760821	9/2013	S39-PMC3760821	['WHILE it HAS BEEN SPECULATED that Vitamin D deficiency MAY BE causal in the development of adiposity and, POTENTIALLY, its co-morbidities, a RECENT STUDY using Genetic Markers AS instrumental VARIABLES in bi-directional mendelian randomization analysis has PROVIDED EVIDENCE that a higher bmi leads to lower 25ohd and that the LIKELIHOOD of lower 25ohd increasing bmi is small[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 176), ('SUPERFICIAL_RELATIONSHIP', 192), ('PROBABLE_UNDERSTANDING', 257), ('INCOMPLETE_EVIDENCE', 266), ('PROBABLE_UNDERSTANDING', 327)]	11	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0001645', 'genetic_marker', 160, 'genetic markers')]
S0-PMC3773018	PMC3773018	4/2013	S0-PMC3773018	['the longitudinal trajectory of Vitamin D status from Birth to early childhood on the development of Food sensitization\n\nabstract\n\nbackground\nINCREASING EVIDENCE SUPPORTS the immunomodulatory EFFECT of Vitamin D on Allergic diseases.']	[('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('GO_0007567', 'parturition', 53, 'Birth'), ('CHEBI_33290', 'food', 100, 'Food'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0040011', 'locomotion', 214, 'allergic')]
S1-PMC3773018	PMC3773018	4/2013	S1-PMC3773018	['the combined ROLE of Prenatal and Postnatal Vitamin D status in the development of Food Sensitization (fs) and Food Allergy REMAINS under-STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 137)]	3	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('GO_0007567', 'parturition', 34, 'postnatal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_33290', 'food', 83, 'food'), ('GO_0031318', 'detection of folic acid', 83, 'food sensitization'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007631', 'feeding behavior', 111, 'food allergy')]
S7-PMC3773018	PMC3773018	4/2013	S7-PMC3773018	['conclusions\nPrenatal and early Postnatal Vitamin D levels, along with individual Genetic susceptibility, SHOULD BE CONSIDERED in assessing the ROLE of Vitamin D in the development of fs and Food allergy.']	[('FUTURE_WORK', 105), ('FUTURE_WORK', 115), ('SUPERFICIAL_RELATIONSHIP', 143)]	3	[('GO_0007565', 'female pregnancy', 12, 'Prenatal'), ('GO_0007567', 'parturition', 31, 'postnatal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('SO_0000704', 'gene', 81, 'genetic'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_33290', 'food', 190, 'food')]
S9-PMC3773018	PMC3773018	4/2013	S9-PMC3773018	['the Vitamin D HYPOTHESIS, one of several HYPOTHESES on the development Of Food Allergy, was first SUGGESTED in 2007(2), and the POTENTIAL mechanisms were later PROPOSED in detail by vassallo et al.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 160)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0042067', 'establishment of ommatidial planar polarity', 71, 'of food allergy'), ('CHEBI_33290', 'food', 74, 'food')]
S12-PMC3773018	PMC3773018	4/2013	S12-PMC3773018	['PREVIOUS STUDIES (11–15) INDICATE that the immunomodulatory EFFECTS of Vitamin D, including its CONTRIBUTION to the development of allergic diseases, begin in utero .']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
S19-PMC3773018	PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
S61-PMC3773018	PMC3773018	4/2013	S61-PMC3773018	['discussion\nTHIS is the FIRST STUDY TO EXAMINE the EFFECTS of longitudinal trajectory Vitamin D status, by measurement of Plasma 25(Oh)D concentrations from Birth to early childhood, on the development of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 128, '25(OH ... D'), ('GO_0007567', 'parturition', 156, 'birth')]
S63-PMC3773018	PMC3773018	4/2013	S63-PMC3773018	['OUR FINDINGS SUGGEST that both Prenatal and early Postnatal Vitamin D levels APPEAR TO play an IMPORTANT ROLE in the development of fs, ESPECIALLY among those with specific genotypes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 77), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 136)]	6	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S74-PMC3773018	PMC3773018	4/2013	S74-PMC3773018	['the FINDINGS from THIS extended STUDY EMPHASIZE the IMPORTANT ROLE of Postnatal Vitamin D status in the development of fs.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 62)]	6	[('GO_0007567', 'parturition', 70, 'postnatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
S99-PMC3773018	PMC3773018	4/2013	S99-PMC3773018	['the biological mechanisms UNDERPINNING the ASSOCIATIONS between persistently low Vitamin D and the development of fs and then Food allergy include excessive exposure to abundant Food Allergens caused by increased Gastrointestinal Barrier permeability and decreased Immune tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_33290', 'food', 126, 'food'), ('CHEBI_33290', 'food', 178, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 183, 'allergens'), ('UBERON_0010172', 'bulb of aorta', 213, 'gastrointestinal barrier'), ('UBERON_0002405', 'immune system', 265, 'immune')]
S105-PMC3773018	PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]
S55-PMC3809191	PMC3809191	1/2013	S55-PMC3809191	['in ONE cross-sectional STUDY, Serum 25(Oh) D levels during 24-28 weeks of Gestation were lower in gdm women than in nondiabetic Pregnant women.9in ANOTHER STUDY, maternal Serum 25 (Oh) D concentrations measured at the time of gdm screening test were significantly and inversely ASSOCIATED with fasting glucose, ALTHOUGH the ASSOCIATION of Vitamin D with gdm risk was not statistically significant.8our FINDINGS are also CONSISTENT with a study in an indian population, SHOWING no significant ASSOCIATION between 25 (Oh) D concentrations (at 30 weeks of Gestation) and gdm risk.6\ndeficiency of Vitamin D was shown to be ASSOCIATED with fetal and Brain growth deficiency and type 1 diabetes in children.13significantly reduced risk of type 1 Diabetes Mellitus Development was FOUND when high doses of Vitamin D supplementation (up to 2000 iu/d) were given during infancy in a Birth-cohort study.14\nVitamin D deficiency was also ASSOCIATED with INCREASED risk for Pregnancy complications and SERIOUS health PROBLEMS in the offspring.5,15-17higher risks of Preeclampsia and cesarean section ratios were shown in Pregnants with low levels of Vitamin D.16,17moreover supplementation of Vitamin D HAS BEEN DEMONSTRATED to decrease the RISK of Preeclampsia by 27% in a STUDY.18\n\ncaption (fig): fig.1\n\nthe correlation between Serum Vitamin D and pth levels\n\ncaption (fig): fig.2\n\nSerum Vitamin D levels in veiled and nonveiled Pregnant\n\ncaption (fig): fig.3\n\nVitamin D levels and the frequency of muscle cramps (x²=3.57, p=0.05).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 278), ('ANOMALY_CURIOUS_FINDING', 311), ('SUPERFICIAL_RELATIONSHIP', 324), ('INCOMPLETE_EVIDENCE', 402), ('INCOMPLETE_EVIDENCE', 420), ('INCOMPLETE_EVIDENCE', 469), ('SUPERFICIAL_RELATIONSHIP', 492), ('SUPERFICIAL_RELATIONSHIP', 619), ('INCOMPLETE_EVIDENCE', 774), ('SUPERFICIAL_RELATIONSHIP', 926), ('IMPORTANT_CONSIDERATION', 942), ('IMPORTANT_CONSIDERATION', 989), ('IMPORTANT_CONSIDERATION', 1004), ('INCOMPLETE_EVIDENCE', 1190), ('IMPORTANT_CONSIDERATION', 1228), ('INCOMPLETE_EVIDENCE', 1261)]	19	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 36, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_71657', 'versiconol acetate', 177, '25 (OH) D'), ('PR_000009880', 'Lon protease, mitochondrial', 177, '25 ... OH ... D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 339, 'Vitamin'), ('CHEBI_71657', 'versiconol acetate', 512, '25 (OH) D'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('CHEBI_27300', 'vitamin D', 593, 'vitamin D'), ('UBERON_0000955', 'brain', 645, 'brain'), ('GO_1903709', 'uterine gland development', 740, 'diabetes mellitus development'), ('CHEBI_27300', 'vitamin D', 799, 'vitamin D'), ('GO_0007567', 'parturition', 874, 'birth'), ('CHEBI_28384', 'vitamin K', 896, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 1053, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 1108, 'pregnants'), ('CHEBI_28384', 'vitamin K', 1137, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 1236, 'preeclampsia'), ('UBERON_0001977', 'blood serum', 1317, 'serum'), ('CHEBI_28384', 'vitamin K', 1323, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1323, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 1371, 'Serum'), ('CHEBI_28384', 'vitamin K', 1377, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1377, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1418, 'pregnant'), ('CHEBI_28384', 'vitamin K', 1450, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1450, 'Vitamin D')]
S60-PMC3809191	PMC3809191	1/2013	S60-PMC3809191	['first, Serum 25 (Oh) D concentrations determined in late trimester MAY not show the status of maternal Vitamin D during the whole Pregnancy Period and HENCE to IDENTIFY the ASSOCIATION of Gdm Development and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 151), ('QUESTION_ANSWERED_BY_THIS_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_71657', 'versiconol acetate', 13, '25 (OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 21, 'D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('UBERON_0018298', 'stylocone', 130, 'pregnancy period'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 188, 'GDM development'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
S10-PMC3814422	PMC3814422	10/2013	S10-PMC3814422	['introduction\nVitamin D MAY play an IMPORTANT ROLE in normal fetal Lung and Immune System Development1And there is increasing SPECULATION that maternal Vitamin D status in Pregnancy MIGHT be causally LINKED to the development of asthma and atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0006266', 'DNA ligation', 66, 'lung ...'), ('UBERON_0002048', 'lung', 66, 'lung'), ('GO_0002415', 'immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor', 75, 'immune system development1and'), ('UBERON_0002405', 'immune system', 75, 'immune system'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
S137-PMC3814422	PMC3814422	10/2013	S137-PMC3814422	['ALTHOUGH Animal studies HAVE SHOWN that Vitamin D is INVOLVED in normal Fetal Lung Development31, OUR STUDY is IN GENERAL AGREEMENT with OTHER epidemiological STUDIES that have considered later offspring Lung function in the general population – two STUDIES HAVE REPORTED null ASSOCIATIONS of maternal 25(Oh)D13,32or dietary Vitamin D intake32with offspring Lung function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('INCOMPLETE_EVIDENCE', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 277)]	11	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007631', 'feeding behavior', 72, 'fetal'), ('GO_0030324', 'lung development', 78, 'lung development31'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0002048', 'lung', 204, 'lung'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 302, '25(OH)D13'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('UBERON_0002048', 'lung', 358, 'lung')]
S139-PMC3814422	PMC3814422	10/2013	S139-PMC3814422	['in particular, we have not FOUND EVIDENCE to SUGGEST that higher Prenatal Vitamin D status in Pregnancy PROTECTS against the development of early childhood wheezing or later asthma.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
S94-PMC3827489	PMC3827489	10/2013	S94-PMC3827489	['there are prospective studies SUGGESTING that higher maternal Vitamin D status during Pregnancy MAY lower the development of wheezing episodes in infancy70,71)or Lower Respiratory Tract infections72).']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('UBERON_0009567', 'nail of pedal digit', 162, 'lower'), ('UBERON_0000065', 'respiratory tract', 168, 'respiratory tract')]
S95-PMC3827489	PMC3827489	10/2013	S95-PMC3827489	['ONE STUDY FOUND that higher maternal Vitamin D status during Pregnancy increased the development of atopic dermatitis or asthma in the offspring69), and another FOUND no significant associations between maternal late-Pregnancy Vitamin D status and either asthma or wheezing at the age of 6 years73).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 161)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
S0-PMC3888066	PMC3888066	12/2012	S0-PMC3888066	['monitoring maternal Beta Carotene and Retinol consumption MAY decrease the incidence of Neurodevelopmental disorders in offspring\n\nabstract\nRetinoic Acids (13-Cis and 13-trans) are known Teratogens, and their precursor is Retinol, a form of Vitamin A.']	[('INCOMPLETE_EVIDENCE', 58)]	1	[('CHEBI_50102', 'N-methyl-N-nitrosourea', 20, 'Beta Carotene'), ('CHEBI_27810', 'resorcinol', 38, 'Retinol'), ('GO_0007285', 'primary spermatocyte growth', 88, 'Neurodevelopmental'), ('CHEBI_26536', 'retinoic acid', 140, 'Retinoic acids'), ('CHEBI_33804', 'gluconates', 156, '13-cis'), ('CHEBI_50114', 'estrogen', 187, 'teratogens'), ('CHEBI_26536', 'retinoic acid', 222, 'retinol'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin A')]
S14-PMC3888066	PMC3888066	12/2012	S14-PMC3888066	['methodologies used in this study HAVE BEEN CRITICIZED, including aggregating Heart defects as Neural Crest defects, ESTIMATING missing information on Retinol supplementation and DEMONSTRATING the Vitamin A threshold of >10,000 iu/day.9SUBSEQUENT STUDIES have DISPUTED the 10,000 iu/day THRESHOLD BASED ON Non-Human Primate STUDIES and SMALL clinical trials in Humans.10\n\nEVIDENCE to SUPPORT the NOTION that a Toxin is responsible for SOME Neurodevelopmental disorders\na Toxin that MAY cause Neurodevelopmental disorders MUST BE able to cross NOT ONLY the Placenta, BUT ALSO the Blood Brain Barrier (bbb).']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 259), ('PROBABLE_UNDERSTANDING', 286), ('INCOMPLETE_EVIDENCE', 296), ('PROBABLE_UNDERSTANDING', 296), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 371), ('INCOMPLETE_EVIDENCE', 383), ('INCOMPLETE_EVIDENCE', 395), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 481), ('IMPORTANT_CONSIDERATION', 520), ('ANOMALY_CURIOUS_FINDING', 542)]	19	[('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002342', 'neural crest', 94, 'neural crest'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 309, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'primate'), ('NCBITaxon_9606', 'Homo sapiens', 360, 'humans'), ('CHEBI_27026', 'toxin', 409, 'toxin'), ('GO_0007399', 'nervous system development', 439, 'neurodevelopmental'), ('CHEBI_27026', 'toxin', 470, 'toxin'), ('GO_0007399', 'nervous system development', 491, 'neurodevelopmental'), ('UBERON_0001987', 'placenta', 555, 'placenta'), ('UBERON_0000120', 'blood brain barrier', 578, 'blood brain barrier')]
S52-PMC3888066	PMC3888066	12/2012	S52-PMC3888066	['conclusion and implications for care\nhigh levels of fetal Retinoic Acid, a Metabolite of Vitamin A, are KNOWN to be Teratogenic and MAY BE ASSOCIATED with developmental defects of the Central Nervous System, PARTICULARLY involving the Cerebellum, resulting in Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 208)]	4	[('CHEBI_26536', 'retinoic acid', 58, 'retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 75, 'metabolite'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_50905', 'teratogenic agent', 116, 'teratogenic'), ('UBERON_0001017', 'central nervous system', 184, 'central nervous system'), ('UBERON_0002037', 'cerebellum', 235, 'cerebellum'), ('GO_0007399', 'nervous system development', 260, 'neurodevelopmental')]
S58-PMC3888066	PMC3888066	12/2012	S58-PMC3888066	['this author BELIEVES that AWARENESS and simple monitoring of all POTENTIAL sources of Retinoic Acid during the first Trimester of Pregnancy, including nutritional supplements, dietary Vitamin A from Animal sources, and Beta Carotene, MAY decrease the incidence of Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 234)]	4	[('CHEBI_26536', 'retinoic acid', 86, 'retinoic acid'), ('GO_0009294', 'DNA mediated transformation', 117, 'trimester'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 199, 'animal'), ('CHEBI_86157', 'cadmium sulfate hydrate', 219, 'beta'), ('CHEBI_23042', 'carotene', 224, 'carotene'), ('GO_0007399', 'nervous system development', 264, 'neurodevelopmental')]
S94-PMC3901983	PMC3901983	1/2013	S94-PMC3901983	['the adequate level of the Vitamin A is NECESSARY especially in the second and third Pregnancy trimesters for normal Fetal Lung Development and Maturation.']	[('IMPORTANT_CONSIDERATION', 39)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0007631', 'feeding behavior', 116, 'fetal'), ('GO_0030324', 'lung development', 122, 'lung development'), ('UBERON_0002048', 'lung', 122, 'lung'), ('GO_0007618', 'mating', 143, 'maturation')]
S162-PMC3901983	PMC3901983	1/2013	S162-PMC3901983	['it is ESSENTIAL to maintain Micronutrients supplementation also after Delivery and during breastfeeding, to ensure appropriate Vitamins and Minerals intake to neonate and to prevent Vitamin B deficiency, which CAN INDICATE SEVERE COMPLICATIONS including failure in thriving, megaloblastic anemia, and development delays [3,14].']	[('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 230)]	5	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007567', 'parturition', 70, 'delivery'), ('CHEBI_33277', 'gamma-tocotrienol', 127, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 140, 'minerals'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin B')]
S163-PMC3901983	PMC3901983	1/2013	S163-PMC3901983	['it was REPORTED that after adequate Vitamin B supplementation improvements in growth, development and reversal of anemia are OBSERVED [7].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 125)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin B')]
S0-PMC3926113	PMC3926113	1/2014	S0-PMC3926113	['Prenatal Vitamin C deficiency results in DIFFERENTIAL levels of oxidative stress during late Gestation in foetal guinea pig Brains\n\nabstract\nantioxidant defences are comparatively low during Foetal Development making the Brain PARTICULARLY susceptible to oxidative stress during antioxidant deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('UBERON_0000955', 'brain', 124, 'brains'), ('GO_0060324', 'face development', 191, 'foetal development'), ('UBERON_0000955', 'brain', 221, 'brain')]
S1-PMC3926113	PMC3926113	1/2014	S1-PMC3926113	['the Brain is one of the Organs containing the highest concentration of Vitamin C (Vitc) and Vitc deficiency during Foetal Development MAY place the Brain AT RISK of redox status imbalance.']	[('INCOMPLETE_EVIDENCE', 134), ('IMPORTANT_CONSIDERATION', 154)]	2	[('UBERON_0000955', 'brain', 4, 'brain'), ('UBERON_0000062', 'organ', 24, 'organs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('PR_000017299', 'VIP peptides', 82, 'VitC'), ('PR_000017299', 'VIP peptides', 92, 'VitC'), ('GO_0060324', 'face development', 115, 'foetal development'), ('UBERON_0000955', 'brain', 148, 'brain')]
S2-PMC3926113	PMC3926113	1/2014	S2-PMC3926113	['in the PRESENT STUDY, we INVESTIGATED the developmental pattern and EFFECT of vitc deficiency on antioxidants, Vitamin E and Superoxide dismutase (sod), assessed oxidative damage by measuring Malondialdehyde (Mda), Hydroxynonenal (Hne) and Nitrotyrosine (Nt) and analysed Gene and protein Expression of Apoptosis marker Caspase-3 in the guinea pig foetal Brain at two Gestational (gd) time points, gd 45/pre-term and gd 56/near term following either a vitc sufficient (ctrl) or deficient (def) maternal dietary regime.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin E'), ('CHEBI_18421', 'superoxide', 125, 'superoxide'), ('CHEBI_16480', 'nitric oxide', 192, 'malondialdehyde'), ('CHEBI_34840', 'methyl methacrylate', 209, 'MDA'), ('CHEBI_5445', 'glyceraldehyde', 215, 'hydroxynonenal'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 231, 'HNE'), ('CHEBI_50654', 'but-2-enoate ester', 240, 'nitrotyrosine'), ('CHEBI_13389', 'NAD', 255, 'NT'), ('SO_0000704', 'gene', 272, 'gene'), ('GO_0010467', 'gene expression', 289, 'expression'), ('GO_0006915', 'apoptotic process', 303, 'apoptosis'), ('PR_000002319', 'catenin beta-1 isoform 1', 320, 'caspase-3'), ('UBERON_0000955', 'brain', 355, 'brain'), ('GO_0007565', 'female pregnancy', 368, 'gestational')]
S36-PMC3973641	PMC3973641	4/2014	S36-PMC3973641	['considering that exposure to suboptimal nutrition during early development LEADS TO a long-term, age-DEPENDENT Metabolic response[26], we INVESTIGATED the EFFECTS of a Vitamin B-deficient diet during Pregnancy or Pregnancy/Lactation in Mice offspring.']	[('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('GO_0008152', 'metabolic process', 111, 'metabolic'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin B'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('GO_0007595', 'lactation', 223, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'mice')]
S67-PMC3991049	PMC3991049	11/2013	S67-PMC3991049	['the IMPORTANCE of Vitamin D for fetal and infant Skeletal Development HAS LONG BEEN RECOGNIZED.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0001501', 'skeletal system development', 49, 'skeletal development'), ('UBERON_0004288', 'skeleton', 49, 'skeletal')]
S192-PMC4045304	PMC4045304	2/2014	S192-PMC4045304	['BECAUSE activated Vitamin D (1, 25-Dihydroxy Vitamin D), a Secosteroid, upregulates the Dna Repair Gene, Vitamin deficiency during development MAY inhibit the Repair of de novo dna mutations in fetuses and infants and THUS CONTRIBUTE to risk of autism.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 223)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_35785', 'sphingoid', 59, 'secosteroid'), ('GO_0006281', 'DNA repair', 88, 'DNA repair'), ('SO_0000704', 'gene', 99, 'gene'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('GO_0006281', 'DNA repair', 159, 'repair')]
S219-PMC4045304	PMC4045304	2/2014	S219-PMC4045304	"[""ANOTHER PROPOSED HYPOTHESIS for the ROLE of Vitamin D in development of autism HAS TO do with Vitamin D's function in the Dna Repair and maintenance [95].""]"	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 79)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0006281', 'DNA repair', 122, 'DNA repair')]
S227-PMC4045304	PMC4045304	2/2014	S227-PMC4045304	['the ROLE or ROLES Vitamin D MAY play in development of asd MAY BE resolved by randomized clinical trials of Prenatal Vitamin D supplementation or Vitamin D supplementation of newborns or in early childhood.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'prenatal'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
S243-PMC4045304	PMC4045304	2/2014	S243-PMC4045304	['these studies INDICATE that maternal mcs, particularly diabetes, MAY BE ASSOCIATED with Neurodevelopmental PROBLEMS in children and Vitamin D supplementation early in childhood SHOULD BE given further CONSIDERATION in treatment of asd [103–105].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 177), ('FUTURE_WORK', 201)]	6	[('GO_0007399', 'nervous system development', 88, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
S272-PMC4045304	PMC4045304	2/2014	S272-PMC4045304	['POOR maternal Vitamin D status or early childhood Vitamin deficiency or low activity of various Vitamin D RELATED enzymes MAY result in deficient activity in the Vitamin D system crucial for Brain Development.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 50, 'vitamin'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007420', 'brain development', 191, 'brain development'), ('UBERON_0000955', 'brain', 191, 'brain')]
S69-PMC4071151	PMC4071151	6/2014	S69-PMC4071151	['Nutrients such as Vitamins A, b6, b12 and Folic Acid and zinc AFFECT Embryogenesis and a deficiency in any of these elements MAY BE RELATED to spontaneous abortion failure and to a spectrum of Neurodevelopmental disorders [16].']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 18, 'vitamins A'), ('CHEBI_30751', 'formic acid', 42, 'folic acid'), ('GO_0009790', 'embryo development', 69, 'embryogenesis'), ('GO_0007399', 'nervous system development', 193, 'neurodevelopmental')]
S80-PMC4071151	PMC4071151	6/2014	S80-PMC4071151	['signs of congenital Ocular abnormalities such as microphthalmia, characterized by abnormally small Eyes with or without structural abnormalities, MAY depend on Vitamin A deficiency leading to a disruption of Ocular Development [20,25].']	[('INCOMPLETE_EVIDENCE', 146)]	1	[('UBERON_0000970', 'eye', 20, 'ocular'), ('UBERON_0000970', 'eye', 99, 'eyes'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('GO_0001654', 'eye development', 208, 'ocular development'), ('UBERON_0000970', 'eye', 208, 'ocular')]
S1-PMC4072587	PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
S12-PMC4072587	PMC4072587	6/2014	S12-PMC4072587	['IMPORTANT biological functions involving growth and developmental outcomes HAVE BEEN ATTRIBUTED to Vitamin D, and deficiency during Pregnancy MAY result in IMPORTANT health CONSEQUENCES for both mother and child[3],[4],[5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 156), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy')]
S22-PMC4072587	PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]
S24-PMC4072587	PMC4072587	6/2014	S24-PMC4072587	['the ROLE of Vitamin D deficiency during Pregnancy on longer term infant outcomes, PARTICULARLY with regard to early Childhood development is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 82), ('FULL_UNKNOWN', 141)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('UBERON_0013628', 'pollical pad', 116, 'childhood')]
S77-PMC4072587	PMC4072587	6/2014	S77-PMC4072587	['multivariable linear regression was performed to derive estimates of mean differences (95% confidence intervals (ci)) of the continuous outcome data (developmental composite scores of the infant at 6 months, Gestational age and anthropometric measurements) ASSOCIATED with maternal Vitamin D concentrations at 32 weeks, and multivariable logistic regression was used to assess the ASSOCIATIONS between maternal Vitamin D concentrations and the binary outcomes (Preterm Delivery, low Birth weight, small for Gestational age and infant stunting).']	[('SUPERFICIAL_RELATIONSHIP', 257), ('SUPERFICIAL_RELATIONSHIP', 381)]	2	[('GO_0007565', 'female pregnancy', 208, 'gestational'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('GO_0007565', 'female pregnancy', 461, 'preterm'), ('GO_0007567', 'parturition', 469, 'delivery'), ('GO_0007567', 'parturition', 483, 'birth'), ('GO_0007565', 'female pregnancy', 507, 'gestational')]
S82-PMC4072587	PMC4072587	6/2014	S82-PMC4072587	['to further investigate the presence of a POTENTIAL threshold EFFECT of Vitamin D concentration on infant developmental outcomes[24], secondary statistical analyses were performed on maternal Vitamin D concentration categorized as deficient (<37.5 nmol/l), insufficient(≥37.5 nmol/l and <75 nmol/l) or replete (≥75 nmol/l).']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
S99-PMC4072587	PMC4072587	6/2014	S99-PMC4072587	['HOWEVER, lower language composite scores were SEEN in infants Born to women with Vitamin D deficiency (<37.5 nmol/l) compared to those Born to women who were Vitamin D replete (≥75 nmol/l) (md −3.48, 95% ci −5.52 to −1.44) (table 5).10.1371/journal.pone.0099005.t004\n\ncaption (table-wrap): table 4\ndevelopmental composite scores at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted model 1adjusted model 2domainmean developmental composite score [sd]mean difference1,2(95% ci)p valuemean difference1,3(95% ci)p valuemean difference1,4(95% ci)p valuecognitive104.5 [10.1]−0.47 (−1.22 to 0.27)0.21−0.39 (−1.19 to 0.40)0.30−0.43 (−1.23 to 0.370.29language97.8 [7.6]−0.02 (−0.58 to 0.55)0.960.04 (−0.51 to 0.59)0.890.08 (−0.47 to 0.63)0.77motor110.9 [13.4]0.03 (−0.97 to 1.03)0.950.25 (−0.71 to 1.21)0.610.05 (−0.92 to 0.64)0.92socio-emotional79.6 [9.8]−0.12 (−0.85 to 0.61)0.75−0.06 (−0.81 to 0.70)0.88−0.14 (−0.92 to 0.64)0.71\nvalues are ESTIMATED mean difference for each outcome associated with a 25 nmol/l increase in Vitamin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 348), ('INCOMPLETE_EVIDENCE', 1010)]	5	[('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001977', 'blood serum', 373, 'serum'), ('CHEBI_72765', 'verruculogen', 379, '25-OHD'), ('GO_0007565', 'female pregnancy', 421, 'gestation'), ('CHEBI_33229', 'vitamin (role)', 1093, 'vitamin')]
S113-PMC4072587	PMC4072587	6/2014	S113-PMC4072587	['OUR FINDINGS SHOW that low Vitamin D levels in late Pregnancy (<37.5 nmol/l) are ASSOCIATED with reduced infant Language Development at six months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 112, 'language development')]
S122-PMC4072587	PMC4072587	6/2014	S122-PMC4072587	['the OBSERVED ASSOCIATION between Antenatal Vitamin D concentration and infant development is PLAUSIBLE AS Vitamin D has an IMPORTANT ROLE in Neurodevelopment through Cell Differentiation, cytokine Regulation, neurotransmitter synthesis and anti-oxidant activity, and it is HAS BEEN SUGGESTED that in utero exposure to Vitamin D deficiency during the second and third trimesters MAY AFFECT the development of the perisylvian structures, which are responsible for Language in children[24],[39].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 103), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 273), ('INCOMPLETE_EVIDENCE', 378), ('SUPERFICIAL_RELATIONSHIP', 382)]	9	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007399', 'nervous system development', 141, 'neurodevelopment'), ('GO_0030154', 'cell differentiation', 166, 'cell differentiation'), ('GO_0065007', 'biological regulation', 197, 'regulation'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0006266', 'DNA ligation', 462, 'language')]
S124-PMC4072587	PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]
S155-PMC4072587	PMC4072587	6/2014	S155-PMC4072587	['conclusions\nOUR STUDY INDICATES that low levels of Vitamin D during Pregnancy are of CONCERN in rural vietnam, and are ASSOCIATED with impaired Language Development at 6 months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('PROBLEM_COMPLICATION', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 144, 'language development')]
S156-PMC4072587	PMC4072587	6/2014	S156-PMC4072587	['our results STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy and HIGHLIGHT the NEED FOR FURTHER RESEARCH to explore the IMPACT of supplementation on longer term child growth and developmental outcomes, PARTICULARLY with regard to language.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 108), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 149), ('IMPORTANT_CONSIDERATION', 231)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
S441-PMC4113768	PMC4113768	7/2014	S441-PMC4113768	['background: there is GROWING EVIDENCE from OBSERVATIONAL epidemiological and Animal studies that foetal Vitamin D deficiency MAY BE a risk factor for the development of neuropsychiatric disorders in adulthood, and that this MAY BE ASSOCIATED with increased Lateral Ventricle diameter (ventriculomegaly) in the foetal Brain.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('NCBITaxon_33208', 'Metazoa', 77, 'animal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0002285', 'telencephalic ventricle', 257, 'lateral ventricle'), ('UBERON_0000955', 'brain', 317, 'brain')]
S443-PMC4113768	PMC4113768	7/2014	S443-PMC4113768	['IF Vitamin D status does indeed IMPACT on Neurodevelopment, seasonal variation in Lateral Ventricular diameter MIGHT be expected.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007399', 'nervous system development', 42, 'neurodevelopment'), ('UBERON_0004086', 'brain ventricle', 82, 'lateral ventricular')]
S747-PMC4113768	PMC4113768	7/2014	S747-PMC4113768	['25(Oh)D assay standardization is, THEREFORE, ESSENTIAL to the development of EVIDENCED-BASED clinical and PUBLIC HEALTH guidelines for Vitamin D.\nmethods: Vitamin D standardization program (vdsp) is an international program designed to promote the standardized laboratory measurement of 25(Oh)D. it was established in 2010 by the us nih office of dietary supplements in collaboration with us national institute of standards and technology (nist), cdc, and ghent university.']	[('PROBABLE_UNDERSTANDING', 34), ('IMPORTANT_CONSIDERATION', 45), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 6, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 155, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 287, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 287, '25(OH)D')]
S912-PMC4113768	PMC4113768	7/2014	S912-PMC4113768	['studies carried out in a number of types of Dogs by may mellanby SHOWED that Vitamin D deficiency damaged the Development Of Teeth at the same time as Bones and that this COULD BE reversed with a diet high in Vitamin D. she conducted a series of early randomized controlled trials in orphanages too that SHOWED lower rates of caries in children under 12 who were given diets higher in Vitamin D. RECENT RESEARCH in children with specific syndromes and in Gene knockout Mice have CONFIRMED a central ROLE for Vitamin D in Tooth mineralization with EFFECTS on Tooth structure, as described by may mellanby.']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 396), ('INCOMPLETE_EVIDENCE', 479), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 547)]	7	[('NCBITaxon_33208', 'Metazoa', 44, 'dogs'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0042466', 'chemokinesis', 110, 'development of teeth'), ('UBERON_0001091', 'calcareous tooth', 125, 'teeth'), ('UBERON_0001474', 'bone element', 151, 'bones'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin D'), ('SO_0000704', 'gene', 455, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 469, 'mice'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 521, 'tooth'), ('UBERON_0001091', 'calcareous tooth', 558, 'tooth')]
S917-PMC4113768	PMC4113768	7/2014	S917-PMC4113768	['what is LESS CLEAR is the RELEVANT SIGNIFICANCE of Vitamin D deficiency to Tooth Development, at a population level, in the uk at present.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0048538', 'thymus development', 75, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 75, 'tooth')]
S983-PMC4113768	PMC4113768	7/2014	S983-PMC4113768	['apart from its well-DOCUMENTED ROLE in Bone mineralisation, Vitamin D is IMPLICATED in muscle strength and SEVERE Vitamin D deficiency CAN delay gross motor Development, such as walking in children (agarwal, a., et al .']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 135)]	5	[('GO_0007567', 'parturition', 39, 'bone'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0008289', 'lipid binding', 157, 'development')]
S995-PMC4113768	PMC4113768	7/2014	S995-PMC4113768	['our AIM was to EXPLORE ASSOCIATIONS between maternal and Cord 25(Oh)D concentrations and Vitamin D supplementation during Pregnancy and infancy and Gross Motor Development in infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 23)]	3	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 65, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0008406', 'gonad development', 148, 'gross motor development')]
S1460-PMC4113768	PMC4113768	7/2014	S1460-PMC4113768	['this study SUPPORTS a POTENTIAL ROLE for Vitamin D in cvd development, HOWEVER FURTHER RESEARCH IS REQUIRED to establish causality.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 99)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
S1792-PMC4113768	PMC4113768	7/2014	S1792-PMC4113768	['background: within the lina cohort study maternal as well as newborn Vitamin D levels were shown to be positively ASSOCIATED with Allergic Sensitisation and Food Allergy Development within the first two years of Life.']	[('SUPERFICIAL_RELATIONSHIP', 114)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0046631', 'alpha-beta T cell activation', 130, 'allergic sensitisation'), ('CHEBI_33290', 'food', 157, 'food'), ('GO_0048467', 'gynoecium development', 157, 'food allergy development'), ('UBERON_0000104', 'life cycle', 212, 'life')]
S1834-PMC4113768	PMC4113768	7/2014	S1834-PMC4113768	['during this period, the danish government mandated the fortification of Margarine with Vitamin D, 1.25 mg/100 g. in this talk we will analyze and discuss the benefits ASSOCIATED with Prenatal Consumption of Vitamin D fortified Foods in terms of the development of schizophrenia amongst the progeny later in Life.']	[('SUPERFICIAL_RELATIONSHIP', 167)]	1	[('CHEBI_6784', 'mestranol', 72, 'margarine'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'prenatal'), ('GO_0007631', 'feeding behavior', 192, 'consumption'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'foods'), ('UBERON_0000104', 'life cycle', 307, 'life')]
S1846-PMC4113768	PMC4113768	7/2014	S1846-PMC4113768	['conclusion: the results of OUR STUDY SUGGEST that the Vitamin D fortification policy enacted in denmark until june 1st, 1985 had a PROTECTIVE EFFECT amongst children Born during the spring in regards to later development of schizophrenia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'born')]
S1849-PMC4113768	PMC4113768	7/2014	S1849-PMC4113768	['; parr, t.\nbackground: it is WELL KNOWN that Calcitriol, the active form of Vitamin D, is ESSENTIAL for Bone development and maintenance.']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_17823', 'calcitriol', 45, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007567', 'parturition', 104, 'bone')]
S2637-PMC4113768	PMC4113768	7/2014	S2637-PMC4113768	['; inskip, h.m.; cooper, c.; harvey, n.c.\nbackground: maternal 25-Hydroxy-Vitamin D (25(Oh)d) status in Pregnancy HAS BEEN ASSOCIATED with offspring Bone Development and adiposity.']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_70487', '(-)-sanguinolignan C', 62, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 84, '25(OH'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0048539', 'bone marrow development', 148, 'bone development')]
S2638-PMC4113768	PMC4113768	7/2014	S2638-PMC4113768	['THERE IS EVIDENCE TO SUPPORT a ROLE for Vitamin D in muscle function, YET LITTLE IS KNOWN about the ROLE of Antenatal 25(Oh)D exposure in programming muscle development.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 70), ('FULL_UNKNOWN', 74), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
S2780-PMC4113768	PMC4113768	7/2014	S2780-PMC4113768	['development of Bladder cancer is ASSOCIATED with low levels of Vitamin D. both Urinary Tract infections and 90% of Bladder cancers involve the transitional epithelium, which lines the Urinary Bladder.']	[('SUPERFICIAL_RELATIONSHIP', 33)]	1	[('UBERON_0018707', 'bladder organ', 15, 'bladder'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001553', 'medial tarsal artery', 79, 'urinary tract'), ('UBERON_0018707', 'bladder organ', 115, 'bladder'), ('UBERON_0001255', 'urinary bladder', 184, 'urinary bladder')]
S2930-PMC4113768	PMC4113768	7/2014	S2930-PMC4113768	['conclusions: in CONCLUSION THIS STUDY INDICATES that Vitamin D deficiency promotes the development of dysplasia, increases Proliferation and inflammation, which is LIKELY promote the development of frank squamous Cell carcinoma, WHEREAS sufficiency retards this development.']	[('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	5	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0008283', 'cell proliferation', 123, 'proliferation'), ('CL_0000573', 'retinal cone cell', 213, 'cell')]
S3096-PMC4113768	PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S135-PMC4171568	PMC4171568	9/2014	S135-PMC4171568	['Vitamin D as a risk factor for the development of schizophrenia\nit HAS BEEN HYPOTHESIZED that low Prenatal Vitamin D is a risk factor for the incidence of Adult-onset schizophrenia AS the lack of this fat-soluble Vitamin and Steroid Hormone MAY DETRIMENTALLY IMPACT on the developing foetal Brain [102].']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 181), ('INCOMPLETE_EVIDENCE', 241), ('IMPORTANT_CONSIDERATION', 245), ('SUPERFICIAL_RELATIONSHIP', 259)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_33229', 'vitamin (role)', 213, 'vitamin'), ('CHEBI_26764', 'steroid hormone', 225, 'steroid hormone'), ('UBERON_0000955', 'brain', 291, 'brain')]
S136-PMC4171568	PMC4171568	9/2014	S136-PMC4171568	['research using Animal MODELS HAS SHOWN that low Prenatal Vitamin D alters Brain Development [103].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29)]	2	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('GO_0007565', 'female pregnancy', 48, 'prenatal'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007420', 'brain development', 74, 'brain development'), ('UBERON_0000955', 'brain', 74, 'brain')]
S142-PMC4171568	PMC4171568	9/2014	S142-PMC4171568	['THEREFORE, the RELATIONSHIP between Vitamin D and schizophrenia NEEDS FURTHER INVESTIGATION, EVEN THOUGH a RECENT review of the EVIDENCE CONCLUDED that adequate levels of Vitamin D are needed for normal Brain Development and function and furthermore that at-risk groups SHOULD BE offered supplementation [112].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 64), ('FUTURE_WORK', 70), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 137), ('FUTURE_WORK', 270)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007420', 'brain development', 203, 'brain development'), ('UBERON_0000955', 'brain', 203, 'brain')]
S31-PMC4231606	PMC4231606	10/2013	S31-PMC4231606	['DEFICIENCY in Vitamin D during periods of Tooth Development MAY also result in developmental defects [17] including Enamel hypoplasia, a SIGNIFICANT RISK FACTOR for s-ecc.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 60), ('IMPORTANT_CONSIDERATION', 137), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0048538', 'thymus development', 42, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 42, 'tooth'), ('UBERON_0001752', 'enamel', 116, 'enamel')]
S98-PMC4251419	PMC4251419	12/2014	S98-PMC4251419	['a PROPOSED network of INTERACTIONS between Vitamin D and the microbiome that MAY sway the Development Of Immune Tolerance or Tissue Inflammation\nActivation Of Immune Cells like Monocytes and Epithelial cells by bacterial-derived products (e.g.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0032253', 'dense core granule localization', 90, 'development of ... tolerance ... inflammation'), ('UBERON_0002405', 'immune system', 105, 'immune'), ('UBERON_0000479', 'tissue', 125, 'tissue'), ('GO_0006915', 'apoptotic process', 145, 'Activation of immune cells'), ('CL_0000738', 'leukocyte', 159, 'immune cells'), ('UBERON_0002405', 'immune system', 159, 'immune'), ('CL_0000576', 'monocyte', 177, 'monocytes'), ('CL_0000066', 'epithelial cell', 191, 'epithelial'), ('UBERON_0000483', 'epithelium', 191, 'epithelial')]
S118-PMC4251419	PMC4251419	12/2014	S118-PMC4251419	['furthermore, Vitamin D supplementation MAY suppress the development of Intestinal Tumours in susceptible Mice [76].']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0048262', 'determination of dorsal/ventral asymmetry', 71, 'intestinal tumours'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'mice')]
S186-PMC4277121	PMC4277121	12/2015	S186-PMC4277121	['in an ATTEMPT to prevent the developmental consequences of elevated oxidative stress, Pregnant ts65dn female Mice and their offspring were treated with a Vitamin E-enriched diet (0.002%, or tenfold lower than the amounts used in lockrow et al94).94offspring were continued on the enriched diet and tested on the mwm at 10 weeks of age.']	[('DIFFICULT_TASK', 6)]	1	[('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 109, 'mice'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E')]
S193-PMC4302429	PMC4302429	1/2015	S193-PMC4302429	['OTHER mechanisms COULD BE the Regulation of Anti- and proinflammatory Compounds by Vitamin D. for this PURPOSE, we INVESTIGATED the pattern of cytokine and Chemokine Production, a central feature in the development of Neuroinflammation, neurodegeneration, and demyelination in the Cns [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 115)]	5	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_67437', 'Euparin', 44, 'anti-'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0032602', 'chemokine production', 156, 'chemokine production'), ('GO_0007009', 'plasma membrane organization', 218, 'neuroinflammation'), ('UBERON_0001017', 'central nervous system', 281, 'CNS')]
S1-PMC4329404	PMC4329404	10/2014	S1-PMC4329404	['we INVESTIGATED the EFFECT of early-Life Vitamin D deficiency on the development of Murine neonatal allergic Airways disease (aad).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0000104', 'life cycle', 36, 'life'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_39107', 'Murinae', 84, 'murine'), ('UBERON_0001005', 'respiratory airway', 109, 'airways')]
S21-PMC4329404	PMC4329404	10/2014	S21-PMC4329404	"[""maternal Vitamin D status during Pregnancy MAY also determine risk of asthma Development RATHER than the child's own Vitamin D levels.""]"	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
S30-PMC4329404	PMC4329404	10/2014	S30-PMC4329404	['Pregnant females were Fed a Vitamin D-deficient diet starting from day-16 Gestation (last trimester) to FOCUS on Immune-mediated mechanisms of disease development in offspring and to limit any EFFECTS of in utero Vitamin D deficiency on foetal Lung growth and Development (27).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('SUPERFICIAL_RELATIONSHIP', 193)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007631', 'feeding behavior', 22, 'fed'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('UBERON_0002405', 'immune system', 113, 'immune'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0030324', 'lung development', 244, 'lung ... development'), ('UBERON_0002048', 'lung', 244, 'lung')]
S122-PMC4329404	PMC4329404	10/2014	S122-PMC4329404	['the same reduction was still evident when Peri-Bronchiolar collagen was quantified (fig.5c,d), SUGGESTING Vitamin D supplementation MAY PROTECT from the development of Airway Remodelling.']	[('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('UBERON_0001789', 'outer nuclear layer of retina', 42, 'peri'), ('UBERON_0002186', 'bronchiole', 47, 'bronchiolar'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 168, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 168, 'airway')]
S180-PMC4329404	PMC4329404	10/2014	S180-PMC4329404	['it MAY BE that ONLY alterations in circulating T Regulatory Cells are apparent following supplementation with Vitamin D.\nwe have PREVIOUSLY SHOWN that transfer of T Regulatory Cells prevented Development Of Airway Remodelling in an Adult Mouse MODEL of aad (40).']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CL_0000902', 'induced T-regulatory cell', 47, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 49, 'regulatory'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 163, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 165, 'regulatory'), ('GO_0032498', 'detection of muramyl dipeptide', 192, 'development of airway remodelling'), ('UBERON_0001005', 'respiratory airway', 207, 'airway'), ('UBERON_0007023', 'adult organism', 232, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 238, 'mouse')]
S181-PMC4329404	PMC4329404	10/2014	S181-PMC4329404	['a PROMISING ROLE of Vitamin D supplementation in children with asthma is the POTENTIAL of minimizing the development of a very early feature of Airway Remodelling, increased thickness of the reticular basement membrane (41,42), which would incorporate a NOVEL therapeutic target in asthma.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 77), ('FULL_UNKNOWN', 254)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 144, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 144, 'airway')]
S184-PMC4329404	PMC4329404	10/2014	S184-PMC4329404	['our data SUGGEST Vitamin D deficiency in utero and early Life CONTRIBUTES to worse Eosinophilic inflammation and that Vitamin D supplementation after weaning reduces the development of both Pulmonary Eosinophilia and remodelling.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0000104', 'life cycle', 57, 'life'), ('CL_0000771', 'eosinophil', 83, 'eosinophilic'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'pulmonary'), ('CL_0000771', 'eosinophil', 200, 'eosinophilia')]
S113-PMC4340999	PMC4340999	3/2015	S113-PMC4340999	['Vitamin D insufficiency during Pregnancy is highly PREVALENT in a diverse range of populations living at various latitudes and in both developed and developing societies.29,33the adverse EFFECTS of Vitamin D insufficiency on offspring during development and later in Life HAVE also BEEN extended greatly.29–31from a PUBLIC HEALTH perspective, the POTENTIAL to PREVENT common chronic diseases via low-cost, simple, and SAFE Food fortification is an attractive option.33\nsome POTENTIAL limitations of this study WARRANT CONSIDERATION.']	[('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 272), ('IMPORTANT_CONSIDERATION', 316), ('INCOMPLETE_EVIDENCE', 347), ('SUPERFICIAL_RELATIONSHIP', 360), ('IMPORTANT_CONSIDERATION', 418), ('INCOMPLETE_EVIDENCE', 474), ('FUTURE_WORK', 510), ('FUTURE_WORK', 518)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000104', 'life cycle', 267, 'life'), ('CHEBI_33290', 'food', 423, 'food')]
S144-PMC4377870	PMC4377870	3/2015	S144-PMC4377870	['in vitro studies also SUPPORT the LINK between Vitamin D and Airway Remodelling AS active Vitamin D inhibits Airway Smooth Muscle (Asm) Cell Proliferation [114] and deficiency impairs normal Lung Development [115].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('PROBABLE_UNDERSTANDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 61, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 61, 'airway'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CL_0002633', 'respiratory basal cell', 109, 'airway smooth muscle ... cell'), ('UBERON_0001005', 'respiratory airway', 109, 'airway'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 116, 'smooth muscle'), ('UBERON_0001135', 'smooth muscle tissue', 116, 'smooth muscle'), ('UBERON_0001637', 'artery', 131, 'ASM'), ('GO_0008283', 'cell proliferation', 136, 'cell proliferation'), ('GO_0030324', 'lung development', 191, 'lung development'), ('UBERON_0002048', 'lung', 191, 'lung')]
S157-PMC4377870	PMC4377870	3/2015	S157-PMC4377870	['experimental data SUGGEST that Vitamin D MAY BE IMPORTANT in copd for its EFFECT on normal Lung growth and Development, though Human data to support this is not available.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 41), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 91, 'lung ... development'), ('UBERON_0002048', 'lung', 91, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 127, 'human')]
S250-PMC4377870	PMC4377870	3/2015	S250-PMC4377870	['the EVIDENCE for mechanisms of Vitamin D in Lung Development and Immune function are yet to be fully established.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 44, 'lung development'), ('UBERON_0002048', 'lung', 44, 'lung'), ('GO_0007566', 'embryo implantation', 65, 'immune'), ('UBERON_0002405', 'immune system', 65, 'immune')]
S87-PMC4377879	PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
S128-PMC4377879	PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
S25-PMC4377888	PMC4377888	3/2015	S25-PMC4377888	['for example, the EFFECTS of maternal dietary zinc, Vitamin A and protein restriction or maternal dietary fat excess all HAVE BEEN SHOWN to have a negative IMPACT on Kidney Development and later Renal disease in the offspring [16,17,18,19].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0001822', 'kidney development', 165, 'kidney development'), ('UBERON_0002113', 'kidney', 165, 'kidney'), ('UBERON_0002113', 'kidney', 194, 'renal')]
S68-PMC4377888	PMC4377888	3/2015	S68-PMC4377888	['the mechanism UNDERLYING this abnormal Kidney phenotype is MOST LIKELY the fact the Vitamin A is a key ligand for the cret receptor, which Controls the earliest processes of Kidney Development (seesection 2for full details).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('UBERON_0002113', 'kidney', 39, 'kidney'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'controls'), ('GO_0001822', 'kidney development', 174, 'kidney development'), ('UBERON_0002113', 'kidney', 174, 'kidney')]
S12-PMC4377896	PMC4377896	3/2015	S12-PMC4377896	['introduction\nfish is a source of several Nutrients that are IMPORTANT during Pregnancy for healthy Foetal Development including Iodine, Long Chain Omega-3 polyunsaturated Fatty Acids (lc n- 3pufas), and Vitamins A, D and B12 [1].']	[('IMPORTANT_CONSIDERATION', 60)]	1	[('CHEBI_33284', 'nutrient', 41, 'nutrients'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0060324', 'face development', 99, 'foetal development'), ('CHEBI_24859', 'iodine atom', 128, 'iodine'), ('CHEBI_77190', 'CDP-dipalmitoyl-sn-glycerol(2-)', 136, 'long chain omega-3'), ('CHEBI_35366', 'fatty acid', 171, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 203, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 203, 'vitamins A'), ('PR_000006444', 'diacylglycerol kinase delta', 215, 'D'), ('CHEBI_27778', 'abequose', 221, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 221, 'B12')]
S148-PMC4377896	PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
S21-PMC4396835	PMC4396835	1/2015	S21-PMC4396835	['later, the negative IMPACT of Prenatal Vitamin D deficiency on Brain Development was POSTULATED by mcgrath [17], MAINLY BASED on epidemiological data.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 113), ('QUESTION_ANSWERED_BY_THIS_WORK', 120)]	4	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007420', 'brain development', 63, 'brain development'), ('UBERON_0000955', 'brain', 63, 'brain')]
S22-PMC4396835	PMC4396835	1/2015	S22-PMC4396835	['FURTHER research HAS SHOWN that Vitamin D has a ROLE in Brain Development and function, including Neuronal differentiation, Axonal connectivity, Dopamine ontogeny, immunological modulation and transcriptional Control over a large number of Genes [18–21].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007420', 'brain development', 56, 'brain development'), ('UBERON_0000955', 'brain', 56, 'brain'), ('CL_0000540', 'neuron', 98, 'neuronal'), ('GO_0030424', 'axon', 124, 'axonal'), ('CHEBI_18243', 'dopamine', 145, 'dopamine'), ('GO_0065007', 'biological regulation', 209, 'control'), ('SO_0000704', 'gene', 240, 'genes')]
S23-PMC4396835	PMC4396835	1/2015	S23-PMC4396835	['Prenatal Vitamin D deficiency HAS now been PROPOSED as a risk factor for Neurodevelopmental disorders such as schizophrenia [22] and autism [23–27].']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 43)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007399', 'nervous system development', 73, 'neurodevelopmental')]
S131-PMC4396835	PMC4396835	1/2015	S131-PMC4396835	['in conjunction with the elevated incidence of asd in these populations, this MAY SUPPORT a ROLE of Vitamin D deficiency - RATHER than OTHER seasonal factors - in the Development Of Autism.']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	5	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 166, 'development of autism')]
S168-PMC4396835	PMC4396835	1/2015	S168-PMC4396835	['conclusion\nOUR FINDINGS of a low Vitamin D level in a group of newborn children, who later developed asd, provide SUPPORT for the HYPOTHESIS that developmental Vitamin D deficiency during late Pregnancy MAY carry an INCREASED risk of asd in the child, along with several other RISK FACTORS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 216), ('SUPERFICIAL_RELATIONSHIP', 277)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
S169-PMC4396835	PMC4396835	1/2015	S169-PMC4396835	['three DIFFERENT independent findings POINT towards a ROLE for Vitamin D in the development of asd: (1) increased risk for asd in offspring of migrants, especially from countries with a dark-skinned population and from cultures where women use covered clothing; (2) low 25(Oh)D levels in groups of newborn children, who later have developed asd, and in groups of children and Adults with asd; and (3) an ASSOCIATION between season of Birth and asd, in OUR STUDY not extending to the high-risk groups of migrants, SUGGESTING that these groups are exposed to suboptimal Vitamin D levels the whole year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 403), ('QUESTION_ANSWERED_BY_THIS_WORK', 451), ('INCOMPLETE_EVIDENCE', 512)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 269, '25(OH)D'), ('UBERON_0007023', 'adult organism', 375, 'adults'), ('GO_0007567', 'parturition', 433, 'birth'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
S148-PMC4405493	PMC4405493	4/2015	S148-PMC4405493	['for example, there is SOME EVIDENCE Vitamin D AFFECTS transcription and function of Genes responsible for Trophoblast invasion and Angiogenesis, two factors CRITICAL for Placenta Development.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000704', 'gene', 84, 'genes'), ('UBERON_0000088', 'trophoblast', 106, 'trophoblast'), ('GO_0001525', 'angiogenesis', 131, 'angiogenesis'), ('GO_0001890', 'placenta development', 170, 'placenta development'), ('UBERON_0001987', 'placenta', 170, 'placenta')]
S80-PMC4417995	PMC4417995	4/2015	S80-PMC4417995	['this would be a CONSEQUENCE of Vitamin D decreased production in covered skin areas, THUS INDICATING a local PROTECTIVE EFFECT of Vitamin D against the development of ad lesions.']	[('PROBABLE_UNDERSTANDING', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
S96-PMC4417995	PMC4417995	4/2015	S96-PMC4417995	['[44] reported that high Vitamin D values during Pregnancy MIGHT also be harmful with respect to Allergic disease development: children whose mothers had a 25(Oh)D concentration during Pregnancy of greater than 30\u2009ng/ml had an increased risk of atopic eczema on examination at 9 months compared with children whose mothers had a concentration of less than 12\u2009ng/ml.']	[('INCOMPLETE_EVIDENCE', 58)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0040011', 'locomotion', 96, 'allergic'), ('CHEBI_63056', 'zinc cation', 155, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 161, 'D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
S153-PMC4427001	PMC4427001	4/2015	S153-PMC4427001	['POTENTIALLY beneficial EFFECT of Vitamin D supplementation and the PLAUSIBLE pathogenic ROLE of 25(Oh)D deficiency in the subsequent development of diabetes mellitus type 2 in women with gdm history HAS to be FURTHER explored considering the ROLE of Vitamin D in Modulating Insulin sensitivity and Glucose Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 209), ('SUPERFICIAL_RELATIONSHIP', 242)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0065007', 'biological regulation', 263, 'modulating'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('CHEBI_17234', 'glucose', 298, 'glucose'), ('GO_0006006', 'glucose metabolic process', 298, 'glucose metabolism')]
S68-PMC4448820	PMC4448820	5/2015	S68-PMC4448820	['phase i of the bond program included an evaluation of 6 Nutrients— zinc, iron, Folic Acid, Vitamin B-12, Vitamin A, and Iodine—chosen for their PUBLIC HEALTH IMPORTANCE and BECAUSE they represent the range of ISSUES confronting those who are addressing the ROLE of nutrition in research, clinical care, or program development/evaluation.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158), ('PROBABLE_UNDERSTANDING', 173), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 257)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_30751', 'formic acid', 79, 'folic acid'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 120, 'iodine')]
S255-PMC4448820	PMC4448820	5/2015	S255-PMC4448820	['in particular, Nk T Cell Development in Mice is CRITICALLY DEPENDENT on Vitamin D (173).']	[('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CL_0000213', 'lining cell', 15, 'NK T cell'), ('GO_0001822', 'kidney development', 15, 'NK T cell development'), ('GO_0005634', 'nucleus', 15, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
S379-PMC4448820	PMC4448820	5/2015	S379-PMC4448820	['the ESSENTIALITY of Vitamin D in Regulating invariant invariant Nk T Cell Development in Mice IS THOUGHT TO be via epigenetic mechanisms (173).']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulating'), ('CL_0000213', 'lining cell', 64, 'NK T cell'), ('GO_0001822', 'kidney development', 64, 'NK T cell development'), ('GO_0005634', 'nucleus', 64, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice')]
S479-PMC4448820	PMC4448820	5/2015	S479-PMC4448820	['● Host-Pathogen competition for Vitamin A: examples include helminth parasites, such as ascaris and onchocerca , which Express a range of Retinol-binding proteins, Retinol dehydrogenases, and rars and MAY utilize Retinol/Retinoic Acid for growth and development (265–267).']	[('INCOMPLETE_EVIDENCE', 201)]	1	[('NCBITaxon_10088', 'Mus <genus>', 2, 'Host'), ('NCBITaxon_33208', 'Metazoa', 7, 'pathogen'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin A'), ('GO_0010467', 'gene expression', 119, 'express'), ('CHEBI_26536', 'retinoic acid', 138, 'retinol'), ('CHEBI_26536', 'retinoic acid', 164, 'retinol'), ('CHEBI_26536', 'retinoic acid', 213, 'retinol'), ('CHEBI_26536', 'retinoic acid', 221, 'retinoic acid')]
S17-PMC4452099	PMC4452099	6/2015	S17-PMC4452099	['Animal studies DEMONSTRATED that in Mice, Prenatal Vitamin D supplementation PREVENTED the development of t1d [13,14].']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('NCBITaxon_10088', 'Mus <genus>', 36, 'mice'), ('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
S16-PMC4466139	PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
S10-PMC4488777	PMC4488777	5/2015	S10-PMC4488777	['ON THE OTHER HAND, EVIDENCE-BASED research DID NOT prove a significant DIFFERENCE so far in Ovulation stimulation or Embryo Development depending on Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	4	[('GO_0030728', 'ovulation', 92, 'ovulation'), ('GO_0009790', 'embryo development', 117, 'embryo development'), ('UBERON_0000922', 'embryo', 117, 'embryo'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
S102-PMC4488777	PMC4488777	5/2015	S102-PMC4488777	['the direct EFFECT of Vitamin D on Amh level and follicle development was also CONFIRMED in a RECENTLY published in vitro experiment [45].']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 93)]	3	"[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_16027', ""adenosine 5'-monophosphate"", 34, 'AMH')]"
S43-PMC4499266	PMC4499266	4/2015	S43-PMC4499266	['the lack of Gestational Vitamin A HAS BEEN SUGGESTED to CONTRIBUTE to Hearing loss development in developing countries [7].']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('GO_0007565', 'female pregnancy', 12, 'gestational'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('GO_0007605', 'sensory perception of sound', 70, 'hearing')]
S296-PMC4499946	PMC4499946	7/2015	S296-PMC4499946	['the trial is primarily DESIGNED and powered TO EVALUATE the dose–response EFFECTS of Vitamin D on infant length, an outcome that is directly ALIGNED with the classical ROLE of Vitamin D in Mineral Metabolism and bone health BUT MAY also be interpreted as a SURROGATE marker for Organ (including Brain) Growth and Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 257)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_46662', 'mineral', 189, 'mineral'), ('GO_0008152', 'metabolic process', 197, 'metabolism'), ('UBERON_0000062', 'organ', 278, 'organ'), ('GO_0007420', 'brain development', 295, 'brain ... growth ... development'), ('UBERON_0000955', 'brain', 295, 'brain')]
S298-PMC4499946	PMC4499946	7/2015	S298-PMC4499946	['longer-term surveillance of the infant cohort will IDEALLY enable the assessment of OTHER IMPORTANT clinical outcomes (e.g., asthma, Neurodevelopment) that MAY be INFLUENCED by the NON-CLASSICAL ROLE of Vitamin D in immunoregulation and Extraskeletal Cellular Proliferation and Differentiation.']	[('IMPORTANT_CONSIDERATION', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 163), ('PROBLEM_COMPLICATION', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('GO_0007399', 'nervous system development', 133, 'neurodevelopment'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 237, 'extraskeletal'), ('GO_0030154', 'cell differentiation', 251, 'cellular proliferation ... differentiation')]
S74-PMC4514967	PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]
S20-PMC4516109	PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
S187-PMC4516488	PMC4516488	9/2009	S187-PMC4516488	['Pea-15 is also on the list of about 50 differentially Expressed Genes in the Mouse Brain REVEALED by two-dimensional gel electrophoresis in a MODEL of developmental Vitamin D deficiency [44].']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 142)]	2	[('PR_000001904', 'platelet endothelial cell adhesion molecule', 0, 'PEA-15'), ('GO_0010467', 'gene expression', 54, 'expressed'), ('SO_0000704', 'gene', 64, 'genes'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('UBERON_0000955', 'brain', 83, 'brain'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
S245-PMC4586450	PMC4586450	10/2015	S245-PMC4586450	['these results SUGGEST that within the range of fat intakes normally consumed by united kingdom preschool children, there is no EVIDENCE of an EFFECT on growth or obesity development of increasing the proportion of ei coming from fat in the diet.vitamin a\nthe sources of Vitamin A (Retinol equivalents) in the diet and changes in Intake between age 1.5 years and age 3.5 years were examined longitudinally (n = 755 with Food records at both ages).23the diet was categorized by core and noncore Foods, and THERE was EVIDENCE that the quality of the diet deteriorated with age.23between age 1.5 years and age 3.5 years, the dietary Intake of Vitamin A decreased by 56 µg/day (95% ci, −17 to −95 µg/d; p = 0.005) MAINLY due to decreased Intake of whole milk (390 g/d at age 1.5 y; 261 g/d at age 3.5 y) and increased Intake of energy-dense, Nutrient-poor Foods such as puddings, cakes, biscuits, confectionery, and crisps.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 514), ('PROBABLE_UNDERSTANDING', 709)]	6	[('CHEBI_27300', 'vitamin D', 270, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 281, 'retinol'), ('GO_0007631', 'feeding behavior', 329, 'intake'), ('CHEBI_33290', 'food', 419, 'food'), ('CHEBI_33290', 'food', 493, 'foods'), ('GO_0007631', 'feeding behavior', 629, 'intake'), ('CHEBI_27300', 'vitamin D', 639, 'vitamin A'), ('GO_0007631', 'feeding behavior', 733, 'intake'), ('GO_0007631', 'feeding behavior', 813, 'intake'), ('CHEBI_33284', 'nutrient', 837, 'nutrient'), ('CHEBI_33290', 'food', 851, 'foods')]
S252-PMC4586450	PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
S18-PMC4586451	PMC4586451	10/2015	S18-PMC4586451	['this has LED to dietary RECOMMENDATIONS for Pregnancy that limit concentrated sources of Vitamin A and stress the IMPORTANCE of periconceptional Folic Acid supplementation, which HAS BEEN SHOWN to be PROTECTIVE against Neural Tube defects.4\nTHERE IS EVIDENCE that optimal fetal Neurodevelopment is DEPENDENT on specific Nutrients supplied by the mother mainly from dietary sources; these MAY include Long-Chain polyunsaturated Fatty Acids (lc-pufas) such as Docosahexaenoic Acid (Dha), an N-3 Fatty Acid, and arachidonic acid, an N-6 Fatty Acid.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 388)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('UBERON_0001049', 'neural tube', 219, 'neural tube'), ('GO_0007399', 'nervous system development', 278, 'neurodevelopment'), ('CHEBI_33284', 'nutrient', 320, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 400, 'long-chain'), ('CHEBI_35366', 'fatty acid', 427, 'fatty acids'), ('CHEBI_36003', 'decenoic acid', 458, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 480, 'DHA'), ('CHEBI_35245', 'GDP-galactose', 489, 'n-3 fatty acid'), ('CHEBI_18320', '1,4-dithiothreitol', 530, 'n-6'), ('CHEBI_35366', 'fatty acid', 534, 'fatty acid')]
S21-PMC4586451	PMC4586451	10/2015	S21-PMC4586451	['it is also POSSIBLE that fish Intake during Pregnancy INFLUENCES Neurodevelopment via a mechanism not related to its Fatty Acid content; OTHER active substances include its Vitamin D and Iodine content or its POSSIBLE contamination with mercury.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 209)]	4	[('GO_0007631', 'feeding behavior', 30, 'intake'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('GO_0007399', 'nervous system development', 65, 'neurodevelopment'), ('CHEBI_35366', 'fatty acid', 117, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 187, 'iodine')]
S190-PMC4586451	PMC4586451	10/2015	S190-PMC4586451	['a weak ASSOCIATION was FOUND between maternal dietary iron and magnesium Intake and height, particularly sitting height; it was greatly attenuated on full adjustment.19\n\ncaption (table-wrap): table 3\n\nassociations of maternal dietary intakes, iron supplement use, anemia, and Vitamin D status during Pregnancy with measures of offspring growth, Blood pressure, and Bone developmentmeasure in childdietary factoradjustments appliedminimally adjusted resultsfully adjusted resultscommentsheight at 7.5 y, n = 6663 singletons19\niron\nmagnesium\nvitamin c\nminimal: child sex, age at measurement, Pregnancy energy Intake\nfull: plus maternal age, bmi, height, smoking, seb, parity, breastfeeding\nβ = 0.08 (95% ci, 0.05–0.12), p< 0.001\nβ = 0.10 (95% ci, 0.07–0.14), p< 0.001\nβ = 0.05 (95% ci, 0.03–0.08), p< 0.001\nβ = 0.04 (95% ci, 0.01–0.08), p = 0.02\nβ = 0.05 (95% ci, 0.01–0.08), p = 0.04\nβ = 0.02 (95% ci, −0.01 to 0.04), p = 0.2\nregression analysis using standard deviation scores.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 23)]	2	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'pregnancy'), ('UBERON_0000178', 'blood', 345, 'blood'), ('GO_0007567', 'parturition', 365, 'bone'), ('GO_0007565', 'female pregnancy', 590, 'pregnancy'), ('GO_0007631', 'feeding behavior', 607, 'intake')]
S212-PMC4586451	PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
S0-PMC4595656	PMC4595656	10/2015	S0-PMC4595656	['Vitamin D and Hippocampal Development-the story so far\n\nabstract\nepidemiological studies SUGGEST that Vitamin D insufficiency MAY BE PREVALENT in young as well as older populations.']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 126), ('IMPORTANT_CONSIDERATION', 133)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('GO_0003163', 'sinoatrial node development', 14, 'hippocampal development'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S1-PMC4595656	PMC4595656	10/2015	S1-PMC4595656	['the pleiotropic EFFECTS of Vitamin D are now BEYOND DISPUTE and a GROWING NUMBER OF STUDIES provide ACCUMULATING EVIDENCE of a ROLE for Vitamin D in Brain Development and function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007420', 'brain development', 149, 'brain development'), ('UBERON_0000955', 'brain', 149, 'brain')]
S2-PMC4595656	PMC4595656	10/2015	S2-PMC4595656	['a NUMBER OF STUDIES to date have investigated the EFFECTS of early-Life Vitamin D deprivation on Adult hippocampus in Animals and Humans, and there is a growing BODY OF EVIDENCE to SUGGEST a ROLE for this hormone in the development of selected hippocampal functions such as latent inhibition and hole board Habituation in Rats.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 191)]	5	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0007023', 'adult organism', 97, 'adult'), ('NCBITaxon_33208', 'Metazoa', 118, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('GO_0046959', 'habituation', 307, 'habituation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 322, 'rats')]
S3-PMC4595656	PMC4595656	10/2015	S3-PMC4595656	['there are FEW STUDIES to date of Vitamin D deprivation or supplementation on early hippocampal development in vivo .']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
S4-PMC4595656	PMC4595656	10/2015	S4-PMC4595656	['HOWEVER, a SMALL NUMBER OF STUDIES, MOSTLY in vitro , POINT to a ROLE for Vitamin D in Differentiation and Development Of Hippocampal Neurons.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 65)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 87, 'differentiation ...'), ('GO_0048513', 'animal organ development', 107, 'development of ... neurons'), ('CL_0002608', 'hippocampal neuron', 122, 'hippocampal neurons')]
S7-PMC4595656	PMC4595656	10/2015	S7-PMC4595656	['it also REMAINS TO BE ESTABLISHED IF there are CRITICAL developmental windows during which Vitamin D is REQUIRED.']	[('FULL_UNKNOWN', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('IMPORTANT_CONSIDERATION', 47), ('IMPORTANT_CONSIDERATION', 104)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
S8-PMC4595656	PMC4595656	10/2015	S8-PMC4595656	['IN LIGHT OF the IMPORTANCE of the hippocampus in ltp and spatial Learning, FURTHER INVESTIGATIONS on the early EFFECTS of Vitamin D deprivation on hippocampal development ARE WARRANTED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('FUTURE_WORK', 75), ('SUPERFICIAL_RELATIONSHIP', 111), ('FUTURE_WORK', 171)]	5	[('GO_0007612', 'learning', 65, 'learning'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
S19-PMC4595656	PMC4595656	10/2015	S19-PMC4595656	['the QUESTION of reduced Vitamin D concentrations on consequent neonatal, infant and child Development in RELATION to the hippocampus is THEREFORE HIGHLY PERTINENT.']	[('EXPLICIT_QUESTION', 4), ('SUPERFICIAL_RELATIONSHIP', 105), ('PROBABLE_UNDERSTANDING', 136), ('IMPORTANT_CONSIDERATION', 146)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0048513', 'animal organ development', 90, '... development')]
S30-PMC4595656	PMC4595656	10/2015	S30-PMC4595656	['a GROWING BODY of EVIDENCE also POINTS to a ROLE for Vitamin D in the Development Of the Cns.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0030324', 'lung development', 70, 'development of ... CNS'), ('UBERON_0001017', 'central nervous system', 89, 'CNS')]
S40-PMC4595656	PMC4595656	10/2015	S40-PMC4595656	['its overall CONTRIBUTION to healthy Brain Development renders also LIKELY a ROLE for Vitamin D in the developing hippocampus.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('GO_0007420', 'brain development', 36, 'brain development'), ('UBERON_0000955', 'brain', 36, 'brain'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S47-PMC4595656	PMC4595656	10/2015	S47-PMC4595656	['THEREFORE they are germane to an overall understanding of the ROLE of Vitamin D in Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
S74-PMC4595656	PMC4595656	10/2015	S74-PMC4595656	['HOWEVER the phenotype did not extend into Adulthood, SUGGESTING that EITHER normal Postnatal development OR the reintroduction of Vitamin D at Birth MAY have corrected the deficit (harms et al.,2012).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 149)]	5	[('UBERON_0000113', 'post-juvenile adult stage', 42, 'adulthood'), ('GO_0007567', 'parturition', 83, 'postnatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 143, 'birth')]
S93-PMC4595656	PMC4595656	10/2015	S93-PMC4595656	['apart from ELUCIDATING valuable data on the direct EFFECT of Vitamin D on Neurotransmitter levels within the hippocampus, such studies carried out on young Animals COULD also shed valuable light on Hippocampal Development when combined with behavioral testing.']	[('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 164)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 74, 'neurotransmitter'), ('NCBITaxon_33208', 'Metazoa', 156, 'animals'), ('GO_0003163', 'sinoatrial node development', 198, 'hippocampal development')]
S106-PMC4595656	PMC4595656	10/2015	S106-PMC4595656	['this FINDING POINTS to DIFFERENTIAL EFFECTS of varying concentrations of Vitamin D on Cellular Hippocampal Development and WARRANT FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 123)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0045168', 'cell-cell signaling involved in cell fate commitment', 86, 'cellular hippocampal development')]
S112-PMC4595656	PMC4595656	10/2015	S112-PMC4595656	['this CONTRASTS with the restoration of normal development following Vitamin D repletion in whole Animals (féron et al.,2005), and highlights the POTENTIAL DISPARITY between in vitro and in vivo FINDINGS.']	[('ANOMALY_CURIOUS_FINDING', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 97, 'animals')]
S119-PMC4595656	PMC4595656	10/2015	S119-PMC4595656	['FUTURE DIRECTIONS and conclusions\nin LIGHT of the ACCUMULATING Animal and in vitro EVIDENCE to DATE, it is LIKELY that Vitamin D plays a ROLE in hippocampal development in vivo .']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 107), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('NCBITaxon_33208', 'Metazoa', 63, 'animal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
S121-PMC4595656	PMC4595656	10/2015	S121-PMC4595656	['this constitutes a MAJOR lacuna in our overall understanding of the ROLE of Vitamin D in the early development of the hippocampus and is an AVENUE RIPE for EXPLORATION.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 68), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S124-PMC4595656	PMC4595656	10/2015	S124-PMC4595656	['IT IS POSSIBLE that there are temporal variations in the EFFECTS of Vitamin D such that particular time points along the spectrum of hippocampal Development are more sensitive to its absence or its supply, than are others.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0008289', 'lipid binding', 145, 'development')]
S130-PMC4595656	PMC4595656	10/2015	S130-PMC4595656	['low Prenatal Vitamin D HAS BEEN POSTULATED AS an epigenetic risk factor for same (mcgrath,1999), and transient vd IS CONSIDERED a developmental MODEL in schizophrenia research.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 144)]	5	[('GO_0007565', 'female pregnancy', 4, 'prenatal'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
S141-PMC4595656	PMC4595656	10/2015	S141-PMC4595656	['this would shed the MOST valuable light POSSIBLE on the ROLE of Vitamin D in early Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
S15-PMC4600246	PMC4600246	10/2015	S15-PMC4600246	['Vitamin K and vascular calcifications\nCoronary Artery calcium (cac) HAS BEEN SHOWN to have increasing prevalence as Kidney function declines.3indeed, cac prevalence HAS BEEN reported in 13% of ‘healthy’ patients without Renal disease,2140% of patients with chronic Kidney disease patients not on dialysis,2157% of patients starting dialysis22and 83% of patients on long-term dialysis.23diets lacking Vitamin K can PRECIPITATE the development of Vitamin K deficiency in as little as 7\u2005days.24additionally, subclinical Vitamin K deficiency is not UNCOMMON, especially in patients receiving warfarin.25cross-sectional and cohort data HAVE SHOWN a lower risk of Coronary Heart disease (chd), chd mortality, all-cause mortality and SEVERE Aortic calcifications with higher Vitamin K2(Menaquinone) intake526(box 1).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 414), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 631), ('IMPORTANT_CONSIDERATION', 727)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001621', 'coronary artery', 38, 'Coronary artery'), ('UBERON_0002113', 'kidney', 116, 'kidney'), ('UBERON_0002113', 'kidney', 220, 'renal'), ('UBERON_0002113', 'kidney', 265, 'kidney'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 517, 'vitamin K'), ('UBERON_0004151', 'cardiac chamber', 658, 'coronary heart'), ('UBERON_0000947', 'aorta', 734, 'aortic'), ('CHEBI_28934', 'vitamin D2', 768, 'vitamin K2'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 776, 'K2'), ('CHEBI_18154', 'polysaccharide', 779, 'menaquinone')]
S27-PMC4600246	PMC4600246	10/2015	S27-PMC4600246	['low levels of Vitamin K impair activation of Osteocalcin and decrease the activity of Osteoblasts (cells IMPORTANT for building bone).3334thus, Vitamin K is VITAL to the functionality of proteins such as Osteocalcin (IMPORTANT for building bone), (mgp, the most potent Arterial Calcification Inhibitor known) and the growth-arrest sequence-6 protein (Gas6, INVOLVED in Cell Growth Regulation35\nVitamin K HAS BEEN SHOWN to significantly delay the development of cac in a 3-year, double-blind, randomised controlled trial of 452 patients (229 patients on Vitamin K1And 223 patients in the control group).36all patients were assigned to a multivitamin (containing 1.6\u2005mg Thiamine, 1.8\u2005mg riboflavin, 2.1\u2005mg Vitamin B-6, 3\u2005µg Vitamin B12, 75\u2005mg Vitamin C, 12\u2005mg Vitamin E, 6\u2005mg Pantothenic Acid, 20\u2005mg niacin, 160\u2005µg Folate and 30\u2005µg of Biotin) as well as calcium (600\u2005mg Calcium Carbonate) and Vitamin D (Cholecalciferol 400\u2005iu).']	[('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 357), ('INCOMPLETE_EVIDENCE', 404)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 45, 'osteocalcin'), ('CL_0000062', 'osteoblast', 86, 'osteoblasts'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 204, 'osteocalcin'), ('UBERON_0001637', 'artery', 269, 'arterial'), ('GO_0051301', 'cell division', 278, 'calcification'), ('CHEBI_35222', 'inhibitor', 292, 'inhibitor'), ('PR_000008000', 'gap junction beta-4 protein', 351, 'Gas6'), ('GO_0071475', 'cellular hyperosmotic salinity response', 369, 'cell growth regulation35'), ('CHEBI_28384', 'vitamin K', 394, 'Vitamin K'), ('CHEBI_10124', 'zolmitriptan', 553, 'vitamin K1and'), ('PR_000017209', 'utrophin', 553, 'vitamin K1and'), ('CHEBI_26948', 'vitamin B1', 668, 'thiamine'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin B'), ('CHEBI_33279', 'vitamin D5', 722, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 741, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 758, 'vitamin E'), ('CHEBI_7916', 'pantothenic acid', 774, 'pantothenic acid'), ('CHEBI_30863', '5-azaorotic acid', 813, 'folate'), ('CHEBI_15956', 'biotin', 833, 'biotin'), ('CHEBI_3311', 'calcium carbonate', 868, 'calcium carbonate'), ('CHEBI_27300', 'vitamin D', 891, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 902, 'cholecalciferol')]
S68-PMC4600246	PMC4600246	10/2015	S68-PMC4600246	['IN SUMMARY, Vitamin K MAY improve Insulin sensitivity in men with diabetes.40\n\nVitamin K and cancer\nVitamin K2Has BEEN SHOWN to inhibit the growth of Human cancer cell lines, including Hepatoma lines, as well as to treat myelodysplastic syndrome.50–53two trials SEEM to INDICATE that Vitamin K245\u2005mg/day reduces the Development Of Hepatocellular Carcinoma (Hcc) in patients with Liver cirrhosis and that Vitamin K2Significantly reduces the recurrence of hcc in patients following the curative treatment of hcc with an ASSOCIATED reduction in all-cause mortality in these patients.54–61the POSSIBLE reduction in mortality with Vitamin K2May be EXPLAINED by multiple mechanisms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 262), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 518), ('INCOMPLETE_EVIDENCE', 589), ('PROBABLE_UNDERSTANDING', 643)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin K'), ('PR_000045358', 'insulin family protein', 34, 'insulin'), ('CHEBI_28384', 'vitamin K', 79, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 100, 'Vitamin'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 108, 'K2has'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('UBERON_0004705', 'fenestra', 185, 'hepatoma'), ('CHEBI_86324', 'quinolone antibiotic', 284, 'vitamin K245'), ('GO_0002234', 'detection of endoplasmic reticulum overloading', 316, 'development of hepatocellular carcinoma'), ('UBERON_0012474', 'hepatic cecum', 331, 'hepatocellular'), ('GO_0000724', 'double-strand break repair via homologous recombination', 357, 'HCC'), ('UBERON_0002107', 'liver', 379, 'liver'), ('CHEBI_64387', 'thiosultap(1-)', 404, 'vitamin K2significantly'), ('CHEBI_27325', 'xanthophyll', 626, 'vitamin K2may'), ('PR_000017209', 'utrophin', 626, 'vitamin K2may')]
S2-PMC4605923	PMC4605923	11/2015	S2-PMC4605923	['Food intake is a WELL-known environmental FACTOR that INFLUENCES Allergy Development and three specific Nutrients-Vitamin D, Omega 3 polyunsaturated Fatty Acids and Folate-have RECENTLY attracted ATTENTION.1\nthe methyl donor Folate is a WELL-KNOWN Nutrient supplement given during early Pregnancy to prevent neutral Tube defects in the developing fetus.']	[('PROBABLE_UNDERSTANDING', 17), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 237)]	6	"[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0060021', 'roof of mouth development', 65, 'allergy development'), ('CHEBI_33284', 'nutrient', 104, 'nutrients'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_82673', ""2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine"", 125, 'omega 3'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 165, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 225, 'folate'), ('CHEBI_33284', 'nutrient', 248, 'nutrient'), ('GO_0007565', 'female pregnancy', 287, 'pregnancy'), ('UBERON_0000025', 'tube', 316, 'tube')]"
S9-PMC4624803	PMC4624803	10/2015	S9-PMC4624803	['several HYPOTHESES concerning the IMPORTANCE of Vitamin D for Brain Development, ESPECIALLY Prenatally and during the early Neonatal Period, HAVE BEEN formulated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007420', 'brain development', 62, 'brain development'), ('UBERON_0000955', 'brain', 62, 'brain'), ('GO_0019230', 'proprioception', 92, 'prenatally'), ('UBERON_0007221', 'neonate stage', 124, 'neonatal period')]
S17-PMC4624803	PMC4624803	10/2015	S17-PMC4624803	['EVEN IF it is PROBABLE that the Vitamin D levels of the mother is close to the levels of the foetus, it is of INTEREST to compare these results with a study of Vitamin D levels in the child AS a hypothetical RISK FACTOR for later development of adhd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 14), ('ANOMALY_CURIOUS_FINDING', 110), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 190), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
S221-PMC4627942	PMC4627942	10/2015	S221-PMC4627942	"[""caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards.""]"	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
S22-PMC4632418	PMC4632418	10/2015	S22-PMC4632418	['the ROLE of Vitamin D on Gdm Development HAS been studied, and Vitamin D deficiency APPEARS TO BE ASSOCIATED with altered Glucose Homeostasis during Pregnancy [12,13].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 41), ('ANOMALY_CURIOUS_FINDING', 84), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 25, 'GDM development'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 122, 'glucose'), ('GO_0042593', 'glucose homeostasis', 122, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
S52-PMC4645901	PMC4645901	8/2014	S52-PMC4645901	['see supplementary file: ds2663.doc - “tables and figures”\n\ndesign\nfollowing discussions with the parents and the clinical team, we RECOGNISED that there was a LACK OF AWARENESS of the IMPORTANCE of Vitamin D for the health and Development Of Babies.']	[('PROBABLE_UNDERSTANDING', 131), ('PROBLEM_COMPLICATION', 159), ('IMPORTANT_CONSIDERATION', 167), ('IMPORTANT_CONSIDERATION', 184)]	4	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0048513', 'animal organ development', 227, 'development of babies')]
S43-PMC4661586	PMC4661586	4/2015	S43-PMC4661586	['Brain Development and Vitamin B HAVE also BEEN presented in the literature[19].']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin B')]
S1-PMC4673623	PMC4673623	11/2015	S1-PMC4673623	['Folate, Choline, betaine and Vitamin B-12) during Pregnancy is ESSENTIAL for normal maternal and fetal Methionine Metabolism, and is CRITICAL for IMPORTANT Metabolic processes including those INVOLVED in developmental programming.']	[('IMPORTANT_CONSIDERATION', 63), ('IMPORTANT_CONSIDERATION', 133), ('IMPORTANT_CONSIDERATION', 146), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_30863', '5-azaorotic acid', 0, 'folate'), ('CHEBI_15354', 'choline', 8, 'choline'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 29, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0006555', 'methionine metabolic process', 103, 'methionine metabolism'), ('GO_0008152', 'metabolic process', 156, 'metabolic')]
S15-PMC4673623	PMC4673623	11/2015	S15-PMC4673623	['Folate, Vitamin B-12, Choline, and betaine) to several IMPORTANT Metabolic Processes (kalhan and marczewski2012) including those INVOLVED in developmental programming.']	[('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 129)]	2	[('CHEBI_30863', '5-azaorotic acid', 0, 'folate'), ('CHEBI_27300', 'vitamin D', 8, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 8, 'vitamin B-12'), ('CHEBI_15354', 'choline', 22, 'choline'), ('GO_0008152', 'metabolic process', 65, 'metabolic processes')]
S85-PMC4684854	PMC4684854	12/2015	S85-PMC4684854	['NUMEROUS STUDIES have also CORRELATED low levels of Vitamin D with the development of Preeclampsia [52,53,55,56], PERHAPS through Immune mechanisms involving Antiphospholipid Antibody [51], and/or inflammatory mechanisms involving cytokines [56].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 86, 'preeclampsia'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('CHEBI_16240', 'hydrogen peroxide', 158, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibody')]
S108-PMC4684854	PMC4684854	12/2015	S108-PMC4684854	['for example, PRELIMINARY EVIDENCE SUGGESTS that insufficient levels of Prenatal Vitamin D MAY BE a factor in the development of autism [74] and lower Respiratory infections [75].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 90)]	3	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory')]
S115-PMC4684854	PMC4684854	12/2015	S115-PMC4684854	['furthermore, an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks of Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [93].']	[('ANOMALY_CURIOUS_FINDING', 16), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 150, 'gestational'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0030324', 'lung development', 212, 'lung development'), ('UBERON_0002048', 'lung', 212, 'lung'), ('GO_0050905', 'neuromuscular process', 254, 'neurocognitive'), ('GO_0051318', 'G1 phase', 311, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 331, 'adolescence')]
S116-PMC4684854	PMC4684854	12/2015	S116-PMC4684854	['the authors STATE that “Vitamin D MAY have an IMPORTANT, multifaceted ROLE in the Development Of fetal Lungs, Brain, and Bone” [93].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 82, 'development of ... lungs ... brain'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0000955', 'brain', 110, 'brain'), ('GO_0007567', 'parturition', 121, 'bone')]
S117-PMC4684854	PMC4684854	12/2015	S117-PMC4684854	['finally, Gestational Vitamin D levels MAY IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the development of Adult onset multiple sclerosis [94].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('GO_0007565', 'female pregnancy', 9, 'gestational'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0007023', 'adult organism', 178, 'adult')]
S0-PMC4690051	PMC4690051	12/2015	S0-PMC4690051	['Gestational vitamin 25(oh)d status as a risk factor for Receptive Language Development: a 24-month, longitudinal, observational study\n\nabstract\nemerging data suggest that Vitamin D status during childhood and Adolescence CAN AFFECT Neurocognitive Development.']	[('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 225)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('GO_0000003', 'reproduction', 56, 'Receptive'), ('GO_0008584', 'male gonad development', 66, 'Language Development'), ('UBERON_0003215', 'alveolus', 66, 'Language'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 209, 'adolescence'), ('GO_0007399', 'nervous system development', 232, 'neurocognitive development')]
S114-PMC4690051	PMC4690051	12/2015	S114-PMC4690051	['Animal studies provide biological PLAUSIBILITY for the HYPOTHESIS that in utero Vitamin D exposure AFFECTS Human Brain Development [39,40].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 107, 'human'), ('GO_0007420', 'brain development', 113, 'brain development'), ('UBERON_0000955', 'brain', 113, 'brain')]
S116-PMC4690051	PMC4690051	12/2015	S116-PMC4690051	['the presence of 1α-hydroxylase activity within numerous Brain Regions SUGGESTS that Brain Tissue can locally produce Metabolically active Vitamin D, further IMPLICATING a ROLE for Vitamin D in Brain Development.']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 157), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('UBERON_0002616', 'regional part of brain', 56, 'brain regions'), ('UBERON_0000955', 'brain', 84, 'brain'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0008152', 'metabolic process', 117, 'metabolically'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007420', 'brain development', 193, 'brain development'), ('UBERON_0000955', 'brain', 193, 'brain')]
S17-PMC4691762	PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
S19-PMC4691762	PMC4691762	12/2015	S19-PMC4691762	['furthermore as one of the few countries that does not routinely fortify the Food chain supply, australia is uniquely placed internationally to assess the ROLE of Vitamin D in Early Life development.']	[('SUPERFICIAL_RELATIONSHIP', 154)]	1	[('CHEBI_33290', 'food', 76, 'food'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 175, 'early life')]
S111-PMC4691762	PMC4691762	12/2015	S111-PMC4691762	['furthermore we are uniquely placed internationally TO ASSESS the ROLE of Vitamin D in Early Life development since australia does not currently RECOMMEND universal infant Vitamin D supplementation and is one of the few countries where there is no routine fortification of the Food chain supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 86, 'early life'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_33290', 'food', 276, 'food')]
S37-PMC4764019	PMC4764019	1/2016	S37-PMC4764019	['schizophrenia\nmcgrath et al9have EVALUATED the ASSOCIATION between Vitamin D status at Birth and the development of schizophrenia later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 87, 'birth'), ('UBERON_0000104', 'life cycle', 139, 'life')]
S42-PMC4764019	PMC4764019	1/2016	S42-PMC4764019	['mcgrath et al also POINT out that Rats reared on Vitamin D–deficient diets produce pups that have morphologically abnormal Brain structures.9–11schizophrenia is USUALLY considered more a functional disorder with morphological alterations THAN a primarily morphologic one, and the Rat data INDICATE that Vitamin D is ESSENTIAL for normal Brain Development and HENCE plausibly for normal Brain function.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 316), ('PROBABLE_UNDERSTANDING', 359)]	6	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 34, 'rats'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000955', 'brain', 123, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 280, 'rat'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('GO_0007420', 'brain development', 337, 'brain development'), ('UBERON_0000955', 'brain', 337, 'brain'), ('UBERON_0000955', 'brain', 386, 'brain')]
S76-PMC4764019	PMC4764019	1/2016	S76-PMC4764019	['HENCE, the barker HYPOTHESIS, OR something closely approximating it, is very LIKELY to be operative in the functioning of the Vitamin D economy during Human development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 77)]	4	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 151, 'human')]
S123-PMC4765528	PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
S125-PMC4765528	PMC4765528	12/2015	S125-PMC4765528	['further work from that group also SUGGESTS that maternal Vitamin D stores CAN INFLUENCE Fetal Femoral Development at as early as 19 weeks Gestation [59].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007631', 'feeding behavior', 88, 'fetal'), ('GO_0009556', 'microsporogenesis', 94, 'femoral development'), ('UBERON_0000981', 'femur', 94, 'femoral'), ('GO_0007565', 'female pregnancy', 138, 'gestation')]
S0-PMC4770602	PMC4770602	1/2016	S0-PMC4770602	['EFFECT of Vitamin D supplementation in the reduce RISK of Preeclampsia in nulliparous women\n\nabstract\n\nbackground:\nthe exact ROLE of Vitamin D in the development and severity of Preeclampsia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 58, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 178, 'preeclampsia')]
S24-PMC4785305	PMC4785305	3/2016	S24-PMC4785305	"[""ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially.""]"	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
S25-PMC4800340	PMC4800340	5/2016	S25-PMC4800340	"[""THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE.""]"	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
S51-PMC4800340	PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]
S55-PMC4811107	PMC4811107	3/2016	S55-PMC4811107	['maternal atopic status was included because the primary goal of the cohort was to study allergic outcomes in the children and Prenatal and early Life Vitamin D levels have been investigated for their ROLE in allergic disease development [22,24–27].']	[('SUPERFICIAL_RELATIONSHIP', 200)]	1	[('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('UBERON_0000104', 'life cycle', 145, 'life'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
S2-PMC4811441	PMC4811441	3/2016	S2-PMC4811441	['the pathophysiology of the Development Of Hypertension In Pregnancy is UNKNOWN, but studies SUGGEST an ASSOCIATION with Vitamin D status, measured as 25-Hydroxyvitamin D (25(Oh)D).']	[('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0002234', 'detection of endoplasmic reticulum overloading', 27, 'development of hypertension in'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 150, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 173, '(OH)D')]
S34-PMC4811441	PMC4811441	3/2016	S34-PMC4811441	['this LIMITS the evaluation of the POTENTIAL ROLE of Vitamin D status during early Pregnancy in the development and progression Of Pe.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0001554', 'luteolysis', 127, 'of PE')]
S141-PMC4811441	PMC4811441	3/2016	S141-PMC4811441	['THEREFORE, IT IS POSSIBLE that Vitamin D status in early Pregnancy MIGHT not play a MAJOR ROLE in Placental Development, but that an increment during Gestation MAY prevent the Development Of Pe.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0001890', 'placenta development', 98, 'placental development'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0042494', 'detection of bacterial lipoprotein', 176, 'development of PE')]
S131-PMC4848664	PMC4848664	4/2016	S131-PMC4848664	['development of the Folic Acid ul was BASED ON EVIDENCE of masking of Vitamin B-12 deficiency anemia, and THUS, CONCERNS about the Folic Acid ul are ONLY applicable to those with a Vitamin B-12 deficiency and not to the general population.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 105), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 148)]	7	[('CHEBI_30751', 'formic acid', 19, 'folic acid'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 69, 'vitamin B-12'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 180, 'vitamin B-12')]
S124-PMC4859539	PMC4859539	5/2016	S124-PMC4859539	['lastly, total circulating Cathelicidin was measured RATHER than cell-specific mrna Expression of Cathelicidin or 1,25(Oh)2D3Concentration [17], which MAY BE more closely LINKED with Vitamin D status during Fetal and childhood Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('PR_000006009', 'alpha-catulin', 26, 'cathelicidin'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000006009', 'alpha-catulin', 97, 'cathelicidin'), ('CHEBI_52815', 'cresyl violet', 113, '1,25(OH)2D3concentration'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0030540', 'female genitalia development', 206, 'fetal ... development')]
S80-PMC4877864	PMC4877864	6/2015	S80-PMC4877864	['(2009) [21] compared the dietary Intake of children with autistic-spectrum disorders to that of children with typical development, they NOTED that large proportions of children did not meet the national RECOMMENDATIONS for daily intake of Vitamin D and Calcium.']	[('ANOMALY_CURIOUS_FINDING', 136), ('FUTURE_WORK', 203)]	2	[('GO_0007631', 'feeding behavior', 33, 'intake'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 253, 'calcium')]
S84-PMC4877864	PMC4877864	6/2015	S84-PMC4877864	['maintaining Vitamin D sufficiency in utero and during early Life, to satisfy the Vitamin D receptor transcriptional activity in the Brain, MAY BE IMPORTANT for Brain Development as well as for maintenance of mental function later in Life [25].']	[('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 146)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0007420', 'brain development', 160, 'brain development'), ('UBERON_0000955', 'brain', 160, 'brain'), ('UBERON_0000104', 'life cycle', 233, 'life')]
S0-PMC4889866	PMC4889866	5/2016	S0-PMC4889866	['maternal Vitamin D level is ASSOCIATED with Viral toll-like receptor triggered Il-10 response but not the risk of infectious diseases in infancy\n\nabstract\nreports on the EFFECT of Prenatal Vitamin D status on fetal Immune Development and infectious diseases in childhood are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 275)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Viral'), ('PR_000001470', 'interleukin-28B', 79, 'IL-10'), ('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0001822', 'kidney development', 215, 'immune development'), ('UBERON_0002405', 'immune system', 215, 'immune')]
S21-PMC4889866	PMC4889866	5/2016	S21-PMC4889866	['because of the APPARENT IMPORTANCE of Vitamin D in Immune Development, we AIMED TO INVESTIGATE the EFFECT of maternal and/or cord Vitamin D level on tlr-triggered cytokine response in neonates at time of Birth and disease outcome in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 99)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'immune development'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 204, 'birth')]
S90-PMC4889866	PMC4889866	5/2016	S90-PMC4889866	['DESPITE extensive investigations on Vitamin D, its ROLE in Neonatal Immune Development and health outcome REMAINS INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 59, 'neonatal'), ('GO_0001822', 'kidney development', 68, 'immune development'), ('UBERON_0002405', 'immune system', 68, 'immune')]
S147-PMC4891833	PMC4891833	6/2016	S147-PMC4891833	['a household survey will be administered with the following questionnaires:\n\ncaption (table-wrap): table 3\n\noutcomes of interestoutcomeinstrumentnotestiming of data collectionnutritional outcomes: \u2002height/lengthstadiometer (children and caregivers) (locally made, with 1\xa0mm gradations)length/height will be measured to the nearest 0.1\xa0cmbaseline, midline, endline\xa0(mothers/caregivers at endline only)\u2002weightelectronic mother-baby weighing scale with reading increments of 10\xa0g (seca model 874)weight will be measured to the nearest 100\xa0g. duplicate measures will be repeated if the difference between the measurements is >0.1\xa0kg.baseline, midline, endline\u2002anemia/hemoglobinhemocue hb 301 portable photometermeasurements will be obtained to the nearest 0.1\xa0g/dlbaseline, midline, endline\xa0(subsample)\u2002iron and Vitamin A statusenzyme-linked immunoassay (elisa) methodcapillary Blood samples in children 18-24 monthsendline (subsample) Child Development outcomes: \u2002Language and Cognitive and socio-Emotional Developmentages and stages questionnaire: inventory [51]combination of primary caregivers report and direct observation of children 0–36 mo [52]baseline, midline, endlinebayley scale [53]direct assessment\xa0(children 28-34 months)endline (subsample) intermediate indicators \u2002household Food securityhousehold Food security questionnaire (fanta)questions adapted and modified to reflect the cultural context, as NEEDED.']	[('FUTURE_WORK', 1411)]	1	[('CHEBI_27300', 'vitamin D', 807, 'vitamin A'), ('UBERON_0000178', 'blood', 873, 'blood'), ('GO_0007417', 'central nervous system development', 931, 'Child development'), ('GO_0040011', 'locomotion', 960, 'Language ...'), ('GO_0002553', 'histamine secretion by mast cell', 973, 'cognitive ... emotional developmentAges'), ('CHEBI_33290', 'food', 1286, 'food'), ('GO_0007631', 'feeding behavior', 1286, 'food'), ('CHEBI_33290', 'food', 1309, 'Food')]
S2791-PMC4896250	PMC4896250	4/2016	S2791-PMC4896250	['the GROWING DATA SUGGESTS that Vitamin D deficiency plays an IMPORTANT ROLE in the development of childhood asthma.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
S6121-PMC4896250	PMC4896250	4/2016	S6121-PMC4896250	['we AIMED to systematically review observational studies investigating the level of Vitamin D on the prevalence of the current allergic rhinitis (ar) and the development of ar.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
S7049-PMC4896250	PMC4896250	4/2016	S7049-PMC4896250	['a496 the EFFECT of Cord Serum 25-Hydroxyvitamin D (25(Oh)D) on the development of atopic dermatitis in first 3 years of Life : cocoa study\n\nhyun-ju cho1, youn ho shin2, eun lee3, young-ho kim3, darae lee3, mi-jin kang4, song-i yang5, kangmo ahn6, kyung won kim7, yoon hee kim7, hye-sung won3, soo hyun kim2, suk-joo choi6, young han kim7, jong kwan jun8, eun-jin kim9, jeom gyu lee9, so-yeon lee5, soo-jong hong1, dongin suh10\n\n1department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea;2cha medical center;3asan medical center;4asan institute for Life science, asan medical center;5hallym university sacred Heart hospital;6samsung medical center;7yonsei university college of medicine;8seoul national university college of medicine;9korea national institute of health;10seoul national university hospital\n\ncorrespondence: hyun-ju cho – department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea\nbackground: the ASSOCIATION between Serum Vitamin D deficiency at Birth and atopic dermatitis (ad) is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 1115), ('FULL_UNKNOWN', 1201)]	3	"[('UBERON_0000948', 'heart', 19, 'Cord'), ('UBERON_0001977', 'blood serum', 24, 'Serum'), ('CHEBI_27844', ""2',3'-cyclic AMP"", 30, '25-Hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('UBERON_0000104', 'life cycle', 120, 'Life'), ('UBERON_0000104', 'life cycle', 650, 'Life'), ('UBERON_0000948', 'heart', 710, 'Heart'), ('UBERON_0001977', 'blood serum', 1135, 'serum'), ('CHEBI_27300', 'vitamin D', 1141, 'vitamin D'), ('GO_0007567', 'parturition', 1165, 'birth')]"
S87-PMC4897157	PMC4897157	5/2016	S87-PMC4897157	['discussion\nwe HYPOTHESIZED that there MAY BE an ASSOCIATION between the Perinatal Vitamin D status and the development of Allergic Diseases.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('GO_0036268', 'swimming', 72, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 72, 'perinatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 122, 'allergic diseases')]
S106-PMC4897157	PMC4897157	5/2016	S106-PMC4897157	['ALTHOUGH the UNDERLYING mechanism REMAINS TO BE CLEARLY ESTABLISHED, seasonal differences in Ultraviolet B exposure, and PERHAPS also Vitamin D levels, MAY BE INVOLVED in the development of allergic diseases718).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 34), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_72754', 'bisphenol AF', 93, 'ultraviolet B'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
S153-PMC4897157	PMC4897157	5/2016	S153-PMC4897157	['to CONFIRM the EFFECT of sun exposure during infancy on the development of Allergic Diseases, FURTHER prospective INVESTIGATIONS that measure Serum Vitamin D levels ARE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 94), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 169)]	5	[('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 75, 'allergic diseases'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S97-PMC4903143	PMC4903143	5/2016	S97-PMC4903143	"[""an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency is ASSOCIATED with impaired Lung development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [34].""]"	[('ANOMALY_CURIOUS_FINDING', 3), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0002048', 'lung', 196, 'lung'), ('GO_0050905', 'neuromuscular process', 238, 'neurocognitive'), ('GO_0051318', 'G1 phase', 295, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 315, 'adolescence')]
S98-PMC4903143	PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
S14-PMC4908484	PMC4908484	6/2016	S14-PMC4908484	['moreover, Vitamin D is a regulator of Brain Cell Proliferation and Differentiation, and has an ESSENTIAL ROLE in the Brain Development (chopp et\xa0al.2007; stewart et\xa0al.2010) and Neurotransmitter Synthesis (tetich et\xa0al.2004).']	[('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CL_0000359', 'vascular associated smooth muscle cell', 38, 'brain cell'), ('UBERON_0000955', 'brain', 38, 'brain'), ('GO_0030154', 'cell differentiation', 44, 'cell proliferation ... differentiation'), ('GO_0007420', 'brain development', 117, 'brain development'), ('UBERON_0000955', 'brain', 117, 'brain'), ('CHEBI_25512', 'neurotransmitter', 178, 'neurotransmitter'), ('GO_0042136', 'neurotransmitter biosynthetic process', 178, 'neurotransmitter synthesis')]
S55-PMC4918713	PMC4918713	6/2015	S55-PMC4918713	['Animal STUDIES HAVE SHOWN that neonatal copper deficiency is ASSOCIATED with developmental abnormalities and altered Thyroid and Immune function.38\na similar DIFFERENTIAL EFFECT between mother and fetus is also SEEN in Vitamin A Metabolism.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 211)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 219, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 227, 'A')]
S9-PMC4930210	PMC4930210	7/2016	S9-PMC4930210	['introduction\nVitamin D plays an IMPORTANT ROLE in promoting healthy Pregnancy and Fetal Development, and POOR Vitamin D status HAS BEEN ASSOCIATED with adverse maternal and infant health [1].']	[('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007608', 'sensory perception of smell', 68, 'pregnancy ...'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 82, 'fetal development'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S158-PMC4934634	PMC4934634	11/2015	S158-PMC4934634	['when the data were combined with a concurrently run Vitamin D intervention trial (nichd; national institute of child health and Human development) by the same group, there was a marginally significant reduction in hypertension disorders ( p = 0.052) after adjustment for race and study in the 4000 iu/day group when COMPARED TO control women receiving 400 iu/day [60].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 316)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 128, 'Human')]
S176-PMC4934634	PMC4934634	11/2015	S176-PMC4934634	['it HAS BEEN PROPOSED that Vitamin D-induced epigenetic changes during development are INVOLVED in susceptibility to multiple morbidities ranging from allergies to cancer later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
S265-PMC4934634	PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
S2-PMC4969253	PMC4969253	8/2016	S2-PMC4969253	['disruption in ra signaling or Vitamin A deficiency (vad) HAS BEEN LINKED to aberrant Development Of the Lung including alterations in the Airway Smooth Muscle (sm) differentiation, development, and function.']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0008053', 'mitochondrial fusion', 85, 'development of ... lung'), ('UBERON_0002048', 'lung', 104, 'lung'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001135', 'smooth muscle tissue', 145, 'smooth muscle')]
S4-PMC4969253	PMC4969253	8/2016	S4-PMC4969253	['introduction: Retinoic Acid, a CRUCIAL signal for Formation Of the Embryonic Lung\nCLASSIC STUDIES in multiple species, including Hamsters, Rats, and Mice, HAVE SHOWN major pleiotropic EFFECTS of maternal dietary Vitamin A deprivation in Embryonic Development.']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_26536', 'retinoic acid', 14, 'retinoic acid'), ('GO_0001703', 'gastrulation with mouth forming first', 50, 'formation of ... lung'), ('UBERON_0000922', 'embryo', 67, 'embryonic'), ('UBERON_0002048', 'lung', 77, 'lung'), ('NCBITaxon_33208', 'Metazoa', 129, 'hamsters'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('GO_0009790', 'embryo development', 237, 'embryonic development'), ('UBERON_0000922', 'embryo', 237, 'embryonic')]
S41-PMC4969253	PMC4969253	8/2016	S41-PMC4969253	['CONFIRMATION of this Ra-Sm Regulation in vivo was provided by EVIDENCE that restricting maternal Vitamin A dietary intake during initiation of Airway Development resulted in aberrant overly differentiated and ectopic distribution of sm in these Airways.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 62)]	3	[('PR_000013779', 'histone-binding protein RBBP7', 21, 'RA-SM'), ('GO_0065007', 'biological regulation', 27, 'regulation'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035904', 'aorta development', 143, 'airway development'), ('UBERON_0001005', 'respiratory airway', 143, 'airway'), ('UBERON_0001005', 'respiratory airway', 245, 'airways')]
S67-PMC4973215	PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
S42-PMC4976416	PMC4976416	7/2016	S42-PMC4976416	['[27] multiple Human studies HAVE SHOWN no effects of Vitamin E on the prevention or Development Of Skin Cancers.']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('NCBITaxon_9606', 'Homo sapiens', 14, 'human'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin E'), ('GO_0042461', 'photoreceptor cell development', 84, 'development of skin cancers')]
S85-PMC4976416	PMC4976416	7/2016	S85-PMC4976416	['conclusion\nDESPITE development of new Formulations for use in cosmetics and skin care products, there is a LACK OF controlled clinical trials providing a rationale for well-defined dosages and clinical indications for oral and topical Vitamin E. after so MANY YEARS of RESEARCH on Vitamin E, it is STILL UNCLEAR as to WHETHER millions of dollars worth of Vitamin E products paid for by patients and consumers have been of any benefit.']	[('ANOMALY_CURIOUS_FINDING', 11), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 269), ('FULL_UNKNOWN', 298), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 318)]	7	[('CHEBI_38864', 'propetamphos', 38, 'formulations'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
S6-PMC4979151	PMC4979151	8/2016	S6-PMC4979151	['HOWEVER, Pha stimulation significantly induced the Expression of Genes encoding th1 and th2 cytokines and down-regulated a number of Genes INVOLVED in T-Cell Development, Proliferation and Differentiation Of B Cells, signal transduction pathway, transcriptional Regulation and pattern recognition receptors (prrs) in the Vitamin D group (vitd group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_34926', 'Pitrazepin', 9, 'PHA'), ('GO_0010467', 'gene expression', 51, 'expression'), ('SO_0000704', 'gene', 65, 'genes'), ('SO_0000704', 'gene', 133, 'genes'), ('CL_0000084', 'T cell', 151, 'T-cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 151, 'T-cell development'), ('GO_0007565', 'female pregnancy', 171, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 189, 'differentiation of B cells'), ('CL_0000236', 'B cell', 208, 'B cells'), ('GO_0065007', 'biological regulation', 262, 'regulation'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D')]
S15-PMC4979151	PMC4979151	8/2016	S15-PMC4979151	['maternal Vitamin D status during Pregnancy MAY AFFECT the fetal Immune System and CONTRIBUTE to the risk of development of Immune-mediated diseases and infection in the offspring.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002405', 'immune system', 64, 'immune system'), ('UBERON_0002405', 'immune system', 123, 'immune')]
S69-PMC4982007	PMC4982007	8/2016	S69-PMC4982007	['n \u2009=\u20095832: age 4\xa0years \u2003n \u2009=\u20095191; age 8\xa0years \u2003n \u2009=\u20097339; age 16\xa0yearsmaternal Gestational weight gain (kg)3 categories of weight gain1: less than recommended2: as recommended3: more than recommendedpre-Pregnancy weight (kg)school entry assessment score-4\xa0yearsiq- wechsler intelligence scale for children -iii-8\xa0yearsadequate final exam results-16\xa0yearschildren of women gained weight\u2009<\u2009expected-↓ school entry assessment score (-0.075 sd) and adequate final-exam results (or\u2009=\u20090.88); ↑weight gain - early and mid Pregnancy -↑school entry assessment score (0.072 and 0.077 sd)↑ weight gain in all three periods of Pregnancy-↑ iq at 8\xa0years (0.070 to 0.078 sd) and ↑pre-Pregnancy weight-↓ school entry assessment score (-0.004 sd/kg), iq (-0.004 sd) and the odds (or\u2009=\u20090.99) of achieving adequate final exam resultsconfounders adjusted for: the child’s sex, current age, ma; me, parity, pre-Pregnancy bmi, smoking and mode of Delivery16 medium\nbmi body mass index, qs quality score, rb risk of bias, ga Gestational age, ma maternal age, bwt Birthweight, ses socio-economic status, me maternal education, pe paternal education, miq maternal intelligence, he home environment, ms maternal smoking, bf breast-feeding, dm maternal diabetes, pih Pregnancy induced hypertension\n\ncaption (table-wrap): table 3\n\nsummary of the studies examining ASSOCIATIONS of maternal Vitamin D status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb20gale c; 2008 \u2003n \u2009=\u2009178\u2003age 9\xa0years\u2003uk\u2003prospective longitudinalserum Vitamin D concentrations assessed at 28-42 weeks Gestation21.2\xa0% had <27.5\xa0nmol/l28.3\xa0% had 27.5-50\xa0nmol/lwechsler abbreviated scale of intelligencefull-scale, verbal or performance iqno association between Vitamin D concentrations and offspring iq (full-scale, verbal or performance)confounders adjusted for: unadjusted16 medium21whitehouse ajo; 2012\u2003age 5\xa0years ( n \u2009=\u2009534)\u2003age 10\xa0years ( n \u2009=\u2009474)\u2003australia\u2003prospective longitudinalserum Vitamin D concentrations assessed at 18\xa0weeks Gestation25.2\xa0% mothers had insufficiency (≤46\xa0nmol/l)(lowest quartile)peabody picture vocabulary test Receptive Languagechildren of mothers with Vitamin D insufficiency (lowest quartile (≤46\xa0nmol/l) were at INCREASED RISK (or\u2009=\u20091.97) of Language impairment compared to children of mothers without insufficiency (highest quartile (≥72\xa0nmol/l; or\u2009=\u20091.00)confounders adjusted for: ma, ms, parity, family income, season of maternal Blood sampling13 medium22morales\xa0e; 2012 \u2003n \u2009=\u20091820\u2003age 11-23 months\u2003spain\u2003prospective population based\u2003cohort studyplasma Vitamin D concentrations assessed during 12-23 weeks Gestation19.5\xa0% mothers had deficiency (<20\xa0ng/ml)31.5\xa0% had insufficiency (20-30\xa0ng/ml)bayley scales of infant development (mental (mdi) and psychomotor (pdi) developmental score)a positive linear ASSOCIATION between Vitamin D concentrations and mdi and pdiper 10\xa0ng/ml increase in Vitamin D concentrations mdi and pdi score increased by β\u2009=\u20090.79 and β\u2009=\u20090.88 points respectivelycompared to infants of deficient mothers, infants of mothers with normal level scored higher mdi (β\u2009=\u20092.60) and pdi (β\u2009=\u20092.32) points respectivelyconfounders adjusted for: the child’s sex, bwt, area of study, maternal country of origin, ma, parity, Pre-Pregnancy bmi, ses, me, ms, Alcohol and season15 medium\nqs quality score, rb risk of bias, ma maternal age, bwt Birthweight, me Maternal education, ms maternal smoking, bmi body mass index, ses socio-economic status\n\ncaption (table-wrap): table 4\n\nsummary of the studies examining ASSOCIATIONS of maternal Folate status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb23wu btf; 2012 \u2003n \u2009=\u2009154\u2003age 18 months\u2003canada\u2003prospectiveplasma Folate and thcy concentrations assessed at 16 and 36\xa0weeks Gestationno Folate deficiency (plasma Folate <6.8\xa0nmol/l)high thcy not reportedbayley scales of infant developmentreceptive language, expressive language, Cognitive skills, fine motor and gross motorno ASSOCIATION of Folate and thcy with Cognitive functionconfounders adjusted for: the child’s sex, bf, ethnicity, ma, miq, maternal Fatty Acid level13 medium24tamura t; 2005 \u2003n \u2009=\u2009355\u2003age 5\xa0years\u2003usa\u2003prospective\u2003mothers participated in zinc supplementation trial during Pregnancyred cell and Plasma Folate concentrations – 19, 26 and 37\xa0weeks Gestation and thcy concentrations-26 and 37\xa0weekslow Folate-(Plasma Folate <11\xa0nmol/l)19\xa0weeks- 7.4\xa0%; 26\xa0weeks- 8.2\xa0%; 37\xa0weeks- 14.0\xa0%Red Cell Folate <430\xa0nmol/l)19\xa0weeks- 7.2\xa0%; 26\xa0weeks- 3.8\xa0%; 37\xa0weeks- 3.3\xa0%high thcy (thcy\u2009>\u20097\xa0μmol/l)26\xa0weeks- 8.4\xa0%; 37\xa0weeks- 22.1\xa0%differential ability scale (verbal, nonverbal and general iq), Visual and Auditory sequential Memory (Visual and Auditory Memory span)knox cube (attention span and Short-Term Memory)gross motor scale (gross Motor Development and grooved pegboard (manipulative dexterity)no difference in the mental and psychomotor developmental scores between children of mothers with normal and deficient Folate and thcy groups.']	[('SUPERFICIAL_RELATIONSHIP', 1338), ('IMPORTANT_CONSIDERATION', 2306), ('SUPERFICIAL_RELATIONSHIP', 2901), ('SUPERFICIAL_RELATIONSHIP', 3617), ('SUPERFICIAL_RELATIONSHIP', 4142)]	5	[('GO_0007565', 'female pregnancy', 80, 'gestational'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 616, 'pregnancy'), ('GO_0007565', 'female pregnancy', 671, 'pregnancy'), ('GO_0007565', 'female pregnancy', 892, 'pregnancy'), ('GO_0007567', 'parturition', 927, 'delivery16'), ('GO_0007565', 'female pregnancy', 1004, 'gestational'), ('GO_0007596', 'blood coagulation', 1042, 'birthweight'), ('GO_0007565', 'female pregnancy', 1242, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1363, 'vitamin D'), ('GO_0050890', 'cognition', 1395, 'cognitive'), ('CHEBI_27300', 'vitamin D', 1611, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1660, 'gestation21'), ('CHEBI_27300', 'vitamin D', 1818, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2052, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2098, 'gestation25'), ('GO_0000724', 'double-strand break repair via homologous recombination', 2201, 'Receptive languageChildren'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin D'), ('GO_0006266', 'DNA ligation', 2336, 'language'), ('UBERON_0000178', 'blood', 2527, 'blood'), ('CHEBI_27300', 'vitamin D', 2650, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2703, 'gestation19'), ('CHEBI_27300', 'vitamin D', 2921, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2986, 'vitamin D'), ('GO_0007568', 'aging', 3332, 'pre'), ('GO_0007565', 'female pregnancy', 3336, 'pregnancy'), ('CHEBI_30879', 'alcohol', 3364, 'alcohol'), ('GO_0007596', 'blood coagulation', 3448, 'birthweight'), ('GO_0007618', 'mating', 3464, 'maternal'), ('CHEBI_30863', '5-azaorotic acid', 3642, 'folate'), ('GO_0050890', 'cognition', 3671, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 3881, 'folate'), ('GO_0007565', 'female pregnancy', 3940, 'gestationNo'), ('CHEBI_30863', '5-azaorotic acid', 3952, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 3978, 'folate'), ('GO_0050890', 'cognition', 4095, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 4157, 'folate'), ('GO_0050890', 'cognition', 4178, 'cognitive'), ('CHEBI_35366', 'fatty acid', 4272, 'fatty acid'), ('GO_0007605', 'sensory perception of sound', 4410, 'pregnancyRed'), ('UBERON_0001969', 'blood plasma', 4432, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4439, 'folate'), ('GO_0007565', 'female pregnancy', 4483, 'gestation'), ('CHEBI_30863', '5-azaorotic acid', 4536, 'folate'), ('UBERON_0001969', 'blood plasma', 4544, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4551, 'folate'), ('CL_0000232', 'erythrocyte', 4619, 'Red cell'), ('CHEBI_30863', '5-azaorotic acid', 4628, 'folate'), ('GO_0007601', 'visual perception', 4819, 'Visual'), ('GO_0006754', 'ATP biosynthetic process', 4830, 'Auditory ...'), ('GO_0007613', 'memory', 4850, 'Memory'), ('GO_0007601', 'visual perception', 4858, 'visual'), ('GO_0007605', 'sensory perception of sound', 4869, 'auditory'), ('GO_0007613', 'memory', 4878, 'memory'), ('GO_0007608', 'sensory perception of smell', 4920, 'short-term memory'), ('GO_0009653', 'anatomical structure morphogenesis', 4963, 'motor development'), ('CHEBI_30863', '5-azaorotic acid', 5145, 'folate')]
S75-PMC4982007	PMC4982007	8/2016	S75-PMC4982007	['m; 2010 \u2003n \u2009=\u20099983 14\xa0years \u2003n \u2009=\u200910474 16\xa0years\u2003finland\u2003prospective Birth cohort studyhb concentrations at 3rd 7th and 9th Gestational monthsanaemiaschool performance14\xa0years- self report16\xa0years- school report↑maternal hb at 9\xa0months-↑ total school performance score (β\u2009=\u20090.03) and theory score at 14\xa0years and total score at 16\xa0years offspring of mothers with anaemia –low school scores (or\u2009=\u2009-0.05 at 14\xa0years and (or\u2009=\u2009-0.06) at 16\xa0yearsconfounders adjusted for: the child’s sex, bwt, Pregnancy wanted or not, me, social class, parity, marital status, ms, maternal mental health status18 low40davidson pw; 2008 \u2003n \u2009=\u2009229\u2003age 5, 9, 25and 30\xa0months\u2003republic of seychelles\u2003longitudinal cohort studyiron- total body stores at 14-24 weeks of Gestation assessed before the start of iron supplementationbayley scales of infant development: mental development index (mdi) and psychomotor development index (pdi) (9 and 30\xa0months)infant Cognition (fagan infantest-novelty preference) and Visual expectation paradigm –Visual recognition Memory (9 and 25\xa0months)a-not-b and delayed spatial alternation: inhibition, Working Memory, Planning and attention (25\xa0months)no association between maternal iron stores and Cognitive function at any age.confounders adjusted for: the child’s sex, bwt, ma, ses, he, miq and both parents living with the child (yes/no)19 low41lewis sj; 2013 \u2003n \u2009=\u2009~3,500\u2003age 8\xa0years\u2003uk\u2003population based prospective birth cohorthb concentrationsbefore 18\xa0weekshb <11.0\xa0g/dl -8\xa0%after 28\xa0weekshb <11.0\xa0g/dl -30\xa0%wechsler intelligence scale for children-iii- full- scale iqno ASSOCIATION between maternal hb and child’s iqconfounders adjusted for: ga, me, the child’s genotype, Iron supplementation, population stratification15 medium42tran td; 2013 \u2003n \u2009=\u2009378\u2003age 6\xa0months\u2003vietnam\u2003population based prospective cohort studyiron deficiency anaemia (hb <11.0\xa0g/dl and Serum ferritin <15\xa0ng/ml) during 12-28 weeks of Gestation-16\xa0%bayley scales of infant and toddler development-iii edition-Cognitive scoreinfants of anaemic mothers scored 11.6 points (0.77sd) lower in bsid Cognitive scores compared to infants of non-anaemic mothers.confounders adjusted for: parity, ma, me, wealth index, the child’s Birth and current weight, family support, bf.18 low43zhou sj; 2006 \u2003n \u2009=\u2009302\u2003age 4\xa0years; australia\u2003double blind randomized controlled trialiron Supplements (20\xa0mg/day) or placebo from 20\xa0weeks Gestation until deliverycompliance-86\xa0%stanford binet intelligence scale – iq (Verbal Reasoning, Visual Reasoning, Quantitative Reasoning and Short-Term Memory)no difference between the children of supplement group and placebo group in the mean score of composite iq or any subscales iq or in the proportion of children whose iq fell 1 or 2 sd below the mean.confounders adjusted for: sex, Birth order, Gestational age, ma, me, pe, he, bf20 low44li q; 2009 \u2003n \u2009=\u20091305\u2003age 3, 6 and 12\xa0months\u2003double blind cluster randomized controlled trial\u2003china3 intervention groups (all received Folic Acid)Folic Acid alone400\xa0μg ( n \u2009=\u2009471)-controliron 60\xa0mg\u2009+\u2009Folic Acid400\xa0μg ( n \u2009=\u2009438)multiple Micronutrients ((b Vitamins (1,2,3 6 and 12), Vitamin A, d, c, e and minerals (zinc, Iodine, copper, Selenium)\u2009+\u2009iron 30\xa0mg\u2009+\u2009400\xa0μg Folic Acid)) ( n \u2009=\u2009396)daily supplementation from enrolment until Delivery; inadequate information about compliancebayley scales of Infant Development :mental (md) and Psychomotor Development (pd)no significant difference in infants md and pd score at 3 and 6\xa0months and pd score at 12\xa0months between Supplement groupsmean md score among children of multiple Micronutrient group increased by 1 to 1.22 points COMPARED to children of Folic Acid alone, or Folic Acid\u2009+\u2009Iron group at 12\xa0monthsconfounders adjusted for: infants age, sex, Gestational age, apgar score, bwt, infant health, maternal age and bmi, parental education, occupation, ses, number of tablets consumed19 low\nqs quality score , rb risk of bias , hb haemoglobin , ga Gestational age , ma maternal age , bwt birthweight , ses socio-economic status , me maternal education , pe paternal education , miq maternal intelligence , he home environment , ms maternal smoking , bf breast-feeding , bmi body mass index\n\ncaption (table-wrap): table 7\n\nsummary of the studies examining ASSOCIATIONS of maternal Carbohydrate/protein with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb45alderman h; 2014 \u2003n \u2009=\u20096774\u2003age 16-22 years\u2003double blind cluster randomized controlled trial\u2003gambiacarbohydrate/protein supplementsintervention group:2 biscuits daily (1015\xa0kcal Carbohydrate and 22\xa0g protein) from 20\xa0weeks of Gestation to Deliverycontrol group: same Supplements for 20\xa0weeks during Postpartum but not during Pregnancyno information about complianceraven’s progressive matrices- nonverbal reasoning abilitythe mill hill vocabulary testthe backward and forward digit-span testschooling achievement (questionnaire)no difference in any of the Cognitive test scores or schooling achievement between children whose mothers received thesupplements during Pregnancy and children whose mothers received Supplements during Postpartum.confounders adjusted for: the child’s sex, age, ga, me, pe, maternal height, parity, season of Birth, language and village allocation19 low\nqs quality score, rb risk of bias, ga Gestational age, me Maternal education, pe paternal education\n\nmaternal anthropometry (table\xa02)\nall were observational studies and from developed countries [8–19].']	[('SUPERFICIAL_RELATIONSHIP', 1587), ('ANOMALY_CURIOUS_FINDING', 3631), ('SUPERFICIAL_RELATIONSHIP', 4262)]	3	[('GO_0007567', 'parturition', 69, 'Birth'), ('GO_0007565', 'female pregnancy', 124, 'gestational'), ('GO_0007565', 'female pregnancy', 490, 'pregnancy'), ('GO_0007565', 'female pregnancy', 742, 'gestation'), ('GO_0050890', 'cognition', 933, 'cognition'), ('GO_0007601', 'visual perception', 984, 'Visual'), ('GO_0007601', 'visual perception', 1013, 'visual ...'), ('GO_0007613', 'memory', 1032, 'memory'), ('GO_0007631', 'feeding behavior', 1109, 'working memory'), ('GO_0006260', 'DNA replication', 1125, 'planning'), ('GO_0050890', 'cognition', 1207, 'cognitive'), ('CHEBI_24870', 'ion', 1689, 'iron'), ('UBERON_0001977', 'blood serum', 1876, 'serum'), ('GO_0007565', 'female pregnancy', 1924, 'gestation'), ('GO_0050890', 'cognition', 1998, 'cognitive'), ('GO_0050890', 'cognition', 2082, 'cognitive'), ('GO_0007567', 'parturition', 2210, 'birth'), ('CHEBI_33341', 'titanium atom', 2355, 'supplements'), ('GO_0007565', 'female pregnancy', 2404, 'gestation'), ('GO_0016055', 'Wnt signaling pathway', 2483, 'verbal reasoning'), ('GO_0007602', 'phototransduction', 2501, 'visual reasoning'), ('GO_0031028', 'septation initiation signaling', 2519, 'quantitative reasoning'), ('GO_0007608', 'sensory perception of smell', 2546, 'short-term memory'), ('GO_0007567', 'parturition', 2794, 'birth'), ('GO_0007565', 'female pregnancy', 2807, 'gestational'), ('CHEBI_30751', 'formic acid', 2985, 'folic acid'), ('CHEBI_30751', 'formic acid', 2996, 'Folic acid'), ('CHEBI_52727', 'ethyl nile blue A', 3051, 'folic acid400'), ('CHEBI_33839', 'macromolecule', 3088, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 3107, 'vitamins'), ('CHEBI_27300', 'vitamin D', 3134, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 3173, 'iodine'), ('CHEBI_27568', 'selenium atom', 3189, 'selenium'), ('CHEBI_30751', 'formic acid', 3221, 'folic acid'), ('GO_0007567', 'parturition', 3288, 'delivery'), ('GO_0060119', 'inner ear receptor cell development', 3354, 'Infant Development'), ('GO_0035210', 'prepupal development', 3390, 'Psychomotor development'), ('CHEBI_16158', 'steroid sulfate', 3523, 'supplement'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 3581, 'micronutrient'), ('CHEBI_30751', 'formic acid', 3655, 'folic acid'), ('CHEBI_30751', 'formic acid', 3676, 'folic acid'), ('CHEBI_24870', 'ion', 3689, 'iron'), ('GO_0007565', 'female pregnancy', 3756, 'gestational'), ('GO_0007565', 'female pregnancy', 3955, 'gestational'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4287, 'carbohydrate'), ('GO_0050890', 'cognition', 4323, 'cognitive'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4649, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 4697, 'gestation'), ('GO_0051607', 'defense response to virus', 4710, 'deliveryControl'), ('CHEBI_33341', 'titanium atom', 4738, 'supplements'), ('GO_0007565', 'female pregnancy', 4770, 'postpartum'), ('GO_0007605', 'sensory perception of sound', 4796, 'pregnancyNo'), ('GO_0050890', 'cognition', 5027, 'cognitive'), ('GO_0007565', 'female pregnancy', 5136, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 5182, 'supplements'), ('GO_0007565', 'female pregnancy', 5201, 'postpartum'), ('GO_0007567', 'parturition', 5307, 'birth'), ('GO_0007565', 'female pregnancy', 5390, 'gestational'), ('GO_0007618', 'mating', 5410, 'maternal')]
S127-PMC4982007	PMC4982007	8/2016	S127-PMC4982007	['ANOTHER STUDY FOUND higher Mental and Psychomotor Development scores (2-3 score points (0.1-0.2 sd)) in children of mothers with normal Vitamin D status (>75\xa0nmol/l) compared to those with deficiency (<50\xa0nmol/l) [22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('GO_0007613', 'memory', 27, 'mental ...'), ('GO_0030324', 'lung development', 38, 'psychomotor development'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
S128-PMC4982007	PMC4982007	8/2016	S128-PMC4982007	['it also FOUND a positive ASSOCIATION between maternal Vitamin D concentrations and offspring Mental and Psychomotor Development scores (0.8-0.9 score points (~0.06 sd) per 25\xa0nmol/l increase).']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007613', 'memory', 93, 'mental ...'), ('GO_0030324', 'lung development', 104, 'psychomotor development')]
S359-PMC4982007	PMC4982007	8/2016	S359-PMC4982007	['we FOUND SOME EVIDENCE LINKING maternal obesity and low Micronutrient status, in particular, that of Vitamin D, Folate and B12 during Pregnancy with poorer offspring Cognitive function, SUGGESTING that maternal nutrition is IMPORTANT for optimal offspring Neurodevelopment and Long-Term Cognition.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 224)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 56, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 112, 'folate'), ('CHEBI_27778', 'abequose', 123, 'B12'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0050890', 'cognition', 166, 'cognitive'), ('GO_0007399', 'nervous system development', 256, 'neurodevelopment'), ('GO_0007040', 'lysosome organization', 277, 'long-term cognition')]
S241-PMC4989298	PMC4989298	8/2016	S241-PMC4989298	['evaluate the EFFECT of the administration of antioxidants (Β-Carotene, Vitamin C, Vitamin E, copper and zinc) on the development of allergic disease in children [93].']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 59, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin E')]
S242-PMC4989298	PMC4989298	8/2016	S242-PMC4989298	['their results demonstrate a PROTECTIVE EFFECT of Vitamin C on the incidence of wheezing and a preventive EFFECT of the CONTRIBUTION of copper on the development of various allergic diseases.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 105), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin C')]
S299-PMC4990268	PMC4990268	8/2016	S299-PMC4990268	['that said, there is also EVIDENCE that Vitamin A deficiency INTERFERES with proper fetal development[103].']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A')]
S333-PMC4990268	PMC4990268	8/2016	S333-PMC4990268	['all infants are Born with limited to modest Liver reserves of Vitamin A and depend on breastfeeding to provide this ESSENTIAL Nutrient for proper growth and development[115].']	[('IMPORTANT_CONSIDERATION', 116)]	1	[('GO_0007567', 'parturition', 16, 'born'), ('UBERON_0002107', 'liver', 44, 'liver'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33284', 'nutrient', 126, 'nutrient')]
S40-PMC4992225	PMC4992225	8/2016	S40-PMC4992225	['it SEEMS that in addition to Calcium Homeostasis and bone health, Vitamin D is also ESSENTIAL for Brain Development and function [20,21].']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 84)]	2	[('GO_0055073', 'cadmium ion homeostasis', 29, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007420', 'brain development', 98, 'brain development'), ('UBERON_0000955', 'brain', 98, 'brain')]
S10-PMC4998950	PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
S43-PMC4998950	PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
S45-PMC4998950	PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
S16-PMC5014971	PMC5014971	8/2016	S16-PMC5014971	['POOR Vitamin D status is a RISK FACTOR for POOR Skeletal Development and fractures in newborns [3].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 43)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0001501', 'skeletal system development', 48, 'skeletal development'), ('UBERON_0004288', 'skeleton', 48, 'skeletal')]
S1-PMC5039809	PMC5039809	10/2016	S1-PMC5039809	['TO OUR KNOWLEDGE, the ASSOCIATIONS between maternal Vitamin A status and offspring Bone Development have NOT previously BEEN ELUCIDATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FULL_UNKNOWN', 105)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0048539', 'bone marrow development', 83, 'bone development')]
S21-PMC5039809	PMC5039809	10/2016	S21-PMC5039809	['FEW STUDIES to OUR KNOWLEDGE have RELATED maternal Vitamin A nutrition during Pregnancy to Offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 91, 'offspring'), ('GO_0048539', 'bone marrow development', 101, 'bone development')]
S112-PMC5039809	PMC5039809	10/2016	S112-PMC5039809	['there are FEW STUDIES to OUR KNOWLEDGE that have RELATED maternal Vitamin A status to offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0048539', 'bone marrow development', 96, 'bone development')]
S13-PMC5045784	PMC5045784	10/2016	S13-PMC5045784	['introduction\nbronchopulmonary dysplasia (bpd) is the MOST PREVALENT long-term morbidity among surviving EXTREMELY preterm infants and has a MULTIFACTORIAL etiology.1bpd is ASSOCIATED with later risk of reactive Airways disease, such as asthma,2post neonatal mortality and adverse Neurodevelopmental outcomes.1bpd AFFECTS ~20% of preterm infants, and up to 60% of extremely preterm infants who are Born before 26 completed weeks of Gestation.2an ESTIMATED 10\u2009000 to 15\u2009000 infants are affected in the united states each year and this has substantial medical and socioeconomic IMPLICATIONS.2,3\nACCUMULATING epidemiologic EVIDENCE SUGGESTS that Vitamin D deficiency or insufficiency is ASSOCIATED with Respiratory disease in children.']	[('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 104), ('DIFFICULT_TASK', 140), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 445), ('IMPORTANT_CONSIDERATION', 575), ('INCOMPLETE_EVIDENCE', 592), ('INCOMPLETE_EVIDENCE', 628), ('SUPERFICIAL_RELATIONSHIP', 683)]	10	[('UBERON_0001005', 'respiratory airway', 211, 'airways'), ('GO_0007399', 'nervous system development', 280, 'neurodevelopmental'), ('GO_0007567', 'parturition', 397, 'born'), ('GO_0007565', 'female pregnancy', 431, 'gestation'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 699, 'respiratory')]
S17-PMC5045784	PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S59-PMC5045784	PMC5045784	10/2016	S59-PMC5045784	['SIMILARLY, a RECENT interventional TRIAL of three dosing regimens for Vitamin D supplementation in extremely preterm infants FOUND no association between Vitamin D status and Respiratory outcomes.17\nthe IMPORTANCE of Vitamin D status in pediatric Respiratory health is SUPPORTED by large epidemiologic studies of term infants SHOWING an ASSOCIATION between suboptimal Vitamin D status and wheezing.4,18in addition, Animal studies demonstrate an IMPORTANT biologic ROLE for Vitamin D in Lung Development and Maturation, including Differentiation Of Type Ii Pneumocytes, Surfactant Phospholipid synthesis and secretion,19as well as an immunomodulatory ROLE in Epithelial Cells, Neutrophils and Macrophages.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 269), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 337), ('IMPORTANT_CONSIDERATION', 445), ('SUPERFICIAL_RELATIONSHIP', 464), ('SUPERFICIAL_RELATIONSHIP', 650)]	10	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 415, 'animal'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D'), ('GO_0035180', 'larval wandering behavior', 486, 'lung development ... maturation'), ('UBERON_0002048', 'lung', 486, 'lung'), ('GO_0007620', 'copulation', 529, 'differentiation of ...'), ('CL_0002063', 'type II pneumocyte', 548, 'type II pneumocytes'), ('CHEBI_53015', 'N(6)-carboxymethyl-L-lysine residue', 569, 'surfactant phospholipid'), ('CL_0000066', 'epithelial cell', 658, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 658, 'epithelial'), ('CL_0000775', 'neutrophil', 676, 'neutrophils'), ('CL_0000235', 'macrophage', 692, 'macrophages')]
S60-PMC5045784	PMC5045784	10/2016	S60-PMC5045784	['finally, interventional Animal and Human studies provide STRONG EVIDENCE for a beneficial ROLE of Vitamin D supplementation in Pulmonary outcomes.7,20\nthe ROLE of Vitamin D status in the development of bpd REMAINS incompletely understood.']	[('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 206)]	5	[('NCBITaxon_33208', 'Metazoa', 24, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0002048', 'lung', 127, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S66-PMC5045784	PMC5045784	10/2016	S66-PMC5045784	['given that Vitamin D has IMPORTANT ROLES in early Lung Development and Innate Immunity, the LACK OF ASSOCIATION between Vitamin D status and development of bpd SUPPORTS the multifactorial etiology of and POSSIBLE Genetic predisposition to bpd.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0030324', 'lung development', 50, 'lung development'), ('UBERON_0002048', 'lung', 50, 'lung'), ('GO_0045087', 'innate immune response', 71, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('SO_0000704', 'gene', 213, 'genetic')]
S48-PMC5062906	PMC5062906	10/2016	S48-PMC5062906	['to address the ROLE of maternal Vitamin D in determining offspring epigenetic state, we used a Mouse MODEL to characterize WHETHER depletion of maternal Vitamin D during Gestation and Lactation AFFECTS epigenetic and developmental outcomes of progeny.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('SUPERFICIAL_RELATIONSHIP', 194)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 95, 'mouse'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('GO_0007595', 'lactation', 184, 'lactation')]
S89-PMC5062906	PMC5062906	10/2016	S89-PMC5062906	['panel above the graph lists all statistically significant ( p value <0.05) comparisons determined by regression analysis for overall diet-dependent effects (diet) and diet\u2009×\u2009strain INTERACTIVE EFFECTS (diet\u2009×\u2009strain)\n\nmaternal Vitamin D depletion alters g1and g2offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner\nwe next ASSESSED WHETHER maternal Vitamin D depletion AFFECTS offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner across multiple generations.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 193), ('SUPERFICIAL_RELATIONSHIP', 333), ('QUESTION_ANSWERED_BY_THIS_WORK', 358), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('SUPERFICIAL_RELATIONSHIP', 404), ('SUPERFICIAL_RELATIONSHIP', 483)]	7	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D')]
S115-PMC5062906	PMC5062906	10/2016	S115-PMC5062906	['2\n\nmaternal (g0) Vitamin D deficiency is LINKED to (g1) offspring developmental outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 41)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
S136-PMC5062906	PMC5062906	10/2016	S136-PMC5062906	['3\n\nGrandmaternal (g0) Vitamin D deficiency is LINKED to g2offspring developmental outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('GO_0000050', 'urea cycle', 3, 'Grandmaternal'), ('UBERON_0001225', 'cortex of kidney', 3, 'Grandmaternal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
S153-PMC5062906	PMC5062906	10/2016	S153-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation in Soma and germline of Adult g1and g2males in a parent and grandparent of origin-DEPENDENT manner\nwe INVESTIGATED WHETHER Vitamin D depletion AFFECTS Dna Methylation state at Imprinted Genes in g1and g2males and WHETHER these differences are LINKED to the developmental changes described above.']	[('SUPERFICIAL_RELATIONSHIP', 134), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('SUPERFICIAL_RELATIONSHIP', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0044297', 'cell body', 55, 'soma'), ('UBERON_0007023', 'adult organism', 76, 'adult'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 228, 'imprinted'), ('SO_0000704', 'gene', 238, 'genes')]
S242-PMC5062906	PMC5062906	10/2016	S242-PMC5062906	['we also FIND that parent and grandparent of origin plays in an IMPORTANT ROLE in the direction and extent of Vitamin D-DEPENDENT developmental and epigenetic EFFECTS in the offspring.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 158)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
S251-PMC5062906	PMC5062906	10/2016	S251-PMC5062906	['our data HIGHLIGHT two mechanisms that CONTRIBUTE to interindividual DIFFERENCES in response to Vitamin D deficiency: the Genetic INFLUENCE on maternal Plasma depletion of 25(Oh)D and the INFLUENCE of parent and grandparent of origin in the extent of Vitamin D-DEPENDENT developmental and epigenetic outcomes.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('SO_0000704', 'gene', 122, 'genetic'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
S121-PMC5084016	PMC5084016	10/2016	S121-PMC5084016	['with Aging, the Synthesis Of Vitamin D in the Epidermis Layer becomes less efficient; also, diseases ASSOCIATED with Intestinal malabsorption, such as celiac disease, crohn’s disease, cystic fibrosis, ulcerative colitis, Liver and Kidney disorders and SOME Pharmacological treatments, MAY CONTRIBUTE to the development of Vitamin D deficiency [57].']	[('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 289)]	4	[('GO_0007568', 'aging', 5, 'aging'), ('GO_0030474', 'spindle pole body duplication', 16, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002027', 'stratum corneum of epidermis', 46, 'epidermis layer'), ('UBERON_0000160', 'intestine', 117, 'intestinal'), ('UBERON_0002107', 'liver', 221, 'liver'), ('UBERON_0002113', 'kidney', 231, 'kidney'), ('CHEBI_52217', 'pharmaceutical', 257, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
S130-PMC5084016	PMC5084016	10/2016	S130-PMC5084016	['low Birth weight, impaired Skeletal Development, and Respiratory infections and allergic diseases in the early years of Life are OFTEN ASSOCIATED with INADEQUATE CONTRIBUTION of Vitamin D from the mother’s diet.']	[('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('GO_0007567', 'parturition', 4, 'birth'), ('GO_0001501', 'skeletal system development', 27, 'skeletal development'), ('UBERON_0004288', 'skeleton', 27, 'skeletal'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
S185-PMC5084016	PMC5084016	10/2016	S185-PMC5084016	['in cases of post-surgery Conception, specific nutritional deficiencies CAN AFFECT Visual Acuity (Vitamin A) and the Development Of the Nervous System (Vitamin B12) and Neural Tube (folates) [87,88].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('GO_0007620', 'copulation', 25, 'conception'), ('GO_0019042', 'viral latency', 82, 'visual acuity'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035882', 'defecation rhythm', 116, 'development of ... nervous system'), ('UBERON_0001016', 'nervous system', 135, 'nervous system'), ('CHEBI_33279', 'vitamin D5', 151, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 151, 'vitamin B12'), ('UBERON_0001049', 'neural tube', 168, 'neural tube')]
S16-PMC5085625	PMC5085625	9/2016	S16-PMC5085625	['the active form of Vitamin D, i.e., 1,25(Oh)2D, is now recognized as an IMPORTANT hormone playing a CRUCIAL role in Skeletal Homeostasis (classical effects) and exerting NON-CLASSICAL EFFECTS in various pathological and physiological conditions, such as cancer, Arterial hypertension, Cardiovascular diseases, Brain Development and Immunomodulation [3,4,5,6].']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	"[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 38, '25(OH)2D'), ('GO_0043276', 'anoikis', 116, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 116, 'skeletal'), ('UBERON_0001637', 'artery', 262, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 285, 'cardiovascular'), ('GO_0007420', 'brain development', 310, 'brain development'), ('UBERON_0000955', 'brain', 310, 'brain'), ('GO_0050900', 'leukocyte migration', 332, 'immunomodulation')]"
S95-PMC5085625	PMC5085625	9/2016	S95-PMC5085625	['CONSEQUENTLY, Vitamin D level in early Pregnancy is less LIKELY to play a MAJOR ROLE in Placental Development, and it is later increased in this parameter which may PREVENT the development of pe [13].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 57), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0001890', 'placenta development', 88, 'placental development'), ('UBERON_0001987', 'placenta', 88, 'placental')]
S97-PMC5095257	PMC5095257	11/2016	S97-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period coupled with Vitamin D deficiency leading to dysregulation of innate immunity COULD BE the POTENTIAL initial triggers for the eventual development of aad, ALTHOUGH this REQUIRES FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 240)]	5	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S118-PMC5129897	PMC5129897	10/2016	S118-PMC5129897	"[""“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\xa0weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\xa0y.83\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\n\nall-cause mortality rate\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment.""]"	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]
S108-PMC5133057	PMC5133057	10/2016	S108-PMC5133057	['it is IMPORTANT TO NOTE that EVEN IF the reduction occurs with more intensity in the second and third quarter due to Plasma volume expansion and increased Vitamin A transfer from the mother to the fetus, special ATTENTION throughout Pregnancy is NECESSARY, PARTICULARLY in the first trimester, when the major changes in the Fetal Development occur.']	[('IMPORTANT_CONSIDERATION', 6), ('ANOMALY_CURIOUS_FINDING', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 257)]	7	[('UBERON_0001969', 'blood plasma', 117, 'plasma'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 324, 'fetal development')]
S25-PMC5146866	PMC5146866	12/2016	S25-PMC5146866	['improved understanding of FACTORS ASSOCIATED with development of Vitamin D deficiency/ insufficiency will facilitate the creation and implementation of appropriate preventive STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 34), ('FUTURE_WORK', 175)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
S45-PMC5146866	PMC5146866	12/2016	S45-PMC5146866	['variables with significant between-group variability ( p value of less than 0.05) were classified for inclusion into the multiple regression models to estimate their independent ROLE in the development of Vitamin D deficiency and insufficiency in cb as compared to those with sufficient levels of Vitamin D. in addition multiple regression models were stratified by race/ethnicity defined as white, black, hispanic, and asian.']	[('SUPERFICIAL_RELATIONSHIP', 178)]	1	[('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
S85-PMC5146866	PMC5146866	12/2016	S85-PMC5146866	['moreover, the internal VALIDITY of the EXISTING STUDIES is a subject for discussion because the INDEPENDENT EFFECT of maternal race/ethnicity on the Vitamin D status was not controlled for and other maternal FACTORS MAY also have an ASSOCIATION with the development of Vitamin D deficiency/insufficiency in infants at Birth.']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 216), ('SUPERFICIAL_RELATIONSHIP', 233)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0007567', 'parturition', 318, 'birth')]
S14-PMC5155676	PMC5155676	12/2016	S14-PMC5155676	['maternal Vitamin D INSUFFICIENCY during Pregnancy is common (1,2), and THERE IS EVIDENCE that this MIGHT have DETRIMENTAL EFFECTS on maternal health, Fetal Development (3,4) and the long-term Skeletal health of children (1,3).']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 150, 'fetal development'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
S125-PMC5155676	PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
S136-PMC5223368	PMC5223368	12/2016	S136-PMC5223368	['a study in london REPORTED that maternal Vitamin D insufficiency at Pregnancy as early as 19\xa0weeks CAN INFLUENCE Fetal Femoral Development, and SUGGESTED that maternal Vitamin D should be improved in early Pregnancy [14].']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 144)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007631', 'feeding behavior', 113, 'fetal'), ('GO_0009556', 'microsporogenesis', 119, 'femoral development'), ('UBERON_0000981', 'femur', 119, 'femoral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy')]
S48-PMC5310660	PMC5310660	1/2017	S48-PMC5310660	['Gestational Vitamin D concentration IS CONSIDERED IMPORTANT for the Development Of the Immune System.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 50)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0002020', 'protease binding', 68, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 87, 'immune system')]
S52-PMC5310660	PMC5310660	1/2017	S52-PMC5310660	['in Animal models, Gestational Vitamin D deficiency AFFECTS Brain Development [23], and the myelination process [24], and it COULD have an EFFECT on Retinal Cells.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('GO_0007565', 'female pregnancy', 18, 'gestational'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007420', 'brain development', 59, 'brain development'), ('UBERON_0000955', 'brain', 59, 'brain'), ('CL_0009004', 'retinal cell', 148, 'retinal cells'), ('UBERON_0000966', 'retina', 148, 'retinal')]
S19-PMC5318550	PMC5318550	2/2017	S19-PMC5318550	['HOWEVER, an integral test of these POSSIBLE explanations for the RISK of POOR Neurodevelopmental outcomes is LACKING and newer HYPOTHESES, such as variation in Vitamin D levels, HAVE NOT BEEN INVESTIGATED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('FULL_UNKNOWN', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 178), ('IMPORTANT_CONSIDERATION', 178)]	10	[('GO_0007399', 'nervous system development', 78, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
S21-PMC5318550	PMC5318550	2/2017	S21-PMC5318550	['the MAJORITY of studies focused on maternal influenza as the primary cause for a higher prevalence of schizophrenia ASSOCIATED with certain Birth months.3poor Prenatal nutrition HAS BEEN PROPOSED to be RELATED to the Birth seasonality of Individuals who develop schizophrenia.4\nadverse Birth outcomes are RISK FACTORS for impaired Cognitive Development.56PREVIOUS STUDIES have repeatedly described RELATIONSHIPS between season of Birth and Birth weight, and duration of Gestation.7\nRECENTLY, a strong INTEREST in the EFFECTS of Vitamin D on development of the Brain emerged.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 398), ('INCOMPLETE_EVIDENCE', 482), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 517)]	11	[('GO_0007567', 'parturition', 140, 'birth'), ('GO_0007565', 'female pregnancy', 159, 'prenatal'), ('GO_0007567', 'parturition', 217, 'birth'), ('NCBITaxon_1', 'root', 238, 'individuals'), ('GO_0007567', 'parturition', 286, 'birth'), ('GO_0050787', 'detoxification of mercury ion', 331, 'cognitive development'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007567', 'parturition', 440, 'birth'), ('GO_0007565', 'female pregnancy', 470, 'gestation'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('UBERON_0000955', 'brain', 560, 'brain')]
S13-PMC5340372	PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]
S16-PMC5340372	PMC5340372	3/2017	S16-PMC5340372	['measurements of Vitamin D Serum level 25-Hydroxyvitamin D [25(Oh)D] have yielded CONFLICTING results regarding the RELATIONSHIP between maternal- or Cord-Blood levels and subsequent Asthma Development [6–15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 38, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('UBERON_0000178', 'blood', 154, 'blood'), ('GO_0035801', 'adrenal cortex development', 182, 'asthma development')]
S99-PMC5340372	PMC5340372	3/2017	S99-PMC5340372	['Animal STUDIES have FOUND that Vitamin D deficiency CAN cause deficits in Lung function, which CAN be EXPLAINED by a change in Lung Development [32].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 102)]	5	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0002048', 'lung', 74, 'lung'), ('GO_0030324', 'lung development', 127, 'lung development'), ('UBERON_0002048', 'lung', 127, 'lung')]
S10-PMC5351212	PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
S25-PMC5351212	PMC5351212	3/2017	S25-PMC5351212	['another epidemiologically valid developmental RISK FACTOR for later psychiatric disease is developmental Vitamin D (Dvd) deficiency [22].']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 116, 'DVD')]
S27-PMC5351212	PMC5351212	3/2017	S27-PMC5351212	['Birth cohort studies have provided EVIDENCE that maternal Vitamin D deficiency is ASSOCIATED with a range of later autism-related outcomes including impaired Language Development [24] and Cognitive Development in offspring [25].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 158, 'language development'), ('GO_0050787', 'detoxification of mercury ion', 188, 'cognitive development')]
S34-PMC5351212	PMC5351212	3/2017	S34-PMC5351212	['developmental Vitamin D deficiency HAS further BEEN shown to induce persistent alterations in Immune function, by increasing central Immune Organ size and inducing a pro-inflammatory Lymphocyte phenotype [32].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0000945', 'stomach', 133, 'immune organ'), ('CL_0000542', 'lymphocyte', 183, 'lymphocyte')]
S35-PMC5351212	PMC5351212	3/2017	S35-PMC5351212	['THEREFORE, inflammatory factors produced early in Brain Development EITHER directly, by inducing mia, OR indirectly, by the maternal absence of a potent anti-inflammatory factor such as Vitamin D MAY, REPRESENT a CONVERGENT pathway towards developmental Brain abnormalities and psychiatric conditions later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 201), ('SUPERFICIAL_RELATIONSHIP', 213)]	5	[('GO_0007420', 'brain development', 50, 'brain development'), ('UBERON_0000955', 'brain', 50, 'brain'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0000955', 'brain', 254, 'brain'), ('UBERON_0000104', 'life cycle', 310, 'life')]
S36-PMC5351212	PMC5351212	3/2017	S36-PMC5351212	['INITIAL EVIDENCE for this HYPOTHESIS stems from PREVIOUS OBSERVATIONS SHOWING Prenatal poly(I:c)-induced mia, and developmental Vitamin D deficiency in rodents produce an overlapping spectrum of long-term behavioral abnormalities and early molecular changes in the fetal Brains [33–37].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 70)]	5	[('GO_0007565', 'female pregnancy', 78, 'prenatal'), ('CHEBI_16382', 'iodide', 92, 'I:'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0000955', 'brain', 271, 'brains')]
S3-PMC5372327	PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]
S6-PMC5372327	PMC5372327	3/2017	S6-PMC5372327	['discussion\nthe study ENABLES evaluation of short and long term EFFECTS of supplemental Vitamin D on growth, Immune functions and Skeletal and developmental parameters in infants, and the EFFECTS of Genetic FACTORS therein.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('UBERON_0004288', 'skeleton', 129, 'skeletal'), ('SO_0000704', 'gene', 198, 'genetic')]
S31-PMC5372327	PMC5372327	3/2017	S31-PMC5372327	['in infants, severe Vitamin D deficiency (<25\xa0nmol/l) ASSOCIATES with poor linear growth and delayed motor development POSSIBLY due to muscle weakness [16,17].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 118)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
S53-PMC5372327	PMC5372327	3/2017	S53-PMC5372327	['LITTLE EVIDENCE exists on the EFFECTS of Vitamin D on the Cognitive Development among children and adolescents.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 58, 'cognitive development')]
S57-PMC5372327	PMC5372327	3/2017	S57-PMC5372327	['ALTHOUGH PRELIMINARY results POINT to IMPORTANCE of early Life exposure, the ROLE of Vitamin D in Cognitive Development during childhood and Adolescence REMAINS LARGELY UNSTUDIED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 169)]	8	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 98, 'cognitive development'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence')]
S64-PMC5372327	PMC5372327	3/2017	S64-PMC5372327	['vdr polymorphisms together with Vitamin D supplementation AFFECT bone Mineral accrual SUGGESTING that Vitamin D supplementation COULD BE used to change the developmental trajectory and induce phenotype with lowered risk for chronic disease or disorder [59,60].']	[('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 128)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_46662', 'mineral', 70, 'mineral'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S1-PMC5385921	PMC5385921	4/2017	S1-PMC5385921	['the ASSOCIATION between Vitamin D deficiency during Gestation, a CRITICAL period in Neurodevelopment, and asd is NOT WELL UNDERSTOOD.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 65), ('FULL_UNKNOWN', 113)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'gestation'), ('GO_0007399', 'nervous system development', 84, 'neurodevelopment')]
S13-PMC5385921	PMC5385921	4/2017	S13-PMC5385921	['within the domain of nutritional exposures, there is GROWING INTEREST in the POSSIBLE LINKS between Gestational Vitamin D deficiency and an INCREASED RISK of asd.3–6this research HAS BEEN inspired BY Birth cohort studies, which have provided EVIDENCE that Prenatal Vitamin D deficiency (as assessed in maternal Sera) is ASSOCIATED with a range of later Brain-related outcomes including impaired Language Development7,8and Cognitive Development in offspring.9,10ALTHOUGH SEVERAL STUDIES HAVE REPORTED that Vitamin D deficiency or insufficiency is MORE COMMON in children with asd compared with controls,11few STUDIES addressed the specific HYPOTHESIS that Vitamin D deficiency during Gestation, a CRUCIAL time point in Neurodevelopment, is RELATED to the risk of subsequent asd.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 140), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 242), ('SUPERFICIAL_RELATIONSHIP', 320), ('ANOMALY_CURIOUS_FINDING', 459), ('INCOMPLETE_EVIDENCE', 470), ('INCOMPLETE_EVIDENCE', 486), ('PROBABLE_UNDERSTANDING', 546), ('INCOMPLETE_EVIDENCE', 608), ('INCOMPLETE_EVIDENCE', 639), ('IMPORTANT_CONSIDERATION', 696), ('SUPERFICIAL_RELATIONSHIP', 739)]	16	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('GO_0007565', 'female pregnancy', 256, 'prenatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'sera'), ('UBERON_0000955', 'brain', 353, 'brain'), ('GO_0001763', 'morphogenesis of a branching structure', 395, 'language development7'), ('GO_0050787', 'detoxification of mercury ion', 422, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 505, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 655, 'vitamin D'), ('GO_0007565', 'female pregnancy', 683, 'gestation'), ('GO_0007399', 'nervous system development', 718, 'neurodevelopment')]
S15-PMC5385921	PMC5385921	4/2017	S15-PMC5385921	['THIS STUDY REPORTED lower 25-Hydroxyvitamin D (25Ohd) concentrations in neonatal samples from the asd cases compared with their unaffected siblings.6RECENTLY, a chinese asd case–control study ( n =68 cases) compared first trimester (11–13 weeks) maternal 25Ohd concentrations and REPORTED significantly lower concentrations of 25Ohd in the asd cases compared with their gender- and age-matched controls.12\nwe RECENTLY REPORTED an ASSOCIATION between developmental Vitamin D deficiency and a measure of social impairment within the autism spectrum, based on a large dutch Birth cohort.13in this study, Vitamin D was measured at two occasions: at mid-Gestation and at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 280), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 430)]	7	"[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 26, '25-hydroxyvitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 47, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 255, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 327, '25OHD'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('GO_0007567', 'parturition', 571, 'birth'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0007565', 'female pregnancy', 649, 'gestation'), ('GO_0007567', 'parturition', 666, 'birth')]"
S18-PMC5385921	PMC5385921	4/2017	S18-PMC5385921	['we had the opportunity to explore the ASSOCIATION between developmental Vitamin D status and risk of asd, based on the same dutch Birth cohort in which we previously reported an ASSOCIATION between low mid-Gestational and neonatal Vitamin D concentrations and autistic traits.13within the cohort, we had access to an extensive set of POTENTIAL CONFOUNDING variables as well as the children’s individual-level Genome-wide genotype data.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 178), ('INCOMPLETE_EVIDENCE', 334), ('PROBLEM_COMPLICATION', 344)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth'), ('GO_0007565', 'female pregnancy', 206, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('SO_0001026', 'genome', 409, 'genome')]
S121-PMC5385921	PMC5385921	4/2017	S121-PMC5385921	['the FINDING from THIS STUDY LENDS weight to the GROWING BODY of epidemiological and Animal MODEL-based research LINKING Gestational Vitamin D deficiency and altered Brain Development.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 112)]	6	[('NCBITaxon_33208', 'Metazoa', 84, 'animal'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007420', 'brain development', 165, 'brain development'), ('UBERON_0000955', 'brain', 165, 'brain')]
S123-PMC5385921	PMC5385921	4/2017	S123-PMC5385921	['Rodent MODELS BASED ON transient Prenatal exposure to Vitamin D deficiency have FOUND a range of persistent molecular, neurochemical and behavioural changes of interest to neuropsychiatry.32a number OF STUDIES have LINKED asd with Neuronal Migration.33migration-ASSOCIATED phenotypes such as changes in Neuronal density and volume, aberrant Minicolumns and heterotopias HAVE BEEN detected in patients with asd.34,35as Neuronal Migration starts at 6 weeks Gestation and USUALLY ends around 24 weeks Gestation, the OBSERVED ASSOCIATION between our mid-Gestation samples, which were drawn at ~20 weeks Gestation, and risk of asd CORROBORATES our PREVIOUS FINDINGS LINKING Vitamin D deficiency with abnormal Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 215), ('SUPERFICIAL_RELATIONSHIP', 262), ('INCOMPLETE_EVIDENCE', 370), ('INCOMPLETE_EVIDENCE', 469), ('INCOMPLETE_EVIDENCE', 513), ('SUPERFICIAL_RELATIONSHIP', 522), ('INCOMPLETE_EVIDENCE', 626), ('INCOMPLETE_EVIDENCE', 643), ('SUPERFICIAL_RELATIONSHIP', 661)]	15	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rodent'), ('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0000540', 'neuron', 231, 'neuronal'), ('GO_0001764', 'neuron migration', 231, 'neuronal migration'), ('CL_0000540', 'neuron', 303, 'neuronal'), ('UBERON_0016512', 'lumen of duodenum', 341, 'minicolumns'), ('CL_0000540', 'neuron', 418, 'neuronal'), ('GO_0001764', 'neuron migration', 418, 'neuronal migration'), ('GO_0007565', 'female pregnancy', 455, 'gestation'), ('GO_0007565', 'female pregnancy', 498, 'gestation'), ('GO_0007565', 'female pregnancy', 550, 'gestation'), ('GO_0007565', 'female pregnancy', 599, 'gestation'), ('CHEBI_27300', 'vitamin D', 669, 'vitamin D'), ('GO_0007420', 'brain development', 704, 'brain development'), ('UBERON_0000955', 'brain', 704, 'brain')]
S124-PMC5385921	PMC5385921	4/2017	S124-PMC5385921	['furthermore, neonatal Vitamin D deficiency HAS been PREVIOUSLY ASSOCIATED with an increased risk of schizophrenia.36asd and schizophrenia are KNOWN to share Genetic risk variants;37our findings provide ADDITIONAL EVIDENCE of the shared risk ARCHITECTURE between these two Neurodevelopmental disorders.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 142), ('FUTURE_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 241)]	7	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000704', 'gene', 157, 'genetic'), ('GO_0007399', 'nervous system development', 272, 'neurodevelopmental')]
S132-PMC5385921	PMC5385921	4/2017	S132-PMC5385921	['DEFINING the precise CRITICAL window during which developmental Vitamin D deficiency adversely AFFECTS Brain Development at this stage would be premature.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007420', 'brain development', 103, 'brain development'), ('UBERON_0000955', 'brain', 103, 'brain')]
S140-PMC5385921	PMC5385921	4/2017	S140-PMC5385921	['developmental Vitamin D deficiency at mid-Gestation was ASSOCIATED with a twofold increased risk of asd.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'gestation')]
S141-PMC5385921	PMC5385921	4/2017	S141-PMC5385921	['the ASSOCIATION between developmental Vitamin D deficiency and asd MAY have IMPORTANT IMPLICATIONS from a PUBLIC HEALTH perspective.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 86), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
S8-PMC5405075	PMC5405075	4/2017	S8-PMC5405075	['the PREVENTION of Asthma Development is one of the MANY POTENTIAL health benefits of Vitamin D (6).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 56)]	3	[('GO_0035801', 'adrenal cortex development', 18, 'asthma development'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S11-PMC5405075	PMC5405075	4/2017	S11-PMC5405075	['several OBSERVATIONAL STUDIES explored THIS issue and SUGGESTED a PUTATIVE PROTECTIVE ROLE of Prenatal Vitamin D sufficiency in the development Of Wheezing and Asthma in the offspring [reviewed in ref.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0001503', 'ossification', 144, 'of wheezing'), ('GO_0006953', 'acute-phase response', 160, 'asthma')]
S13-PMC5405075	PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
S14-PMC5405075	PMC5405075	4/2017	S14-PMC5405075	['in THIS mini-REVIEW ARTICLE, we AIM to present the CURRENT KNOWLEDGE as it EMERGES from studies FOCUSED on the IMPACT of maternal Vitamin D status and Vitamin d supplementation on the Development Of Asthma in early childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 111)]	7	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 151, 'vitamin'), ('GO_0009602', 'detection of symbiont', 184, 'development of asthma')]
S30-PMC5405075	PMC5405075	4/2017	S30-PMC5405075	['Gestational Vitamin D has now been LINKED to a variety of diseases such as osteoporosis, Autoimmune disorders, altered Brain Development and Adult mental health, Food allergies, and asthma (17,29,31–33).']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('GO_0007420', 'brain development', 119, 'brain development'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('CHEBI_33290', 'food', 162, 'food')]
S36-PMC5405075	PMC5405075	4/2017	S36-PMC5405075	['mainly, the Food-approached studies have SUGGESTED a PROTECTIVE ROLE of Vitamin D Intake on the Development Of Wheezing and Asthma in offspring, with an attenuated effect after adjustment for multiple covariables (43–48).']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_33290', 'food', 12, 'food'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007631', 'feeding behavior', 82, 'intake'), ('GO_0098789', 'pre-mRNA cleavage required for polyadenylation', 96, 'development of wheezing'), ('GO_0006953', 'acute-phase response', 124, 'asthma')]
S10-PMC5418719	PMC5418719	5/2017	S10-PMC5418719	['DUE TO the POTENTIAL IMPACT of Vitamin D on many developmental processes in preterm infants, jobe et al.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
S11-PMC5418719	PMC5418719	5/2017	S11-PMC5418719	['[1] EMPHASIZED the FUNDAMENTAL BENEFITS of Vitamin D treatment for multiple developmental abnormalities, REFERRING to the high percentage of preterm infants with Blood Vitamin D levels\u2009<\u200920\xa0ng/ml [2].']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 105)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
S15-PMC5489519	PMC5489519	6/2017	S15-PMC5489519	['it HAS BEEN REPORTED that Vitamin D is INVOLVED in Mammary Gland Development and Lactation11.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0060611', 'mammary gland fat development', 51, 'mammary gland development'), ('UBERON_0001911', 'mammary gland', 51, 'mammary gland'), ('GO_0007595', 'lactation', 81, 'lactation11')]
S20-PMC5489519	PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]
S95-PMC5489519	PMC5489519	6/2017	S95-PMC5489519	['the functional ROLE of Vitamin D in fetus and infant’s Bone Development has been PREVIOUSLY demonstrated.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 81)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0048539', 'bone marrow development', 55, 'bone development')]
S99-PMC5489519	PMC5489519	6/2017	S99-PMC5489519	['THEREFORE, elevated levels of Trail Expression due to Vitamin D deficiency MAY have a significant IMPACT on both mother and infant bone Growth/Development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0040007', 'growth', 136, 'growth'), ('GO_0008289', 'lipid binding', 143, 'development')]
S107-PMC5489519	PMC5489519	6/2017	S107-PMC5489519	['THEREFORE, specific modulators of the Trail Signaling axis and Vitamin D analogs MAY lead to the development of randomized clinical trials to rescue from the consequences of Vitamin D deficiency in both mother and infant.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 81)]	2	[('GO_0038008', 'TRAF-mediated signal transduction', 38, 'TRAIL signaling'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 38, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
S116-PMC5513133	PMC5513133	7/2017	S116-PMC5513133	['EVIDENCE to SUPPORT the ROLE of Vitamin D in pe\nSEVERAL cohort and case control studies measuring Vitamin D before the development of pe SHOW an ASSOCIATION between Vitamin D and pe (tables2and3).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 145)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
S213-PMC5513133	PMC5513133	7/2017	S213-PMC5513133	['individuals receive the MAJORITY of their Vitamin D from sunlight, LINKING seasonality to the development of pe.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S4-PMC5521778	PMC5521778	7/2017	S4-PMC5521778	['alterations in this balance, including Vitamin A deficiency and gc excess, CONTRIBUTE to the development of chronic Lung disorders.']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('UBERON_0002048', 'lung', 116, 'lung')]
S137-PMC5521778	PMC5521778	7/2017	S137-PMC5521778	['suppression of Bco1 Expression and activity by Glucocorticoids\nsince Retinoids (Vitamin A) and Gcs play INTERACTIVE ROLES in Lung Development and Regeneration [40], we ASKED WHETHER gcs alter Carotenoid-to-Retinoid Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('EXPLICIT_QUESTION', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174)]	4	[('PR_000004693', 'Bcl-2-like protein 10', 15, 'BCO1'), ('GO_0010467', 'gene expression', 20, 'expression'), ('CHEBI_36597', 'phthalazine', 47, 'glucocorticoids'), ('CHEBI_26537', 'retinoid', 69, 'retinoids'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CL_0000740', 'retinal ganglion cell', 95, 'GCs'), ('GO_0060424', 'lung field specification', 125, 'lung development ... regeneration'), ('UBERON_0002048', 'lung', 125, 'lung'), ('CHEBI_23044', 'carotenoid', 192, 'carotenoid'), ('GO_0016116', 'carotenoid metabolic process', 192, 'carotenoid- ... metabolism'), ('CHEBI_26537', 'retinoid', 206, 'retinoid')]
S20-PMC5537904	PMC5537904	7/2017	S20-PMC5537904	['there is also a notable LACK OF study on body composition during infancy, a time in which Postnatal exposures (infant Vitamin D supplementation, Vitamin D-fortified formula use) MAY also play a PIVOTAL ROLE in Adiposity Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 178), ('IMPORTANT_CONSIDERATION', 194), ('SUPERFICIAL_RELATIONSHIP', 202)]	4	[('GO_0007567', 'parturition', 90, 'postnatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 210, 'adiposity development')]
S15-PMC5546866	PMC5546866	8/2017	S15-PMC5546866	['furthermore, ASSOCIATIONS between maternal Vitamin D status and obstetric COMPLICATIONS (4) and offspring Musculoskeletal Development (5–7) HAVE BEEN REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBLEM_COMPLICATION', 74), ('INCOMPLETE_EVIDENCE', 140)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0061375', 'mammillotectal axonal tract development', 106, 'musculoskeletal development'), ('UBERON_0002204', 'musculoskeletal system', 106, 'musculoskeletal')]
S99-PMC5659607	PMC5659607	10/2017	S99-PMC5659607	['the combined analysis of the Vitamin D intervention SHOWED no effect on development of elevated total Ige level (above the median): or = 0.90 (0.71 to 1.16), p = 0.46 ( table 4 ), i2= 0%, p = 0.46.']	[('INCOMPLETE_EVIDENCE', 52)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 102, 'IgE')]
S111-PMC5659607	PMC5659607	10/2017	S111-PMC5659607	['these analyses yielded results SIMILAR as the random effects meta-analyses (table 5), with or = 0.75 (0.57 to 0.97), p = 0.03 for development of asthma/recurrent wheeze.10.1371/journal.pone.0186657.t005\n\ncaption (table-wrap): table 5\nmeta-analyses of individual patient data (ipd), of Vitamin D vs. Placebo on the primary and secondary end-points at age 0–3.']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 299, 'placebo')]
S130-PMC5659607	PMC5659607	10/2017	S130-PMC5659607	['furthermore, including a third trial of Vitamin D supplementation in the meta-analysis, which intervened at a later Pregnancy stage (week 27) and with a much lower dose (800 iu/day) [22] also SHOWED an overall PROTECTIVE EFFECT of Vitamin D on Development Of Asthma/recurrent Wheeze.']	[('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 221)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0009602', 'detection of symbiont', 244, 'development of asthma'), ('GO_0006386', 'termination of RNA polymerase III transcription', 276, 'wheeze')]
S138-PMC5659607	PMC5659607	10/2017	S138-PMC5659607	['when the two trials were initiated, IT WAS THOUGHT that the EFFECTS of Vitamin D were confined to the Alveolar stage of Lung Development, occurring in the third Trimester of Pregnancy[28].']	[('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0003215', 'alveolus', 102, 'alveolar'), ('GO_0030324', 'lung development', 120, 'lung development'), ('UBERON_0002048', 'lung', 120, 'lung'), ('GO_0009294', 'DNA mediated transformation', 161, 'trimester'), ('GO_0007565', 'female pregnancy', 174, 'pregnancy')]
S140-PMC5659607	PMC5659607	10/2017	S140-PMC5659607	['THEREFORE, initiating the supplementation at 10–18 weeks’ Gestation in vdaart and in particular at 22–26 weeks’ Gestation in copsac2010was PRESUMABLY too late to achieve a maximal EFFECT of Vitamin D on fetal Lung Development.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 180)]	3	[('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007565', 'female pregnancy', 112, 'gestation'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_0030324', 'lung development', 209, 'lung development'), ('UBERON_0002048', 'lung', 209, 'lung')]
S141-PMC5659607	PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
S145-PMC5659607	PMC5659607	10/2017	S145-PMC5659607	['the LACK OF effect of the Vitamin D supplement among women with low 25(Oh)D levels at trial entry also SUGGESTS that the dose MIGHT have been too low to reverse developmental changes caused by insufficient Vitamin D exposure before the supplementation was initiated.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 126)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 74, 'D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
S115-PMC5664622	PMC5664622	9/2017	S115-PMC5664622	['THUS, we were unable to evaluate the RELATIONSHIP between Vitamin D levels and the development Of Gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0044477', 'envenomation resulting in negative regulation of platelet aggregation in other organism', 95, 'of GDM')]
S10-PMC5716389	PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
S31-PMC5716389	PMC5716389	9/2017	S31-PMC5716389	['Micronutrients\nseveral Micronutrients (Minerals or Vitamins) are KNOWN to be IMPORTANT in Fetal Immune System Development and child Immune Response to vaccines.table 1summarizes findings relevant to Immune functioning (zinc, Vitamin A, d, Folate, Iodine and Iron).']	[('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_33839', 'macromolecule', 23, 'micronutrients'), ('CHEBI_46751', 'quinolizidine', 39, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('UBERON_0000922', 'embryo', 90, 'fetal'), ('GO_0002520', 'immune system development', 96, 'immune system development'), ('UBERON_0002405', 'immune system', 96, 'immune system'), ('GO_0006955', 'immune response', 132, 'immune response'), ('UBERON_0002405', 'immune system', 132, 'immune'), ('UBERON_0002405', 'immune system', 199, 'immune'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 239, 'folate'), ('CHEBI_24859', 'iodine atom', 247, 'iodine'), ('CHEBI_24870', 'ion', 258, 'iron')]
S38-PMC5716389	PMC5716389	9/2017	S38-PMC5716389	['in fetal development, the ROLE of Vitamin A HAS BEEN RELATED to general Embryonic and fetal survival, Regulation Of Hematopoiesis and fetal growth.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007608', 'sensory perception of smell', 72, 'embryonic ...'), ('UBERON_0000922', 'embryo', 72, 'embryonic'), ('GO_1903706', 'regulation of hemopoiesis', 102, 'regulation of hematopoiesis')]
S41-PMC5716389	PMC5716389	9/2017	S41-PMC5716389	"[""FURTHER, Vitamin A IS NEEDED in the Development and functioning Of the Cell-Mediated and humoral Immune Systems, with deficiency at Birth POTENTIALLY reducing the infant's response to vaccines.""]"	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0009566', 'fertilization', 36, 'development ... of ...'), ('GO_0007464', 'R3/R4 cell fate commitment', 71, 'cell-mediated ... immune systems'), ('UBERON_0002405', 'immune system', 97, 'immune systems'), ('GO_0007567', 'parturition', 132, 'birth')]
S128-PMC5758521	PMC5758521	1/2018	S128-PMC5758521	['THUS, our OBSERVED negative ASSOCIATIONS of Cord Blood Vitamin E with leptin and adiponectin SUGGEST a POTENTIAL beneficial ROLE of Vitamin E in early Life in preventing the development of childhood obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('UBERON_0009472', 'axilla', 44, 'cord blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('UBERON_0000104', 'life cycle', 151, 'life')]
S131-PMC5758521	PMC5758521	1/2018	S131-PMC5758521	['a RECENT STUDY in Mice SUGGESTS that Vitamin A deficiency MAY AFFECT fetal Islet Development27.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 62)]	4	[('NCBITaxon_10088', 'Mus <genus>', 18, 'mice'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('CL_0000214', 'synovial cell', 75, 'islet'), ('GO_0036165', 'invasive growth in response to heat', 75, 'islet development27'), ('UBERON_0002533', 'post-anal tail bud', 75, 'islet')]
S20-PMC5784894	PMC5784894	1/2018	S20-PMC5784894	['[14]\nconsidered TOGETHER, THESE FINDINGS IMPLY that early Life Vitamin D exposure has EFFECTS that persist into childhood, MAY IMPACT on peak bone mass accrual and INFLUENCE subsequent bone loss, the development of osteoporosis and the risk of Life-limiting fracture.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000104', 'life cycle', 244, 'life')]
S20-PMC5838372	PMC5838372	3/2018	S20-PMC5838372	['the lack of Vitamin D during Pregnancy is the MOST IMPORTANT RISK FACTOR for infantile rickets and MAY also result in POOR fetal growth and Neonatal Development (8,9,10,11).']	[('PROBABLE_UNDERSTANDING', 46), ('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0021985', 'neurohypophysis development', 140, 'neonatal development')]
S17-PMC5841533	PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
S122-PMC5941617	PMC5941617	5/2018	S122-PMC5941617	['the same RECOMMENDATION HAS BEEN worldwide PROPOSED also by an expert position statement on Vitamin D in childhood [1], the department of nutrition for health and development of the world health organization [116], the espghan [19], the european academy of pediatrics [30], and the Vitamin D GUIDELINES for united arab emirates [27] and central europe [20].']	[('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 292)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
S134-PMC5941617	PMC5941617	5/2018	S134-PMC5941617	['Ketoconazole)• infants Born from mothers with multiple RISK FACTORS for Vitamin D deficiency, particularly in absence of Vitamin D supplementation during Pregnancy\n\npreterm\npreterm infants are AT RISK for Calcium-Phosphorus Metabolism alterations, with POSSIBLE development of osteopenia of prematurity [120].']	[('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 193), ('INCOMPLETE_EVIDENCE', 253)]	3	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('GO_0007567', 'parturition', 23, 'born'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_30272', 'arsonium', 205, 'calcium-phosphorus'), ('GO_0050655', 'dermatan sulfate proteoglycan metabolic process', 205, 'calcium-phosphorus metabolism')]
S251-PMC5941617	PMC5941617	5/2018	S251-PMC5941617	['among these, three italian STUDIES assessed bone Mineral status in infants using quantitative ultrasound [201–203], SUGGESTING that Vitamin D supplementation is IMPORTANT to provide an adequate Bone Development, PARTICULARLY in exclusively breastfed infants.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 212), ('IMPORTANT_CONSIDERATION', 212)]	5	[('CHEBI_46662', 'mineral', 49, 'mineral'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048539', 'bone marrow development', 194, 'bone development')]
S354-PMC5941617	PMC5941617	5/2018	S354-PMC5941617	['RECENTLY, litonjua SHOWED that Vitamin D has both in utero and post-Natal EFFECTS on Lung Development and Immune System Development and function [304].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'natal'), ('GO_0030324', 'lung development', 85, 'lung development'), ('UBERON_0002048', 'lung', 85, 'lung'), ('GO_0002520', 'immune system development', 106, 'immune system development'), ('UBERON_0002405', 'immune system', 106, 'immune system')]
S366-PMC5941617	PMC5941617	5/2018	S366-PMC5941617	['OBSERVATIONAL studies on the RELATIONSHIP between Vitamin D in Pregnancy and wheezing, asthma, and allergies Development in early Life SHOWED UNCLEAR results.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 135), ('FULL_UNKNOWN', 142)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('GO_0048513', 'animal organ development', 109, '... development'), ('UBERON_0000104', 'life cycle', 130, 'life')]
S391-PMC5941617	PMC5941617	5/2018	S391-PMC5941617	['HOWEVER, at LEAST two longitudinal STUDIES have CORRELATED the Vitamin D Cord Blood low levels to the development of ad in the offsprings, FINDING that low levels in the Cord Blood significantly increased the risk to develop the disease [347,348].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('UBERON_0009472', 'axilla', 170, 'cord blood')]
S422-PMC5941617	PMC5941617	5/2018	S422-PMC5941617	['IF data of OBSERVATIONAL studies in general population in infancy are ENCOURAGING, in the daisy study, conducted in subjects at higher RISK, the Vitamin D nutritional intake in the first years of Life as well as the Serum 25(Oh)D levels at 9\xa0months of age were not associated with the development of Autoantibodies or with the progression to t1dm [381].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('FUTURE_WORK', 70), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 216, 'serum'), ('CHEBI_71657', 'versiconol acetate', 222, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 222, '25 ... OH ... D'), ('GO_0044308', 'axonal spine', 300, 'autoantibodies')]
S609-PMC5941617	PMC5941617	5/2018	S609-PMC5941617	['moreover, the RECENTLY SUGGESTED ROLE of Vitamin D in the development of other non-Skeletal diseases reinforced the interest in the promotion of an adequate Vitamin D status during pediatric age.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S691-PMC5941617	PMC5941617	5/2018	S691-PMC5941617	['at PRESENT, there is NO EVIDENCE that Vitamin D supplementation MAY delay the development of t1dm or MAY ameliorate its clinical features.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
S112-PMC5952272	PMC5952272	5/2018	S112-PMC5952272	['while all Nutrients are IMPORTANT for Brain Development, certain Nutrients (eg, protein, Long-Chain polyunsaturated Fatty Acids, iron, copper, zinc, Iodine, Folate, Choline, and Vitamins A, B6, and B12) have particularly large EFFECTS early in Life and exhibit CRITICAL or sensitive periods for Neurodevelopment.8all highly Metabolic, rapidly developing Organs have high iron requirements BECAUSE iron supports fundamental Metabolic Processes.9early-Life id is PARTICULARLY DETRIMENTAL as this is a period of rapid Neurodevelopment.']	[('IMPORTANT_CONSIDERATION', 24), ('SUPERFICIAL_RELATIONSHIP', 227), ('IMPORTANT_CONSIDERATION', 261), ('PROBABLE_UNDERSTANDING', 389), ('ANOMALY_CURIOUS_FINDING', 461), ('IMPORTANT_CONSIDERATION', 474)]	6	[('CHEBI_33284', 'nutrient', 10, 'nutrients'), ('GO_0007420', 'brain development', 38, 'brain development'), ('UBERON_0000955', 'brain', 38, 'brain'), ('CHEBI_33284', 'nutrient', 65, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 89, 'long-chain'), ('CHEBI_35366', 'fatty acid', 116, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 149, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 157, 'folate'), ('CHEBI_15354', 'choline', 165, 'choline'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 178, 'vitamins A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 190, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 198, 'B12'), ('UBERON_0000104', 'life cycle', 244, 'life'), ('GO_0007399', 'nervous system development', 295, 'neurodevelopment'), ('GO_0008152', 'metabolic process', 324, 'metabolic'), ('UBERON_0000062', 'organ', 354, 'organs'), ('GO_0008152', 'metabolic process', 423, 'metabolic processes'), ('UBERON_0000104', 'life cycle', 450, 'life'), ('GO_0007399', 'nervous system development', 515, 'neurodevelopment')]
S141-PMC5952272	PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
S143-PMC5952272	PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]
S238-PMC5956785	PMC5956785	5/2018	S238-PMC5956785	['WHILE THIS REVIEW FOCUSED on Vitamin D status in children with jia, Vitamin D MAY BE INVOLVED in both disease development and subsequent disease activity status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 85)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
S239-PMC5956785	PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
S255-PMC5956785	PMC5956785	5/2018	S255-PMC5956785	['the ROLE of Genes in the Vitamin D pathway on both disease development and disease activity are still in the early stages of investigation.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('SO_0000704', 'gene', 12, 'genes'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
S258-PMC5956785	PMC5956785	5/2018	S258-PMC5956785	['UNDERSTANDING IF Genetic variants increase the risk of disease development will HELP tailor Vitamin D management in individual patients and CONTRIBUTE to improving Control of disease activity and improve outcomes.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'control')]
S261-PMC5956785	PMC5956785	5/2018	S261-PMC5956785	['this first step is IMPORTANT for the development of FUTURE STUDIES leading to the exploration of POTENTIAL OPTIMAL target concentrations of Vitamin D for the reduction of inflammation in children with chronic arthritis.']	[('IMPORTANT_CONSIDERATION', 19), ('FUTURE_WORK', 52), ('INCOMPLETE_EVIDENCE', 97), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
S284-PMC5956785	PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
S103-PMC6011374	PMC6011374	6/2018	S103-PMC6011374	['furthermore, studies HAVE SHOWN that Vitamin D supports early Placental Development [44,45] in which, abnormal Placentation CAN be a characteristic of a number of Pregnancy complications including gdm, pe, Sptb and sga [46].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0001890', 'placenta development', 62, 'placental development'), ('UBERON_0001987', 'placenta', 62, 'placental'), ('GO_0001890', 'placenta development', 111, 'placentation'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy'), ('PR_000015390', 'sterol O-acyltransferase 2', 206, 'sPTB')]
S69-PMC4600246	PMC4600246	10/2015	S69-PMC4600246	['the mechanisms responsible include (1) activation of growth-inhibiting proteins requiring Vitamin K2, such as prothrombin,62(2) Arylation pathways,63(3) activation of growth arrest Genes such as gas 6,64and (4) and increased C-Jun and C-Myc mrna Expression in Hepatoma Cells.57\npreventing the Recurrence of hcc is an IMPORTANT STRATEGY, ESPECIALLY CONSIDERING the fact that EVEN after patients undergo curative therapy recurrence rates REMAIN high.65while triple combination therapy with Boceprevir or Telaprevir, pegylated interferon (ifn) and Ribavirin is effective for the treatment of hepatitis c virus (Hcv), INFORMATION on preventing hcc development and/or recurrence as well as all-cause mortality is LACKING.6667moreover, this combination therapy is expensive, REQUIRES injections (ifn) and is OFTEN not well tolerated DUE TO adverse events (ie, fever and pancytopenia).']	[('IMPORTANT_CONSIDERATION', 317), ('FUTURE_WORK', 327), ('IMPORTANT_CONSIDERATION', 337), ('IMPORTANT_CONSIDERATION', 348), ('ANOMALY_CURIOUS_FINDING', 374), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 614), ('FULL_UNKNOWN', 708), ('INCOMPLETE_EVIDENCE', 708), ('IMPORTANT_CONSIDERATION', 769), ('PROBABLE_UNDERSTANDING', 802), ('PROBLEM_COMPLICATION', 827)]	12	[('CHEBI_28934', 'vitamin D2', 90, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 90, 'vitamin K2'), ('GO_0006915', 'apoptotic process', 128, 'arylation'), ('SO_0000704', 'gene', 181, 'genes'), ('PR_000004968', 'calretinin', 225, 'c-Jun'), ('PR_000000084', 'c-myc protein', 235, 'c-Myc'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CL_0000632', 'hepatic stellate cell', 260, 'hepatoma cells'), ('GO_0000003', 'reproduction', 293, 'recurrence'), ('CHEBI_68621', 'boceprevir', 488, 'boceprevir'), ('CHEBI_68593', 'eurysterol B(1-)', 502, 'telaprevir'), ('CHEBI_63580', 'ribavirin', 545, 'ribavirin'), ('NCBITaxon_10088', 'Mus <genus>', 608, 'HCV')]
